{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "tbsYqhxL07zc"
      },
      "source": [
        "# Treat Clinical notes\n",
        "\n",
        "**COLAB link** https://colab.research.google.com/github/samsung-ai-course/6-7-edition/blob/main/NLP/Computers%20dont%20read%20numbers/clinical_notes.ipynb"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "id": "b_BbqlmP07zi",
        "outputId": "62043b68-558f-4792-fc2f-432913a1f979",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt.zip.\n",
            "[nltk_data] Downloading package punkt_tab to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt_tab.zip.\n",
            "[nltk_data] Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]   Unzipping corpora/stopwords.zip.\n",
            "[nltk_data] Downloading package wordnet to /root/nltk_data...\n",
            "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
            "[nltk_data]     /root/nltk_data...\n",
            "[nltk_data]   Unzipping taggers/averaged_perceptron_tagger.zip.\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "execution_count": 1
        }
      ],
      "source": [
        "# Standard library imports\n",
        "import os\n",
        "import re\n",
        "import requests\n",
        "import pickle\n",
        "from tqdm import tqdm\n",
        "\n",
        "# Data manipulation libraries\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "\n",
        "# Data visualization libraries\n",
        "import matplotlib.pyplot as plt\n",
        "from wordcloud import WordCloud\n",
        "from PIL import Image\n",
        "\n",
        "# openAI API library\n",
        "from openai import OpenAI\n",
        "\n",
        "# NLTK imports\n",
        "import nltk\n",
        "from nltk import pos_tag\n",
        "from nltk.corpus import stopwords, wordnet\n",
        "from nltk.stem import WordNetLemmatizer\n",
        "\n",
        "# Download required NLTK data files (run only once)\n",
        "nltk.download('punkt')\n",
        "nltk.download('punkt_tab')\n",
        "nltk.download('stopwords')\n",
        "nltk.download('wordnet')\n",
        "nltk.download('averaged_perceptron_tagger')\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "uA1zdACq07zk"
      },
      "source": [
        "# Read files into a Data Frame"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "id": "KXMogJ1Y07zl",
        "outputId": "0fdc15b8-f6df-42db-8e2b-37bd9f197579",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "100%|██████████| 15/15 [00:03<00:00,  4.01it/s]\n"
          ]
        }
      ],
      "source": [
        "files_list = requests.get(\"https://raw.githubusercontent.com/samsung-ai-course/6-7-edition/refs/heads/main/NLP/Computers%20dont%20read%20numbers/directories.txt\")\n",
        "files_list  = files_list.text.split(\"\\n\")\n",
        "notes = []\n",
        "# run this cells only once this can be blocked by github if a lot of runs are tried\n",
        "for file in tqdm(files_list[:15]):\n",
        "\n",
        "    note = requests.get(\"https://raw.githubusercontent.com/samsung-ai-course/6-7-edition/refs/heads/main/NLP/Computers%20dont%20read%20numbers/data/\"+file)\n",
        "    notes.append(note.text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "metadata": {
        "id": "2lgMZt_707zm",
        "outputId": "27a4fb21-d464-446b-92a1-717bf87f86d0",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[\" \\nName:  ___                  Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nCodeine\\n \\nAttending: ___\\n \\nChief Complaint:\\nI feel shaky\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n \\nHistory of Present Illness:\\nPt is a ___ year old woman who presents to ED from opthomologists \\noffice after she began feeling shaky, nauseous and weak. Blood \\nsugar was noted to be 308 and she was sent to the ED. She felt \\nnauseous this morning and did not eat breakfast or take her \\nmedications, including her insulin. She notes she has been \\nfeeling generally weak for the last month and fatigued for about \\n6 months. She has been taking prednisone daily since a \\nhospitalization in ___ for PNA and new onset AFib. \\nAdditionally, she developed sunburn over both feet 5 weeks ago, \\nand developed ulcerating blisters for which she has been taking \\namoxicillin for the last 5 weeks. She has noted diarrhea with \\nthe amoxicillin. She denies recent fevers or chills. She \\nbelieves her foot blisters are healing and denies pain. No chest \\npain. Noticed foul smelling urine this morning.     \\n.  \\nIn the ED, initial vs were: T97.9 P 74 BP 150/60 R 18 O2 sat \\n97%2L. UA was notable for likely infection. Labs showed BG 361, \\nanion gap of 21, and positive ketones in the urine, and lactate \\nof 4.6. Patient was given her home insulin dose of 42 units \\n70/30 and 1 g ceftriaxone for presumed UTI. Pt recieved total of \\n2 L IVF's and her BG decreased to 254, gap reduced to 18 and \\nlactate decreased to 4.0. She was transferred to the floor for \\nfurther management.   \\n.  \\nReview of systems:  \\n(+) Per HPI. Also notes recent weight gain while on prednisone \\nalong with fatigue and weakness. \\n(-) Denies fever, chills, or recent weight loss. Denies \\nheadache, sinus tenderness, rhinorrhea or congestion. Denied \\ncough, shortness of breath. Denied chest pain or tightness, \\npalpitations. Denied arthralgias or myalgias.  \\n \\nPast Medical History:\\n-IDDM c/b retinopathy\\n-HTN\\n-AFib, diagnosed during hospitalization in ___\\n-s/p hysterectomy, rt breast benign tumor removal, and \\ndebridement of left foot infection \\n \\nSocial History:\\n___\\nFamily History:\\n- 6 children, one daughter died last year from ?complications of \\nhemachromatosis (runs in late husband's side of family)\\n- Mother died of complications of diabetes, another brother with \\nDM\\n- No known history of cardiovascular disease or stroke\\n \\nPhysical Exam:\\nFEX ON ADMISSION\\nVitals: T: 98.4 BP: 176/96 P: 86 R: 20 O2:  96%RA \\nGeneral: Pleasant elderly woman. Alert and oriented. Somewhat \\ntremulous but appears comfortable.  \\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated, diffusely enlarged nontender \\nthyroid   \\nLungs: Wet crackles at bases, Nonlabored and speaking in full \\nsentences.  \\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \\ngallops  \\nAbdomen: Obese, moderately distended. Positive bowel sounds. No \\nfluid shift noted. Non-tender, difficult to evaluate for \\norganomegaly  \\nExt: ___ nonpitting edema of lower extremities. No clubbing or \\ncyanosis. 1+ DP pulses. 2+ radial.\\nNeuro: CNs2-12 intact, Strength ___ throughout. No gross sensory \\nloss.\\nSkin: Poorly demarcated erythema over bilateral lower \\nextremities up to mid shin. 1-2cm healing ulcer on dorsum of \\nleft foot, and smaller 1 cm healing ulcer on dorsum of rt foot. \\nDiffusely dry skin with leathery changes over the waistband area \\non abdomen on right side.\\n\\nFEX ON DISCHARGE\\nVitals: T: 97.9 BP: 127/59 P: 73 R: 20 O2:  93%RA \\nGeneral: Pleasant elderly woman. Alert and oriented. \\nComfortable.\\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated, diffusely enlarged nontender \\nthyroid   \\nLungs: Wet crackles halfway up bilaterally, mild expiratory \\nwheeze anteriorly. Nonlabored and speaking in full sentences.  \\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \\ngallops  \\nAbdomen: Obese, moderately distended. Positive bowel sounds. No \\nfluid shift noted. Non-tender, difficult to evaluate for \\norganomegaly  \\nExt: ___ nonpitting edema of lower extremities. No clubbing or \\ncyanosis. 1+ DP pulses. 2+ radial.\\nNeuro: CNs2-12 intact, Strength ___ throughout. No gross sensory \\nloss.\\nSkin: Poorly demarcated erythema over bilateral lower \\nextremities up to mid shin. 1-2cm healing ulcer on dorsum of \\nleft foot, and smaller 1 cm healing ulcer on dorsum of rt foot. \\nDiffusely dry skin with leathery changes over the waistband area \\non abdomen on right side. \\n \\nPertinent Results:\\n___ 11:55AM BLOOD WBC-8.8 RBC-4.40 Hgb-14.6 Hct-40.3 MCV-92 \\nMCH-33.1* MCHC-36.1* RDW-13.5 Plt ___\\n___ 06:30AM BLOOD WBC-7.3 RBC-3.88* Hgb-12.8 Hct-35.0* \\nMCV-90 MCH-33.1* MCHC-36.7* RDW-13.7 Plt ___\\n\\n___ 03:30PM BLOOD ___ PTT-36.7* ___\\n___ 06:30AM BLOOD ___ PTT-36.0* ___\\n\\n___ 11:55AM BLOOD Glucose-361* UreaN-19 Creat-0.8 Na-136 \\nK-3.6 Cl-95* HCO3-24 AnGap-21*\\n___ 02:50PM BLOOD Glucose-306* UreaN-17 Creat-0.8 Na-137 \\nK-4.1 Cl-98 HCO3-25 AnGap-18\\n___ 06:30AM BLOOD Glucose-158* UreaN-11 Creat-0.6 Na-144 \\nK-4.2 Cl-105 HCO3-31 AnGap-12\\n\\n___ 06:30AM BLOOD Calcium-9.1 Phos-3.0 Mg-1.3*\\n\\n___ 02:59PM BLOOD pO2-78* pCO2-46* pH-7.37 calTCO2-28 Base \\nXS-0 Comment-GREEN TOP\\n\\n___ 02:59PM BLOOD Glucose-281* Lactate-4.6* Na-137 K-4.2 \\nCl-97*\\n___ 05:33PM BLOOD Glucose-254* Lactate-4.0*\\n___ 09:04PM BLOOD Lactate-3.4*\\n___ 07:27AM BLOOD Lactate-2.1*\\n\\n___ 02:10PM URINE Color-Yellow Appear-Clear Sp ___\\n___ 02:10PM URINE Blood-MOD Nitrite-POS Protein-30 \\nGlucose-500 Ketone-40 Bilirub-NEG Urobiln-0.2 pH-5.0 Leuks-NEG\\n___ 02:10PM URINE RBC-0 ___ Bacteri-MANY Yeast-NONE \\nEpi-0\\n\\n___ 2:10 pm URINE     Site: NOT SPECIFIED      OLD S# \\n___. \\n\\n                            **FINAL REPORT ___\\n\\n   URINE CULTURE (Final ___: \\n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \\nWITH FECAL\\n      CONTAMINATION. \\nECGStudy Date of ___  11:34:48 AM\\n \\nAtrial fibrillation with a controlled ventricular response. \\nNon-specific\\nST-T wave changes. No previous tracing available for comparison.\\n \\nRead ___.\\n ___\\n___\\nCXR ___\\n\\nFINDINGS: Frontal and lateral views of the chest were obtained. \\nThere are\\nslightly low lung volumes, which accentuate the bronchovascular \\nmarkings.\\nGiven this, no focal consolidation, pleural effusion, or \\npneumothorax is seen. Cardiac and mediastinal silhouettes are \\nunremarkable. There are aortic calcifications.\\nIMPRESSION: Low lung volumes which accentuate the \\nbronchovascular markings.\\nGiven this, no acute cardiopulmonary process.\\n \\nBrief Hospital Course:\\n___ year old woman with IDDM and AFib on coumadin who presents to \\nED from clinic after feeling nauseous, light headed, dizzy and \\nfound to have BG of 308.\\n\\nACTIVE PROBLEMS\\n\\n1. High blood sugar: Patient with long history of diabetes and \\ndifficult to control BS. Urine was positive for ketones in ED \\nwith BG >300 and anion gap of 21. Patient had been feeling \\nnauseated and did not eat or take her insulin on the morning of \\nadmission. She was given her home insulin dose of 44 units 70/30 \\nalong with 2L NS in the ED. On the floor she was continued on \\nhome insulin of 42 units 70/30 in the evening along with HISS. \\nBG morning of discharge was 158. K was trended and remained \\nstable.\\n\\n2. Elevated lactate: Lactate was 4.6 on admission. Etiology was \\nthought to be combination of increased diarrhea, possible UTI, \\nand dehydration due to elevated blood sugar. Patient was given \\n2L normal saline in the ED and an additional liter overnight. \\nMorning of discharge, lactate had trended down to 2.1 and \\npatient felt at her baseline.\\n\\n3. UTI: UA in the ED showed evidence of infection. She recieved \\n1 dose of ceftriaxone in ED and was transitioned to bactrim DS \\nbid on the floor. She was discharged to complete 5 days of \\ntreatment. Urine culture returned after discharge and showed \\nlikely fecal contamination.\\n\\n4. AFib: Patient found to be in atrial fibrillation with good \\nventricular rate control. She was maintained on home dose of \\nmetoprolol tartrate for rate control. She is on coumadin \\nprophylaxis and INR was noted to be 3.7 on admission. Coumadin \\nwas held and on day of discharge again noted to be high at 3.8. \\nPatient was instructed to again hold her coumadin dose and was \\ninstructed to follow closely with her ___ clinic and PCP.\\n\\n5. Foot ulcers: Appeared after sunburn 5 weeks ago. Blistered \\nand developed into weeping ulcers on dorsum of feet bilaterally \\nwith edema and poorly demarcated erythema. Has been on \\namoxicillin bid during this time during which patient developed \\ndiarrhea. Ulcers were shallow and appeared to be healing well. \\nDid not appear to be clinically infected and amoxicillin was \\ndiscontinued. Patient was started on bactrim for 5 days as \\nabove.\\n\\n6. Diarrhea: Appears to be side effect of amoxicillin. \\nConsidering lack of white count and nonmalignant course, there \\nwas low suspicion for CDiff. \\n\\nCHRONIC PROBLEMS\\n\\n1. HTN: Patient was hypertensive on floor night of admission to \\n170's SBP. She had not recieved home meds. She was given her \\nhome regimen of amlodipine 10, diovan 160, and metoprolol \\ntartrate 50 bid. She was normotensive day of discharge.\\n\\nOUTSTANDING STUDIES\\n-Blood cultures: No growth to date at time of writing\\n\\nTRANSITIONAL ISSUES\\n-Please check INR and adjust coumadin as needed as patient was \\nsupratherapeutic on admission and discharge.\\n \\nMedications on Admission:\\n- Metformin 1000bid\\n- Gabapentin 100qhs\\n- Metoprolol 50 bid\\n- Omeprazole 40 bid\\n- Torsemide 10 bid\\n- Amlodipine 10\\n- Diovan 160\\n- Warfarin 4mg daily\\n- Ativan 0.5 mg prn\\n- Insulin 70/30 44 qam and 42 with dinner\\n \\nDischarge Medications:\\n1. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID \\n(2 times a day).  \\n2. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO HS (at \\nbedtime) as needed for Insomnia.  \\n3. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  \\n\\n4. valsartan 160 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n5. insulin NPH & regular human 100 unit/mL (70-30) Suspension \\nSig: ___ (44) units Subcutaneous qam.  \\n6. insulin NPH & regular human 100 unit/mL (70-30) Suspension \\nSig: ___ (42) units Subcutaneous With dinner.  \\n7. gabapentin 100 mg Capsule Sig: One (1) Capsule PO HS (at \\nbedtime).  \\n8. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \\nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \\n9. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) \\nTablet PO BID (2 times a day) for 4 days.\\nDisp:*8 Tablet(s)* Refills:*0*\\n10. torsemide 5 mg Tablet Sig: Two (2) Tablet PO BID (2 times a \\nday).  \\n11. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a \\nday.  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nLactic acidosis\\nHyperglycemia\\nUrinary tract infection\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nDear Ms. ___,\\n\\nYou were admitted to ___ because you were feeling weak and \\nshaky at your eye doctor's office. We found that you had high \\nblood sugar along with a urinary tract infection. Additionally, \\na marker in your blood called lactate was elevated, which is \\nusually an indication that you aren't getting enough blood to \\nyour body. We gave you insulin and fluids and your blood sugar \\nand lactate levels came down nicely. Additionally, we gave you \\nantibiotics for your UTI, which you will need to take for four \\nmore days. Please note the following changes we have made to \\nyour medications:\\n\\nSTOP Amoxicillin\\nSTOP Prednisone\\nSTART Bactrim DS 1 tab twice daily for 4 more days\\n\\nPlease be sure to check your blood sugar regularly, and let your \\nprimary care doctor now if it gets above 300. Please note the \\nfollowing appointment with Dr. ___ have already \\nscheduled. It has been a pleasure taking care of you.\\n\\nYou should discuss with your primary care doctor why you are not \\non aspirin or a cholesterol medication, if you need these.\\n \\nFollowup Instructions:\\n___\\n\",\n",
              " \" \\nName:  ___                  Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nDemerol\\n \\nAttending: ___.\\n \\nChief Complaint:\\nDyspnea\\n \\nMajor Surgical or Invasive Procedure:\\nBronchoscopy\\n\\n \\nHistory of Present Illness:\\nThis is an ___ yo M with history of mild dementia, possible \\ndiastolic dysfunction, who is admitted with subjective shortness \\nof breath. The patient has been complaining to his outpatient \\nprovider about dyspnea, cardiac work up has been negative, so a \\nCT chest was ordered. There was no PE, however, there was \\nevidence of a large pulmonary mass with evidence of bony \\nmetastasis. He is admitted for further\\nwork up and evaluation. Of note, the family has requested that \\nthey tell the patient on their terms of his diagnosis, so at the \\ntime of this admission note, the patient is unaware of the CT \\nfindings.\\n\\nIn the ED, initial VS were stable, with respiratory rate < 18. \\nOn the floor, the patient continues to be stable with complaints \\nofmild dyspnea, which he notes is worse with exertion, \\nespecially with stair\\nclimbing. He says this has been going on for months. He also \\nnotes a dry cough for about that long. He denies unintentional \\nweight loss, anorexia, nightsweats or other B symptoms. He \\ndenies sick contacts, fevers/chills or URI symptoms.\\n\\nROS:\\n(+) Per HPI\\n(-) Denies fever, chills, night sweats, recent weight loss or \\ngain. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denied chest pain or tightness, palpitations. Denied \\nnausea, vomiting, diarrhea, constipation or abdominal pain. No \\nrecent change in bowel or bladder habits. No dysuria. Denied \\narthralgias or myalgias.\\n \\nPast Medical History:\\ngastroesophageal reflux disease\\nhypercholesterolemia\\ns/p LGIB with discovery of large colonic lipoma at hepatic \\nflexure that was removed by right transverse colectomy in ___\\ntransurethral resection of prostate\\nTIA in ___\\nFrequent UTI's\\nLeft shoulder impingement syndrome/full thickness rotator cuff \\ntear\\n \\nSocial History:\\n___\\nFamily History:\\nstrong family history of diabetes mellitus, and \\nhypercholesterolemia. His sister deceased of ___ at age \\n___. Question of renal disease in the family.\\n \\nPhysical Exam:\\nVS: T 98.6max, 97.3current, BP ___, HR 79 RR 18, 02sat 97% on \\n2L\\nGEN: NAD, resting comfortably watching TV in chair, NC 02 on.\\nHEENT: Pupils unequel, R, RRL, Left surgical pupil. No \\ninjections, no icterus. OP wnl. Neck supple, nontender, no JVD, \\nno bruits.\\nPULM: mild dry cough, Bibasilar rales 112 way up back, no focal \\nfindings.\\nCARD: RRR, s 1, s2 wnl, no mlrlg\\nABD: obese, firm, nontender, BS+, midline surgical scar, old.\\nEXT: DP 1 +, 2+pitting edema up to knees\\nNEURO: CNII-XI1 intact. A+Ox3, poor memory.\\nPSYCH: appropriate affect\\n \\nPertinent Results:\\n___ 01:30PM BLOOD WBC-15.1* RBC-4.32* Hgb-13.1* Hct-38.3* \\nMCV-89 MCH-30.4 MCHC-34.2 RDW-13.9 Plt ___\\n___ 06:45AM BLOOD WBC-13.8* RBC-3.98* Hgb-12.1* Hct-35.4* \\nMCV-89 MCH-30.5 MCHC-34.3 RDW-14.5 Plt ___\\n___ 05:00AM BLOOD WBC-11.1* RBC-3.83* Hgb-11.5* Hct-34.0* \\nMCV-89 MCH-30.0 MCHC-33.8 RDW-14.4 Plt ___\\n___ 01:30PM BLOOD Neuts-54 Bands-9* ___ Monos-11 \\nEos-2 Baso-0 Atyps-1* Metas-3* Myelos-0\\n___ 01:30PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-1+ \\nMacrocy-NORMAL Microcy-NORMAL Polychr-1+ Schisto-1+\\n___ 01:30PM BLOOD PTT-24.2\\n___ 01:30PM BLOOD Plt Smr-LOW Plt ___\\n___ 08:00PM BLOOD ___ PTT-24.3 ___\\n___ 06:45AM BLOOD Plt ___\\n___ 05:00AM BLOOD Plt ___\\n___ 01:30PM BLOOD D-Dimer-4038*\\n___ 01:30PM BLOOD UreaN-41* Creat-1.4* Na-139 K-4.1 Cl-97 \\nHCO3-29 AnGap-17\\n___ 06:45AM BLOOD Glucose-90 UreaN-42* Creat-1.4* Na-139 \\nK-4.2 Cl-98 HCO3-29 AnGap-16\\n___ 05:00AM BLOOD Glucose-106* UreaN-47* Creat-1.3* Na-139 \\nK-4.3 Cl-96 HCO3-30 AnGap-17\\n___ 01:30PM BLOOD ALT-370* AST-342* CK(CPK)-139 \\nAlkPhos-136* TotBili-1.0 DirBili-0.7* IndBili-0.3\\n___ 06:45AM BLOOD ALT-394* AST-396* ___ \\nAlkPhos-145* TotBili-1.5\\n___ 06:45AM BLOOD Lipase-168*\\n___ 01:30PM BLOOD CK-MB-4 cTropnT-0.04* proBNP-146\\n___ 01:30PM BLOOD TotProt-6.5 Albumin-4.0 Globuln-2.5 \\nCalcium-9.9\\n___ 06:45AM BLOOD Albumin-3.9 Calcium-10.0 Phos-4.9* Mg-2.6\\n___ 05:00AM BLOOD Calcium-9.6 Phos-4.5 Mg-2.6\\n\\n___ ECG: Sinus tachycardia. Right bundle-branch block. T \\nwave abnormalities.\\nSince the previous tracing of ___ the rate is faster. \\nClinical correlation\\nis suggested.\\n\\n___ CT-Chest w/contrast, CT-ABD/PELV:\\nINDICATION: Shortness of breath, chest pain, malaise, fatigue.\\nCOMPARISON: None.\\nTECHNIQUE: Contrast-enhanced MDCT-acquired axial images of the \\nchest,\\nabdomen, and pelvis from the thoracic inlet to the pubic \\nsymphysis.\\nMultiplanar reformatted images were obtained.\\nCT OF THE CHEST WITH INTRAVENOUS CONTRAST: A 4.1 x 2.8 x 3.7 cm \\nmass-like\\nconsolidation in the posterior right lower lobe, with associated \\nright hilar\\nand mediastinal lymphadenopathy is worrisome for malignancy. The \\nlargest\\nlymph node is located in the lower right paratracheal station \\n(3:28) 3.2 x 3.0\\ncm; subcarinal station (3:43) 4.4 x 2.8 cm and right hilum \\n(3:39) 3.1 x 1.9\\ncm. There is no pleural or pericardial effusion. Dense \\natherosclerotic\\ncalcification is seen involving the aortic arch. The heart size \\nis normal.\\nThe central pulmonary arteries are opacified normally without \\nevidence of\\nfilling defect. Attenuation of the subsegmental branches of the \\nright lower\\nlobe pulmonary arteries on the early study, which is less \\nconspicuous on the\\ndelayed images is most likely related to perfusion abnormality \\nresulting from\\ncompression of the vessel by lymphadenopathy.\\nCT OF THE ABDOMEN WITH INTRAVENOUS CONTRAST: The liver shows \\nnumerous ill-\\ndefined hypodense lesions scattered throughout the liver, \\nworrisome for\\nmetastatic disease. The spleen, adrenal glands, and pancreas are \\nnormal.\\nThe kidneys enhance and excrete contrast symmetrically. Numerous \\nhypodensities\\nare identified in both kidneys. The largest in the upper pole of \\nthe right\\nkidney measures 2.3 cm and in the lower pole of the left kidney \\nmeasures 2.2\\ncm and most consistent with cysts; the remainder are too small \\nto\\ncharacterize.\\nThe intra-abdominal loops of large and small bowel maintain a \\nnormal caliber\\nwithout evidence of obstruction. Note is made of a small \\nduodenal\\ndiverticulum (6:45). Post- surgical changes related to resection \\nof a colonic\\nlipoma are identified adjacent to the proximal right colon.\\nThe abdominal aorta maintains a normal caliber. Aortic \\natherosclerotic\\ncalcification is moderate. The celiac axis, SMA, and ___ are \\npatent. There\\nis no lymphadenopathy, free air or free fluid.\\nCT OF THE PELVIS WITH INTRAVENOUS CONTRAST: The bladder, rectum, \\nand pelvic\\nloops of small bowel are normal. The prostate is enlarged and \\nmeasures 6.5\\ncm. There is sigmoid diverticulosis without evidence of \\ndiverticulitis. Note\\nis made of a fat-containing right inguinal hernia. There is no \\nfree fluid or\\nlymphadenopathy.\\nBONE WINDOWS: No suspicious lytic or sclerotic lesion is \\nidentified. Mild\\ndegenerative changes are seen involving the thoracolumbar lumbar \\nspine.\\n \\nIMPRESSION:\\n1. A 4.1 x 2.8 cm mass-like consolidation in the posterior \\naspect of the\\nright lower lobe, with associated right hilar and mediastinal \\nlymphadenopathy\\nsuggests primary lung malignancy with metastases.\\n2. Innumerable ill-defined hypodensities scattered throughout \\nthe liver\\nconsistent with metastatic disease.\\n3. No evidence of pulmonary embolus. Slight attenuation of the \\nsubsegmental\\npulmonary arteries involving the right lower lobe likely relates \\nto perfusion\\nabnormality secondary to compression of the proximal pulmonary \\nartery by\\nenlarged lymph nodes.\\n4. Numerous hypodense lesions in the kidneys, the largest of \\nwhich are most\\nconsistent with cysts. The remainder are too small to \\ncharacterize.\\n5. Post-surgical changes in the region of the proximal right \\ncolon,\\nconsistent with history of resection of colonic lipoma.\\n6. Scattered colonic diverticulosis without evidence of \\ndiverticulitis.\\n\\n___ Pathology\\nCytology ReportPRECARINAL LNProcedure Date of ___\\n  \\nREPORT APPROVED ___\\nSPECIMEN ___    ___    PRECARINAL LN\\n \\nSPECIMEN DESCRIPTION: Received bloody specimen in Cytolyt.\\n  Prepared 1 ThinPrep slide.\\n \\nCLINICAL DATA: ___ y/o with tobacco abuse, RLL mass and\\n  mediastinal lymphadenopathy.\\nPREVIOUS BIOPSIES:\\n___ SUBCARINAL LN\\nREPORT ___. ___\\n \\n___: FNA, Precarinal lymph node:\\n\\n  POSITIVE FOR MALIGNANT CELLS, consistent with metastatic\\n  small cell carcinoma.\\n\\n___\\nCytology ReportSUBCARINAL LNProcedure Date of ___\\n  \\nREPORT APPROVED ___\\nSPECIMEN ___    ___    SUBCARINAL LN\\n \\nSPECIMEN DESCRIPTION: Received bloody specimen in Cytolyt.\\n  Prepared 1 ThinPrep slide.\\n \\nCLINICAL DATA: ___ y/o with tobacco abuse, RLL mass and\\n  mediastinal lymphadenopathy.\\nREPORT ___. ___\\n \\n___: FNA, Subcarinal lymph node:\\n  \\n  POSITIVE FOR MALIGNANT CELLS, consistent with metastatic\\n  small cell carcinoma.\\n  \\n  Note: Drs. ___ and ___ were notified of the\\n  results via email on ___ by Dr. ___.\\nDIAGNOSED BY:\\n___, CT(___)\\n___, M.D.\\n\\n___ Pathology\\nytology ReportBRONCHIAL WASHINGSProcedure Date of ___\\n  \\nREPORT APPROVED ___\\nSPECIMEN ___    ___    BRONCHIAL WASHINGS\\n \\nSPECIMEN DESCRIPTION: Received 25ml pink fluid.\\n  Prepared 1 ThinPrep slide.\\n  BAL RLL specimen.\\n \\nCLINICAL DATA: ___ y/o with tobacco abuse, RLL mass and\\n  mediastinal lymphadenopaty.\\nPREVIOUS BIOPSIES:\\n___ BRONCHIAL BRUSHINGS\\n___ SUBCARINAL LN\\nREPORT ___. ___\\n \\n___: Bronchial BAL RLL:\\n  \\n  NEGATIVE FOR MALIGNANT CELLS.\\n  \\n  Pulmonary macrophages, squamous cells, and bronchial\\n  epithelial cells.\\n  \\n  Note: Drs. ___ and ___ were notified of the\\n  results via email on ___ by Dr. ___.\\nDIAGNOSED BY:\\n___, CT(___)\\n___, M.D.\\n\\n___ ECHO\\nImpression:\\nThe left atrium is elongated. Left ventricular wall thicknesses \\nare normal. The left ventricular cavity size is normal. Left \\nventricular systolic function is hyperdynamic (EF 80%). Right \\nventricular chamber size and free wall motion are normal. The \\naortic root is mildly dilated at the sinus level. The aortic \\nvalve leaflets (3) are mildly thickened but aortic stenosis is \\nnot present. Trace aortic regurgitation is seen. The mitral \\nvalve leaflets are mildly thickened. There is no mitral valve \\nprolapse. Trivial mitral regurgitation is seen. There is mild \\npulmonary artery systolic hypertension. There is no pericardial \\neffusion. \\n\\n___ CT Head: \\nINDICATION: ___ man with new lung mass and likely liver \\nmets, history\\nof CVA, TIA symptoms in ___, to evaluate for large mass, mets.\\n \\nCOMPARISON: CT of the head done on ___.\\n \\nTECHNIQUE: Non-contrast CT of the head was performed.\\n \\nFINDINGS:\\n \\nThere is a small, 0.8 x 1.3 cm hyperdense extra-axial lesion in \\nthe right\\ninferior frontal lobe, adjacent to the coronal suture, causing \\nmild\\nindentation on the adjacent portion of the sylvian fissure. No \\nlarge area of\\nsurrounding edema is noted. There is no hyperostosis of the \\nadjacent bone.\\nThis is not definitely identifiable on the prior study of ___, \\nalthough a\\nsubtle focus is not excluded on that study. Prominent areas of \\nossification\\nfrom the inner table of the frontal bones can represent areas of \\nhyperostosis\\nor less likely ossified lesions. (series 2, image 16), slightly \\nmore prominent\\non the present study and may relate to the differences in the\\ngantry angulation.\\nThe ventricles and extra-axial CSF spaces are unremarkable. \\nAtherosclerotic\\nvascular calcifications are noted in the cavernous carotid \\narteries. The\\nvisualized portions of the paranasal sinuses are unremarkable.\\n \\nIMPRESSION:\\n1. 0.8 x 1.3 cm hyperdense extra-axial lesion in the right \\ninferior frontal\\nregion, which can represent a meningioma; other dural-based \\nneoplasms like\\nmetastasis, or lymphoma. Further evaluation with MR of the head \\nwithout and\\nwith IV contrast is necessary, for better assessment and to \\nexclude other\\nlesions. Given the lack of history of trauma, hematoma is less \\nlikely but not\\ncompletely excluded. No surrounding mass effect.\\n \\nFindings and recommendations were discussed with ___ by Dr. \\n___ on\\n___, around 4 p.m.\\n \\nBrief Hospital Course:\\n___ year old  male with complaints of dyspnea and malaise, found \\nto have a large mass in the posterior aspect of the right lower \\nlobe with hilar lymphadenopathy and evidence of liver \\nmetastasis. He was admitted to the medical service in stable \\ncondition. He had evidence of mild fluid overload and underwent \\ngentile diuresis. A bronchoscopy was performed to assess the \\nlung mass.\\n\\n# Pulmonary mass - likely primary malignancy with evidence \\nalready of lymphatic and bony mets. Calcium is stable. Pt \\nunderwent bronchoscopy on ___ showing LNs positive for \\nmalignant cells consistent with metastatic small cell carcinoma. \\nGiven the likely presence of liver metastases, an MRI was \\nordered, but despite premedication, he was not able to tolerate \\nthe procedure. After discussion with his family, an outpatient \\nMRI will be scheduled at a facility with an open MRI. A head CT \\nwas performed on ___ to assess for large mets (last HD CT \\n___ and showed a 1. 0.8 x 1.3 cm hyperdense extra-axial lesion \\nin the right inferior frontal region that will need to be \\nfurther assess on MRI. A cardiac ECHO was also perfomred on \\n___ showing an EF of 80% and no evidence of a pericradial \\neffusion. Followup for his new malignancy was planned with \\nThoracic Oncology. He continued to have an oxygen requirement in \\nthe hospital and home services of supplemental oxygen were \\narranged.\\n\\n# Transaminitis - Elevated LFTs on admission. Unclear etiology, \\nbut given findings on CT scan, is likely secondary to metastatic \\ninvasion of the liver. He had no abdominal pain or tenderness. \\nHis LFTs were trended and remained relatively stable over his \\nhospital admission. His statin was held.\\n\\n# Edema, possibly secondary to diastolic failure, however, his \\nECHO did not show evidence of failure. He was diuresed with some \\nimprovement of his symptoms. He was discharged home on lasix.\\n\\n# Acute Renal Failure - Baseline creatinine had previously been \\n1.0, and was 1.4 at admission. He did not appear dry and his \\ncardiac ECHO did not show significant failure. He was diuresed \\ngentely, and his Cr improved slightly to 1.3 prior to discharge. \\nHe was discharged on a lower dose of lasix and will follow up \\nwith his primary care physician.\\n \\nMedications on Admission:\\nTravaprost\\nLipitor\\nASA ___\\nMVI\\n \\nDischarge Medications:\\n1. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \\nPO DAILY (Daily).  \\n2. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n3. Travatan  Ophthalmic\\n4. home oxygen by nasal cannula\\nO2 at 2L NC continuous. Titrate as needed for O2Sat > 92. ___ \\nMD for O2 sat < 90. \\nConserving device for portable.\\n5. Lasix 20 mg Tablet Sig: Two (2) Tablet PO once a day.  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nLung mass\\nAcute renal failure\\nHypoxia\\n\\n \\nDischarge Condition:\\nStable, for home with services.\\n\\n \\nDischarge Instructions:\\nYou were admitted to the hospital because of your symptoms of \\nshortness of breath and because of the findings of a mass on \\nyour CT scan of your lungs. The CT scan also showed changes to \\nyour liver that may be related to the mass in your lung.\\n\\nYour blood work showed some worsening of your kidney function, \\nwhich improved somewhat during your stay. Your diuretics (water \\npills) were stopped becuase of your kidney function. You were \\nrestarted on a lower dose of lasix, and should discuss returning \\nto your regular dose with your PCP.\\n\\nYou had a bronchoscopy in order to diagnose the mass in your \\nlung. The results will take several days and you will need to \\nfollow up with Thoracic Oncology to discuss the results.\\n\\nYou also had an echocardiogram to examine your heart function \\nthat did not show any heart failure as a cause for your \\nshortness of breath.\\n\\nYou had a head CT-scan which showed a small abnormal finding \\nthat needs to be followed up by MRI. You should discuss the \\nscheduling of an outpatient open-MRI with your PCP ___ \\nThoracic Oncology.\\n\\nYou continued to require oxygen while in the hospital and will \\nneed to continue using oxygen at home. Home services for oxygen \\nwere arranged for you.\\n\\nYour lipitor was stopped due to the elevation of your liver \\nblood tests. Please discuss restarting this medication with your \\nPCP at your followup visit.\\n\\nPlease ___ your doctor or go to the ER for:\\n-chest pain\\n-worsening shortness of breath\\n-fever or shaking chills\\n-severe HA\\n-severe nausea or vomitting\\n-changes in mental status or lethargy\\n-any new or concerning symptoms\\n\\n \\nFollowup Instructions:\\n___\\n\",\n",
              " ' \\nName:  ___                  Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: ORTHOPAEDICS\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___.\\n \\nChief Complaint:\\nRLE pain\\n \\nMajor Surgical or Invasive Procedure:\\nRight short trochanteric fixation nail\\n\\n \\nHistory of Present Illness:\\n___, blown over by gust of wind w/R ITFx now s/p short TFN\\n \\nPast Medical History:\\nMedHx:\\n-HTN\\n-Hypercholesterolemia\\n-Eczema\\n-Osteopenia\\n-Diverticulosis\\n-Hyperparathyroidism\\n-Mild aortic stenosis\\n-Hypothyroidism\\nSurgHx:\\n-Appendectomy \\n-___ procedure for squamous cell carcinoma\\n \\nSocial History:\\n___\\nFamily History:\\nMother deceased with HTN, CAD. Father deceased with gastric \\ncancer. Sister generally healthy. \\n \\nBrief Hospital Course:\\nThe patient presented to the emergency department and was \\nevaluated by the orthopedic surgery team. The patient was found \\nto have right intertrochanteric femur fracture and was admitted \\nto the orthopedic surgery service. The patient was taken to the \\noperating room on ___ for right short trochanteric fixation \\nnail, which the patient tolerated well. For full details of the \\nprocedure please see the separately dictated operative report. \\nThe patient was taken from the OR to the PACU in stable \\ncondition and after satisfactory recovery from anesthesia was \\ntransferred to the floor. The patient was initially given IV \\nfluids and IV pain medications, and progressed to a regular diet \\nand oral medications by POD#1. The patient was given \\n___ antibiotics and anticoagulation per routine. The \\npatient\\'s home medications were continued throughout this \\nhospitalization. The patient worked with ___ who determined that \\ndischarge to rehab was appropriate. The ___ hospital \\ncourse was otherwise unremarkable.\\n\\nAt the time of discharge the patient\\'s pain was well controlled \\nwith oral medications, incisions were clean/dry/intact, and the \\npatient was voiding/moving bowels spontaneously. The patient is \\nweight bearing as tolerated in the right lower extremity, and \\nwill be discharged on Lovenox for DVT prophylaxis. The patient \\nwill follow up with Dr. ___ routine. A thorough \\ndiscussion was had with the patient regarding the diagnosis and \\nexpected post-discharge course including reasons to call the \\noffice or return to the hospital, and all questions were \\nanswered. The patient was also given written instructions \\nconcerning precautionary instructions and the appropriate \\nfollow-up care. The patient expressed readiness for discharge.\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Atorvastatin 40 mg PO QPM \\n2. Furosemide 20 mg PO DAILY \\n3. Hydrocortisone Oint 2.5% 1 Appl TP AS NEEDED FOR RASH ON FACE \\n\\n4. Levothyroxine Sodium 50 mcg PO DAILY \\n5. Lisinopril 40 mg PO DAILY \\n6. Metoprolol Succinate XL 25 mg PO DAILY \\n7. Omeprazole 20 mg PO DAILY \\n8. Acetaminophen ___ mg PO DAILY:PRN Pain - Mild \\n9. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 \\nmg(1,500mg) -400 unit oral 2 tabs daily  \\n10. Ferrous Sulfate 325 mg PO BID \\n11. Fexofenadine 180 mg PO DAILY:PRN allergies \\n\\n \\nDischarge Medications:\\n1.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation  \\n2.  Calcium Carbonate 500 mg PO TID  \\n3.  Docusate Sodium 100 mg PO BID  \\n4.  Enoxaparin Sodium 30 mg SC Q24H \\nStart: Today - ___, First Dose: Next Routine Administration \\nTime \\nRX *enoxaparin 30 mg/0.3 mL 30 mg subcutaneous daily Disp #*28 \\nSyringe Refills:*0 \\n5.  OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN Pain \\nRX *oxycodone 5 mg 1 capsule(s) by mouth .___ tablet every 4 \\nhours Disp #*42 Capsule Refills:*0 \\n6.  Vitamin D 800 UNIT PO DAILY  \\n7.  Acetaminophen ___ mg PO DAILY:PRN Pain - Mild  \\n8.  Atorvastatin 40 mg PO QPM  \\n9.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 \\nmg(1,500mg) -400 unit oral 2 tabs daily   \\n10.  Ferrous Sulfate 325 mg PO BID  \\n11.  Fexofenadine 180 mg PO DAILY:PRN allergies  \\n12.  Furosemide 20 mg PO DAILY  \\n13.  Hydrocortisone Oint 2.5% 1 Appl TP AS NEEDED FOR RASH ON \\nFACE  \\n14.  Levothyroxine Sodium 50 mcg PO DAILY  \\n15.  Lisinopril 40 mg PO DAILY  \\n16.  Metoprolol Succinate XL 25 mg PO DAILY  \\n17.  Omeprazole 20 mg PO DAILY  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nright intertrochanteric femur fracture\\n\\n \\nDischarge Condition:\\nAAOx3, mentating appropriately, NVI\\n\\n \\nDischarge Instructions:\\nWeigh yourself every morning, call MD if weight goes up more \\nthan 3 lbs.\\nINSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:\\n\\n- You were in the hospital for orthopedic surgery. It is normal \\nto feel tired or \"washed out\" after surgery, and this feeling \\nshould improve over the first few days to week. \\n- Resume your regular activities as tolerated, but please follow \\nyour weight bearing precautions strictly at all times.\\n\\nACTIVITY AND WEIGHT BEARING:\\n- weight bearing as tolerated\\n\\nMEDICATIONS:\\n- Please take all medications as prescribed by your physicians \\nat discharge.\\n- Continue all home medications unless specifically instructed \\nto stop by your surgeon.\\n- Do not drink alcohol, drive a motor vehicle, or operate \\nmachinery while taking narcotic pain relievers.\\n- Narcotic pain relievers can cause constipation, so you should \\ndrink eight 8oz glasses of water daily and take a stool softener \\n(colace) to prevent this side effect.\\n\\nANTICOAGULATION:\\n- Please take Lovenox daily for 4 weeks\\n\\nWOUND CARE:\\n- You may shower. No baths or swimming for at least 4 weeks.\\n- Any stitches or staples that need to be removed will be taken \\nout at your 2-week follow up appointment.\\n- Please remain in your dressing and do not change unless it is \\nvisibly soaked or falling off.\\n\\nPhysical Therapy:\\nweight bearing as tolerated RLE\\nrange of motion as tolerated RLE\\nTreatments Frequency:\\nchange dressing every ___ days as needed\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___                     Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\nAttending: ___.\\n \\nChief Complaint:\\nLow Back ___\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n \\nHistory of Present Illness:\\n___ year old male with chief complaint of severe R leg ___, \\nnumbness and weakness, which he has had for the past 6 weeks. \\nThe symptoms have been slowly progressive. He describes burning \\nsharp ___ that radiates from the right hip to the right knee. \\nHis symptoms were not helped or worsened by anything until \\nyesterday evening when he stopped being able to ambulate due to \\nthe ___. He denies incontinence of urine and bowel. Denies \\nhistory of injury. He also is not taking any anticoagulants, and \\ndoes NOT endorse any IVDU, nor any personal or familial h/o \\ncancer or bone disease.  \\n.  \\nHe went to the ED on ___, and again on ___ \\n- during which he was perscribed valium, ibuprofen, ultram, \\ndilaudid, percocet, a short course of prednisone, and physical \\ntherapy without much help. He states he has similar ___ a year \\nago, for which he was seen on ___ in the context of \\nlifting a heavy trash bag at home (relieved with ibuprofen \\nalone). Looking even further into his chart, he has been having \\nepisodic episodes of similar symptoms for several years, during \\nwhich he has been seen by orthopedics and has received several \\nXR/MRIs of his Lumbar spine beginning in ___.  \\n.  \\nOne day prior to admission he presented to the ED for similar \\nsymptoms and had a Spine consult, a U/A and ___ control. \\nNeurosurgery assessed the patient and decided that the patient \\ndid NOT have pathology amenable to surgical intervention. His \\nmost recent MRI on ___: demonstrated Lumbar spine MRI \\ndisclosed worsening L3-4 R side disc herniation associated with \\nsevere narrowing of R foramen. He has a follow up with the ___ \\nclinic on ___, which is the soonest the appointment could be \\nscheduled. Patient reports taking all ___ medications \\nprescribed from ED yesterday w/o effect.  \\n.  \\nIn the ED: VS: ___. He was treated with \\nMorphine 8mg IV, Toradol 30mg IM, and Dilaudid 2mg IV with good \\neffect. When he arrived to the floor, the patient appears \\ncomfortable and in NAD.  \\n.  \\n\\n \\nPast Medical History:\\n- Hypercholesterolemia  \\n- Insomnia  \\n- Hemorrhoids  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nDM, no CA, no blood disorders.\\n \\nPhysical Exam:\\nVS: ___  \\nGEN: Comfortable and in NAD  \\nHEENT: NC/AT, MMM, OP clear, no LAD  \\nCV: RRR, nl S1 and S2, no MRG  \\nPULM: CTA-B  \\nABD: Soft, NT/ND, BS+, no HSM  \\nEXT: No muscle wasting, no midline back tenderness, TTP over \\nmusculature of the right femur. Reflexes are ___: patellar, \\nachilles and downward going toes; Normal rectal tone; sensation \\nis \"altered\" but present; strength of the LLE is normal and of \\nthe RLE is ___ with strong encouragement, but with significant \\n___. \\n\\n \\nPertinent Results:\\n___ 02:55PM   GLUCOSE-120* UREA N-24* CREAT-0.9 SODIUM-138 \\nPOTASSIUM-4.3 CHLORIDE-101 TOTAL CO2-28 ANION GAP-13\\n___ 02:55PM   estGFR-Using this\\n___ 02:55PM   WBC-9.7# RBC-4.92 HGB-15.9 HCT-44.2 MCV-90 \\nMCH-32.4* MCHC-36.1* RDW-12.8\\n___ 02:55PM   NEUTS-81.2* BANDS-0 LYMPHS-13.2* MONOS-3.2 \\nEOS-0.4 BASOS-0.3\\n___ 02:55PM   PLT COUNT-195\\n___ 12:20PM URINE  COLOR-Yellow APPEAR-Clear SP ___\\n___ 12:20PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \\nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 \\nLEUK-NEG\\n \\nBrief Hospital Course:\\n___ year old male with chief complaint of severe R leg ___, \\nnumbness and weakness, unable to ambulate.  \\n.  \\n# Leg ___.  Monitor ___, labs, and obtained \\na CK all of which were normal.  Neurosurgery - nothing surgical \\nto do at this time.  Acute ___ service consulted.  Pt \\ntransitioned from Dilaudid PCA to PO Dilaudid in addition to \\nreceiving epidural injection.  ___ saw t/o hospitalization \\nwith improvement noted with pian control.   \\n.  \\n# Hypotension: Prerenal per labs, received narcotics, no fevers \\nor elevated WBC.  Fluid boluses and encouraged PO - pressures \\nnormalized.    \\n.  \\n# Hypercholesterolemia: Cont. on outpt regimen of simvastatin.  \\n.  \\n# PPx: SQH  \\n.  \\n# Code status: Full code  \\n.  \\n# Communication: with pt  \\n.  \\n# Disposition: D/c in improved condition. \\n\\n \\nMedications on Admission:\\nIbuprofen 600 mg Tablet by mouth 3 to 4 times day prn with meals \\n \\nSimvastatin 80 mg Tablet 1 Tab PO daily  \\nDilaudid PO 2mg Tabs 1 tab q6-8 hours  \\nPercocet ___ mg Tablet q6hrs  \\nDulcolax 100 mg Capsule PO twice a day for 1 weeks.  \\n\\n \\nDischarge Medications:\\n1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*2*\\n2. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday) as needed.\\nDisp:*60 Tablet(s)* Refills:*2*\\n3. Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY \\n(Daily).  \\n4. Tizanidine 2 mg Tablet Sig: One (1) Tablet PO TID (3 times a \\nday).\\nDisp:*90 Tablet(s)* Refills:*2*\\n5. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO TID (3 \\ntimes a day).\\nDisp:*180 Tablet(s)* Refills:*2*\\n6. Alum-Mag Hydroxide-Simeth 200-200-20 mg/5 mL Suspension Sig: \\n___ MLs PO QID (4 times a day) as needed.\\nDisp:*300 ML(s)* Refills:*1*\\n7. Ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 \\nhours): Please take the simethicone if you experience stomach \\nupset.  Take this medication with food.\\nDisp:*120 Tablet(s)* Refills:*2*\\n8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).\\nDisp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*2*\\n9. Hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q4H (every 4 \\nhours) as needed: Do not drive while taking this medication.\\nDisp:*30 Tablet(s)* Refills:*1*\\n10. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) \\nTablet, Chewable PO QID (4 times a day) as needed.\\nDisp:*60 Tablet, Chewable(s)* Refills:*1*\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary:\\nChronic Low Back ___\\n\\nSecondary: \\nHypercholesterolemia\\n\\n \\nDischarge Condition:\\nImproved\\n\\n \\nDischarge Instructions:\\nPlease continue to take the medications prescribed.  You have \\nbeen prescribed marcotic ___ medication.  Please take it as \\nneeded for your ___ control.  You should not attempt to drive \\nor operate heavy machinery when taking the narcotic ___ \\nmedication.\\n\\nYour back ___ is a chronic issue which will need further \\nfollow-up with your primary care doctor and the ___ clinic.\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___                   Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: PSYCHIATRY\\n \\nAllergies: \\nTrilafon / Paregoric / Pepto-Bismol / Depakote / Tegretol / \\nBromocriptine / Darvocet-N 50 / Clozaril / haloperidol\\n \\nAttending: ___\\n \\nChief Complaint:\\n\"I\\'m feeling kinda depressed...my memories of childhood\\nhaving flashbacks of my father things he did was awful..I was\\nhaving seizures and stuff I started reading and things were\\nblurry and I was dropping things and they were slipping out of \\nmy\\nhands...today I feel sh---y.\"\\n\\n \\nMajor Surgical or Invasive Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\nThe patient is a ___ yo woman, well known to Deaconess ___, \\npreviously diagnosed with schizoaffective disorder, s/p numerous \\npsychiatric hospitalizations, complex partial seizures who was \\nreferred to the ED for evaluation for ongoing seizure activity. \\n.\\nUpon initial interview, patient reports that she has been having \\nincreasing seizures for the past month. She reports that during \\nthe episode she will \"fade out\", have trouble reading due to \\nblurry vision, vertigo and slurry speech and related falls. She \\nalso reported ongoing auditory hallucinations telling her to \\nbite herself and had said that she needed to be \"sectioned\".\\n.\\nMs. ___ reports that she has been having \"flashbacks\" of her \\nchildhood abuse perpetrated by her father triggered by the \\nHolidays and watching children play with toys. She said \"today I \\nfel sh---y when the seizure started I kept blurring in and out \\nand the depression started with the Holiday Season.\"\\nShe states she spent ___ at her sister\\'s and felt that \\nher sister was ___ and said \" I couldn\\'t stand it and \\nit gets me angry\". She also said that her brother was irritating \\nher and she felt the urge \" to smash him or break something.\"\\n.\\nShe reports that she is having a flashback of one holiday when \\nher father was fighting over cider because he wasn\\'t served \\nfirst and he threw her bother on the porch and his shoes after \\nhim. She said \"my father was an ___\\nThe patient was not able to provide further details of what \\nother things might be triggering her today but reports that with \\nthe increased in seizure activity she has been having difficulty \\nremembering things, focussing has felt dizzy.\\n.\\nShe denies problems or changes in her sleep, reports decreased \\nappetite, poor energy, increased depression abnd irritability \\nand feels suicidal with no plan.\\n. \\n\\n \\nPast Medical History:\\nPAST PSYCHIATRIC HISTORY:\\nHospitalizations:Multiple, the most recent @ ___\\n___ and admitted to ___ ___ ? discharge\\ndates, over the years she has been admitted to ___\\nthis past ___.\\n___ in ___ after cutting her wrist with\\na safety pin while in a waiting room.\\nCurrent treaters and ___ ? last name, NP @ ___, Therapist ___ @ ___ in\\n___\\nMedication and ECT trials:\\nSelf-injury:hx of cutting an biting herself\\nHarm to others:Reported trying to kill her father by smashing \\nhis head against the ground in ___ after she was committed to\\na ___ hospital.\\nAccess to weapons: denies access to guns\\n\\nPAST MEDICAL HISTORY:\\nPCP ___ ___\\nNeurologist Dr. ___ ___\\n                                  \\nCOMPLEX PARTIAL SEIZURE DISORDER                                \\nHEADACHE                                              \\nHYPERLIPIDEMIA                                                  \\nHYPERTENSION                                                    \\nHYPOTHYROIDISM                                                  \\nKNEE PAIN                                                       \\nLEG PAIN                                                        \\nMORBID OBESITY                                                  \\nMUSCULOSKELETAL CHRONIC PARANOID                                \\nCOMPLEX PARTIAL SEIZURE DISORDER                                \\nHEADACHE                                                     \\nMORBID OBESITY                                                  \\nMUSCULOSKELETAL PAIN                                            \\nNAUSEA                                               \\nPPD POSITIVE                                                    \\nSYSTOLIC MURMURS                                                \\nURINARY INCONTINENCE                                            \\nOBSTRUCTIVE SLEEP APNEA                                         \\n___                                                             \\nCERVICALGIA                                                     \\nMIGRAINES                                                       \\nUTI                                                             \\nOLIGOMENORRHEA                                                  \\nPPD POSITIVE                                                    \\nSYSTOLIC MURMURS               \\n \\nSocial History:\\n___\\nFamily History:\\n* Father with suspected bipolar do\\n* Brother {___} with schizophrenia {deceased}\\n* Brother {___} with developmental delay\\n\\n \\nPhysical Exam:\\nVS:  BP:140/77    HR:88   temp:99.1    resp:16  O2 sat:100% RA  \\n\\nNeurological:  \\n *station and gait:unsteady ambulates with a walker \\n *tone and ___ strength in upper extremeties, lower\\nextremeties with bilateral edema\\n cranial nerves: not assessed\\n abnormal movements: none noted\\n frontal release:not assessed\\n\\nCognition: \\n Wakefulness/alertness:alert\\n *Attention (digit span, MOYB):MOYB\\n *Orientation:\" the ___ ___, its ___ I don\\'t know the\\ndate\" US.Pres.\"___\"\\n Executive function (go-no go, Luria, trails, FAS):not assessed\\n *Memory: 2 out of 3 in 5\"  \\n *Fund of knowledge:wnl \" the war in ___ and able to\\nname ___  \\n Calculations: 9 quarters =$2.25 \\n Abstraction: statues/paintings \"art\"\\n Visuospatial: not assessed\\n *Speech: somewhat difficult to understand sec to teeth missing\\nreports she is currently being treated for an oral abscess\\n *Language: intact\\n \\nMental Status:\\n *Appearance: ___ yo cauc. overweight female with disconjugate\\ngaze, wearing glasses with very short hair and fair hygiene and\\ngrooming, dressed in hospital gown and holding a small child\\'s\\nfootball and wearing a soft cervical collar\\n Behavior:calm and good control \\n *Mood and Affect:depressed and reports that she feels irritable\\nbut has full range\\n *Thought process / *associations: for the most part linear,\\nsomewhat tangential and is easily derailed  \\n *Thought Content: reports that she is hearing voices \"to bite\\nmyself\" denies VH, reports paranoid ideation of thinking that\\npeople are talking about her\\n *Judgment and Insight: limited/poor\\n\\n \\nPertinent Results:\\n___ 05:25PM   GLUCOSE-106* UREA N-7 CREAT-0.9 SODIUM-139 \\nPOTASSIUM-3.5 CHLORIDE-103 TOTAL CO2-26 ANION GAP-14\\n___ 05:25PM   ALT(SGPT)-15 AST(SGOT)-25 ALK PHOS-122* TOT \\nBILI-0.4\\n___ 05:25PM   CALCIUM-9.5 PHOSPHATE-3.7 MAGNESIUM-2.0\\n___ 05:25PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \\nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\\n___ 05:25PM   WBC-5.1 RBC-4.02* HGB-12.0 HCT-34.0* MCV-85 \\nMCH-29.8 MCHC-35.2* RDW-13.2\\n___ 05:25PM   NEUTS-69.4 ___ MONOS-6.1 EOS-1.0 \\nBASOS-0.3\\n___ 05:25PM   PLT COUNT-235\\n___ 02:55PM URINE  HOURS-RANDOM\\n___ 02:55PM URINE  UHOLD-HOLD\\n___ 02:55PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \\ncocaine-NEG amphetmn-NEG mthdone-NEG\\n___ 02:55PM URINE  COLOR-Straw APPEAR-Clear SP ___\\n___ 02:55PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \\nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \\nLEUK-NEG\\n \\nBrief Hospital Course:\\nLegal/Safety: The patient was admitted on a ___ and \\nsigned a CV once on the unit. She remained in good behavioral \\ncontrol throughout this hospitalization and did not require \\nphysical or chemical restraint. The patient remained on 15 \\nminute checks, which is our lowest acuity level of checks.\\n\\nPSYCHIATRIC\\n#)On admission, the patient reported more \"spacing out\" that she \\nattributed to seizures as well as confusion and auditory \\nhallucinations to harm herself.\\nDuring hospitalization, we decreased her lamictal, gabapentin \\nand seroquel due to concerns that this was causing an \\nencephalopathy. With these medication changes Ms. ___ felt much \\nbetter. \\nOn discharge, mood was good, MSE was pertinent for mostly linear \\nthought process with some tangential thoughts and perseveration. \\nShe denied SI or AVH.\\n\\nGENERAL MEDICAL CONDITIONS\\n#)UTI: patient was recently diagnosed with a UTI and prescribed \\nbactrim. This course was completed while admitted\\n#)HTN: Patient was continued on her home medications and blood \\npressure was well controled\\n#)Questions of Complex Partial Seizures: no seizures noted while \\nadmitted\\n#)Hypothyroidism: Continued home dose of levothyroxine\\n\\nPSYCHOSOCIAL\\n#) MILIEU/GROUPS\\nThe patient was highly animated, euthymic, and participatory in \\nthe milieu. The patient was very visible on the unit and \\nfrequently had conversations with her peers. She attended most \\ngroups. She never engaged in any unsafe behaviors. The pt ate \\nall meals in the milieu, slept well, and cooperated with unit \\nrules.\\n\\nRISK ASSESSMENT:\\nThis patient does not abuse substances, is not \\nsuicidal/homicidal, is feeling well and is animated, euthymic, \\nand participatory in the milieu, all of which indicate a low \\nimmediate risk of harm.\\nDespite history of assaultive behaviors, recent episodes of \\nagitation, active psychosis, current risk of harm to others is \\nlow/moderate given calm demeanor and well controled underlying \\nmental illness.\\n\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 2 \\npuffs q4-6 hours cough/wheezing \\n2. QUEtiapine extended-release 400 mg PO DAILY \\n3. Acetaminophen 650 mg PO Q6H:PRN pain/fever \\n4. Benztropine Mesylate 1 mg PO BID \\n5. Vitamin D 1000 UNIT PO DAILY \\n6. Diltiazem Extended-Release 180 mg PO DAILY \\n7. Gabapentin 900 mg PO TID \\n8. HydrOXYzine 50 mg PO QHS:PRN anxiety/insomnia \\n9. LaMOTrigine 250 mg PO BID \\n10. Levothyroxine Sodium 75 mcg PO DAILY \\n11. Meclizine 25 mg PO TID:PRN vertigo \\n12. Multivitamins 1 TAB PO DAILY \\n13. Naproxen 375 mg PO BID:PRN pain \\n14. Prochlorperazine 10 mg PO TID:PRN nausea/abdominal pain \\n15. Famotidine 20 mg PO BID:PRN reflux \\n16. Senna 8.6 mg PO BID:PRN constipation \\n17. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY \\n18. Sulfameth/Trimethoprim DS 1 TAB PO BID \\n19. Penicillin V Potassium 500 mg PO QID \\n20. ARIPiprazole 30 mg PO DAILY \\n21. Atorvastatin 20 mg PO QPM \\n\\n \\nDischarge Medications:\\n1. Acetaminophen 650 mg PO Q6H:PRN pain/fever \\n2. Diltiazem Extended-Release 180 mg PO DAILY \\n3. Famotidine 20 mg PO BID:PRN reflux \\n4. Gabapentin 600 mg PO TID \\nRX *gabapentin 600 mg 1 tablet(s) by mouth three times a day \\nDisp #*90 Tablet Refills:*0\\n5. HydrOXYzine 50 mg PO QHS:PRN anxiety/insomnia \\n6. LaMOTrigine 200 mg PO BID \\nRX *lamotrigine 200 mg 1 tablet(s) by mouth twice a day Disp \\n#*60 Tablet Refills:*0\\n7. Levothyroxine Sodium 75 mcg PO DAILY \\n8. Meclizine 25 mg PO TID:PRN vertigo \\n9. Naproxen 375 mg PO BID:PRN pain \\n10. Senna 8.6 mg PO BID:PRN constipation \\n11. Triamterene-HCTZ (37.5/25) 1 CAP PO DAILY \\n12. Vitamin D 1000 UNIT PO DAILY \\n13. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 2 \\npuffs q4-6 hours cough/wheezing \\n14. QUEtiapine Fumarate 300 mg PO QHS \\nRX *quetiapine [Seroquel] 100 mg 3 tablet(s) by mouth at bedtime \\nDisp #*30 Tablet Refills:*0\\n15. Multivitamins 1 TAB PO DAILY \\n16. ARIPiprazole 30 mg PO DAILY \\n17. Atorvastatin 20 mg PO QPM \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nmedication induced encephalopathy\\nschizoaffective disorder-Bipolar type\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\n-Please follow up with all outpatient appointments as listed - \\ntake this discharge paperwork to your appointments.\\n-Please continue all medications as directed.\\n-Please avoid abusing alcohol and any drugs--whether \\nprescription drugs or illegal drugs--as this can further worsen \\nyour medical and psychiatric illnesses.\\n-Please contact your outpatient psychiatrist or other providers \\nif you have any concerns.\\n-Please call ___ or go to your nearest emergency room if you \\nfeel unsafe in any way and are unable to immediately reach your \\nhealth care providers.\\n \\n*It was a pleasure to have worked with you, and we wish you the \\nbest of health.*\\n \\n\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___                       Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\n___ Decongestant\\n \\nAttending: ___\\n \\nChief Complaint:\\nExertional chest pain\\n \\nMajor Surgical or Invasive Procedure:\\nCoronary angiogram on ___\\n\\n \\nHistory of Present Illness:\\n___ ___ only, patient of Dr. ___, with premature\\n3v CAD (LAD 30% ISR, Cx 40-50% stenosis, ostial RCA stent ___\\nISR), HTN, HLD, DM2 presenting as transfer from ___ with\\nchest pain c/f unstable angina. \\n\\nDiscussed with patient and her family, daughter was translating\\nper patient preference.  Patient states that pain started on\\n___ while she was at rest.  Substernal chest pain, has been\\nintermittent since then.  Worsens with exertion.  At times\\nrelieved by rest, but not reliably.  Radiating down left arm.  \\nAt\\ntimes is it accompanied by nausea.  On ___, she also had a \\ndry\\ncough.  She also states that she feels dizzy when going from\\nsitting to standing.  Has not had any falls or loss of\\nconsciousness.\\n\\nOn review of systems, denies any other concerns including \\nfevers,\\nchills, recent cold, unintentional weight loss, shortness of\\nbreath, hemoptysis, calf pain, lower extremity swelling,\\northopnea, PND, palpitations.  No vomiting, diarrhea, dysuria,\\nabdominal pain.\\n\\nAt ___, she was admitted for telemetry monitoring, \\nserial\\ntroponins were negative and EKGs were unremarkable.  Her pain \\nwas\\nrelieved with sublingual nitro.  Her flu was negative, her\\nd-dimer was normal, and her chest x-ray was reported as clear. \\nHer white count was slightly low at 3.7.  Her other basic labs\\nwere unremarkable.  Her TSH was low at 0.18, with a normal free\\nT4 of 0.94\\n\\nAlthough she denied this when I spoke with her, she reported\\nfevers, chills to MD at ___, and in setting of cough, \\nshe\\nwas treated with ceftriaxone for bronchitis.  She also reported\\npolyuria, polydipsia, urgency, frequency, mild dysuria while she\\nwas there, which was also covered with ceftriaxone. Urine \\nculture\\nwas negative. Her A1c was 13% and her initial glucose was 511. \\n\\nDespite treatment for suspected URI, her chest pain did not\\nresolve, and cardiology at ___ was concerned that she might\\nneed a CABG and requested that she be transferred here for cath. \\n\\nIn her discharge summary, it states that she was \"stabilized on\\nPlavix\" however this is not mentioned in any other notes and was\\nnot listed on her discharge medications.\\n\\nAt ___, several changes were made to her medication list\\nincluding discontinuing her Crestor in favor of atorvastatin 80\\nmg, and increasing her Lopressor to 50 mg every 12 hours (from \\n50\\nmg daily). \\n\\n \\nPast Medical History:\\nCoronary artery disease/angina, S/P stenting of the LAD & RCA\\nHypertension\\nDiabetes mellitus\\nDyslipidemia\\n \\nSocial History:\\n___\\nFamily History:\\nThere is no family history of premature coronary artery disease \\nor sudden death.  Daughter has sickle cell trait. Multiple \\nfamily members with hypertension, DM, hyperlipidemia. Mother had \\nuterine cancer.\\n \\nPhysical Exam:\\nADMISSION PHYSICAL EXAM\\n=======================\\nVS: ___ 2335 Temp: 98.3 PO BP: 143/84 R Sitting HR: 72 RR:\\n16 O2 sat: 97% O2 delivery: ra FSBG: 299 \\nGENERAL: Well developed, well nourished, NAD, laying comfortably\\nHEENT: sclera anicteric, moist mucous membranes\\nNECK: JVP of 4 cm\\nCARDIAC: Regular rate and rhythm. Normal S1, S2. No murmurs,\\nrubs, or gallops. no thrills or lifts.\\nLUNGS: No chest wall deformities or tenderness. Respiration is\\nunlabored with no accessory muscle use.  Crackles at right base.\\nABDOMEN: Soft, non-tender, non-distended. \\nEXTREMITIES: Warm, well perfused. No cyanosis edema.\\nSKIN: No significant skin lesions or rashes.\\nNEURO: AOx3, ___ only, CNII-XII intact, ___ \\nstrength\\nx4 extremities \\n\\nDISCHARGE PHYSICAL EXAM\\n=======================\\n24 HR Data (last updated ___ @ 706)\\n    Temp: 98.0 (Tm 98.6), BP: 116/73 (116-143/73-84), HR: 73\\n(72-73), RR: 16, O2 sat: 95% (95-99), O2 delivery: Ra, Wt: \\n147.05\\nlb/66.7 kg  \\nGENERAL: NAD, laying comfortably\\nHEENT: sclera anicteric, moist mucous membranes\\nNECK: no JVD noted at 90 degrees.\\nCARDIAC: Regular rate and rhythm. Normal S1, S2. No murmurs,\\nrubs, or gallops. no thrills or lifts.\\nLUNGS: No chest wall deformities or tenderness. Respiration is\\nunlabored with no accessory muscle use.  lungs CTA bilaterally.\\nABDOMEN: Soft, non-tender, non-distended. \\nEXTREMITIES: Warm, well perfused. No cyanosis edema.\\nSKIN: No significant skin lesions or rashes.\\nNEURO: AOx3, ___ only, CNII-XII intact, ___ \\nstrength\\nx4 extremities \\n\\n \\nPertinent Results:\\nADMISSION LABS\\n==============\\n___ 12:14AM BLOOD WBC-4.8 RBC-4.51 Hgb-13.2 Hct-38.6 MCV-86 \\nMCH-29.3 MCHC-34.2 RDW-12.6 RDWSD-38.6 Plt ___\\n___ 12:14AM BLOOD Neuts-48.4 ___ Monos-10.8 Eos-2.9 \\nBaso-0.6 Im ___ AbsNeut-2.32 AbsLymp-1.78 AbsMono-0.52 \\nAbsEos-0.14 AbsBaso-0.03\\n___ 12:14AM BLOOD ___ PTT-33.5 ___\\n___ 12:14AM BLOOD Glucose-296* UreaN-16 Creat-0.8 Na-137 \\nK-4.5 Cl-105 HCO3-23 AnGap-9*\\n___ 12:14AM BLOOD ALT-22 AST-29 LD(LDH)-189 CK(CPK)-38 \\nAlkPhos-93 TotBili-0.2\\n___ 12:14AM BLOOD Albumin-3.8 Calcium-9.5 Phos-3.7 Mg-1.9\\n\\nDISCHARGE LABS\\n==============\\n___ 06:29AM BLOOD WBC-5.4 RBC-4.34 Hgb-12.8 Hct-38.3 MCV-88 \\nMCH-29.5 MCHC-33.4 RDW-12.6 RDWSD-40.5 Plt ___\\n___ 06:29AM BLOOD Glucose-150* UreaN-18 Creat-0.7 Na-142 \\nK-4.3 Cl-109* HCO3-22 AnGap-11\\n___ 12:14AM BLOOD CK-MB-<1 cTropnT-<0.01\\n\\nIMAGING\\n=======\\nCardiac Cath ___\\n\\x95 Normal left and right heart filling pressures.\\n\\x95 Three vessel coronary artery disease.\\n\\x95 Three vessel CAD unchanged from before. Negative iFR and IVUS \\nof pRCA do not explain rest\\nsymptoms.\\n\\nTTE ___\\nMildly dilated right ventricle with normal global and regional \\nbiventricular systolic function. Moderate functional tricuspid \\nregurgitation. EF 59%\\n\\n \\nBrief Hospital Course:\\n___ yo F ___ only, patient of Dr. ___, with \\npremature 3v CAD (LAD 30% ISR, Cx 40-50% stenosis, ostial RCA \\nstent ___ ISR), HTN, HLD, DM2 presenting as transfer from ___ \\n___ with chest pain and concern for unstable angina. \\n\\nCORONARIES: LAD s/p DES (___) w 30% in-stent restenosis, RCA \\nostial stent w 50% in-stent restenosis, LCX 40-50% ___ \\n___ cath)\\nPUMP: HFpEF (ECHO ___\\nRHYTHM: sinus \\n\\n===============\\nACTIVE ISSUES:\\n===============\\n# Chest Pain\\n# CAD s/p stent x2 w known in-stent restenosis \\nCardiac cath was done ___ and showed: Normal left and right \\nheart filling pressures. Three vessel coronary artery disease, \\nincluding distal small om occlusion to small for intervention. \\nNegative iFR and IVUS of pRCA that did not explain rest \\nsymptoms. Chest pain was believed to be musculoskeletal vs from \\nsmall distal OM or microvessel disease. She was initiated on \\nhigh dose atorvastatin 80mg daily and her metoprolol was \\nswitched to metoprolol succinate 50mg daily as titration up of \\nantianginal.\\n\\n# DM\\nvery poorly controlled with an A1c of 13%. She was placed on \\nhome glargine 33 units before bed and Humalog insulin sliding \\nscale while in house. Held home Trulicity as nonformulary\\n\\n================\\nCHRONIC ISSUES:\\n================\\n# Hypertension - cont home losartan \\n# Hyperlipidemia - cont high-dose atorvastatin \\n# Depression - cont home citalopram, monitor QTc\\n# GERD - cont home ranitidine \\n\\n===================\\nTRANSITIONAL ISSUES\\n===================\\n# CODE STATUS: full, presumed\\n# CONTACT: ___, HCP/husband, ___\\n\\nGREATER THAN 30 MINUTES SPENT ON DC PLANNING\\n\\n[ ] MEDICATION CHANGES:\\n-Added: Atorvastatin 80, metoprolol succinate 50\\n-Stopped: Metoprolol tartrate (replaced with succinate), \\nrosuvastatin (replaced with atorvastatin)\\n\\n[ ] FOLLOW-UP LABS:\\n-Low TSH noted on admission labs - c/f subclinical \\nhypothyroidism. Should be repeated in outpatient setting\\n\\n[ ] FOLLOW UP WORKUP FOR CHEST PAIN:\\n-No clear coronary etiology for chest pain was determined. Pt \\nwould benefit from workup and treatment for likely \\nmusculoskeletal etiology vs assessment of improvement with high \\nintensity statin if microvessel disease\\n\\n[ ] FOLLOW UP DIZZINESS:\\n-Pt with intermittent dizziness during hospitalization here, \\northostatic vital signs negative for volume depletion. Consider \\noutpatient workup for causes of same.\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB, wheezing \\n2. Aspirin 81 mg PO DAILY \\n3. Citalopram 40 mg PO DAILY \\n4. Glargine 33 Units Bedtime\\n5. Losartan Potassium 50 mg PO DAILY \\n6. Metoprolol Tartrate 50 mg PO BID \\n7. Topiramate (Topamax) 50 mg PO BID PRN migraine \\n8. Trulicity (dulaglutide) 0 unknown subcutaneous unknown \\n9. Ranitidine 150 mg PO BID \\n10. Rosuvastatin Calcium 40 mg PO QPM \\n\\n \\nDischarge Medications:\\n1.  Atorvastatin 80 mg PO QPM  \\n2.  Metoprolol Succinate XL 50 mg PO DAILY  \\n3.  Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB, wheezing  \\n4.  Aspirin 81 mg PO DAILY  \\n5.  Citalopram 40 mg PO DAILY  \\n6.  Glargine 33 Units Bedtime \\n7.  Losartan Potassium 50 mg PO DAILY  \\n8.  Ranitidine 150 mg PO BID  \\n9.  Topiramate (Topamax) 50 mg PO BID PRN migraine  \\n10.  Trulicity (dulaglutide) 0 unknown subcutaneous Frequency is \\nUnknown  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPRIMARY DIAGNOSIS\\nChest pain with non-obstructive coronary artery disease\\n\\nSECONDARY DIAGNOSES:\\nHistory of hypertension\\nDiabetes mellitus, poorly controlled\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Ms. ___,\\n\\nIt was a pleasure taking care of you at ___ \\n___. \\n\\nWHY WAS I ADMITTED TO THE HOSPITAL?\\n- You were admitted to the hospital because you were having \\nchest pain\\n\\nWHAT HAPPENED WHILE I WAS IN THE HOSPITAL?\\n- You had a cardiac catheterization to look at the blood vessels \\nin your heart\\n- There were no blockages to explain your chest pain\\n\\nWHAT SHOULD I DO WHEN I GO HOME?\\n- You should continue to take your medications as prescribed. \\n- You should attend the appointments listed below. \\n- Weigh yourself every morning, call your doctor at \\n___ if your weight goes up more than 3 lbs.  \\n- Seek medical attention if you have new or concerning symptoms \\nor you develop swelling in your legs, abdominal distention, or \\nshortness of breath at night.  \\n- Your discharge weight: 145 lbs. You should use this as your \\nbaseline after you leave the hospital.  \\n\\nWe wish you the best!\\nYour ___ Care Team \\n \\nFollowup Instructions:\\n___\\n',\n",
              " \" \\nName:  ___                Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: UROLOGY\\n \\nAllergies: \\nNsaids / Xarelto\\n \\nAttending: ___.\\n \\nChief Complaint:\\nBPH, LUTS\\n \\nMajor Surgical or Invasive Procedure:\\nTRANSURETHRAL RESECTION PROSTATE, BIPOLAR\\n\\n \\nHistory of Present Illness:\\n___ year old male with BPH, LUTS presents for TURP. \\n \\nPast Medical History:\\nPMHx:\\nCHF (EF 58%)\\nHLD\\n2nd degree AVB s/p pacer placed ___\\nhx/o A Fib\\nhx/o SDH\\ngastritis\\nhearing loss\\n\\nPSHx: \\ncraniotomy\\nex lap for duodenal ulcer\\ns/p appy\\ns/p bilat cataractecomy\\n\\nDischarge Summary Past Medical History from ___ ___:  \\nHypertension, BPH, atrial fibrillation, idopathic pericardial \\neffusion, s/pt appendectomy, s/p pericardiocentesis.  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nNoncontributory.\\n \\nPhysical Exam:\\nWDWN male\\nconfused at times, pleasant, cooperative\\nfoley in place, pink UOP\\nno l/e e/p/c/d\\n \\nPertinent Results:\\n___ 06:30AM BLOOD WBC-10.2* RBC-3.26* Hgb-9.3* Hct-28.9* \\nMCV-89 MCH-28.5 MCHC-32.2 RDW-15.7* RDWSD-50.9* Plt ___\\n___ 06:30AM BLOOD Glucose-124* UreaN-11 Creat-0.8 Na-136 \\nK-4.6 Cl-102 HCO3-26 AnGap-13\\n\\n___ 11:05 am URINE     Site: CYSTOSCOPY      URINE. \\n\\n                            **FINAL REPORT ___\\n\\n   URINE CULTURE (Final ___: \\n      CORYNEBACTERIUM SPECIES (DIPHTHEROIDS).    >10,000 CFU/ML. \\n\\n      ENTEROCOCCUS SP..    >10,000 CFU/ML. \\n\\n                              SENSITIVITIES: MIC expressed in \\nMCG/ML\\n                      \\n_________________________________________________________\\n                             ENTEROCOCCUS SP.\\n                             |   \\nAMPICILLIN------------   <=2 S\\nNITROFURANTOIN--------  <=16 S\\nTETRACYCLINE----------   <=1 S\\nVANCOMYCIN------------     1 S\\n\\n \\nBrief Hospital Course:\\nMr. ___ was admitted to Dr. ___ service \\nafter bipolar transurethral resection of prostate. No concerning \\nintraoperative events occurred; please see dictated operative \\nnote for details. Mr. ___ received ___ antibiotic \\nprophylaxis and his postoperative course was uncomplicated. He \\nreceived intravenous antibiotics and continuous bladder \\nirrigation overnight. On POD1 the CBI was discontinued. His \\nurine was clear-pink and without clots. He remained a-febrile \\nthroughout his hospital stay.  At discharge, Mr. ___ had \\npain well controlled with oral pain medications, was tolerating \\nregular diet, ambulating and versed on foley care/hygiene.  He \\nwas given oral pain medications on discharge and explicit \\ninstructions to follow up in clinic for trial of void. He was \\ndischarged home with ___ but this service was declined by his \\nson. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Finasteride 5 mg PO DAILY \\n2. Furosemide 20 mg PO QAM \\n3. Metoprolol Succinate XL 25 mg PO BID \\n4. Cyanocobalamin 1000 mcg PO DAILY \\n5. Tamsulosin 0.4 mg PO QHS \\n\\n \\nDischarge Medications:\\n1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \\n2.  Docusate Sodium 100 mg PO BID \\nRX *docusate sodium [Colace] 100 mg ONE capsule(s) by mouth \\ntwice a day Disp #*60 Capsule Refills:*0 \\n3.  Senna 17.2 mg PO HS  \\n4.  Cyanocobalamin 1000 mcg PO DAILY  \\n5.  Finasteride 5 mg PO DAILY  \\n6.  Furosemide 20 mg PO QAM  \\n7.  Metoprolol Succinate XL 25 mg PO DAILY  \\n8.  Tamsulosin 0.4 mg PO QHS  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nBenign prostatic hypertrophy. urinary obstruction, urinary \\nretention\\n\\n \\nDischarge Condition:\\nMental Status: Confused - always.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\n-You may continue to periodically see small amounts of blood in \\nyour urine--this is normal and will gradually improve\\n\\n-Resume your pre-admission/home medications EXCEPT as noted. You \\nshould ALWAYS call to inform, review and discuss any medication \\nchanges and your post-operative course with your primary care \\ndoctor.  \\n\\nShould you HOLD ASPIRIN? Unless otherwise advised;  If the urine \\nis still pink, hold the aspirin until it has been clear/yellow \\nfor at least three days. \\n\\n-If prescribed; complete the full course of antibiotics.\\n\\n-Colace has been prescribed to avoid post surgical constipation \\nand constipation related to narcotic pain medication. \\nDiscontinue if loose stool or diarrhea develops. Colace is a \\nstool softener, NOT a laxative\\n\\n- AVOID STRAINING for bowel movements as this may stir up \\nbleeding.\\n\\n-Do not eat constipating foods for ___ weeks, drink plenty of \\nfluids to keep hydrated\\n\\n-No vigorous physical activity or sports for 4 weeks or until \\notherwise advised\\n\\n-Do not lift anything heavier than a phone book (10 pounds) or \\nparticipate in high intensity physical activity for a minimum of \\nfour weeks or until you are cleared by your Urologist in \\nfollow-up\\n\\n-Tylenol should be your first line pain medication, a narcotic \\npain medication has been prescribed for breakthrough pain >4. \\n\\n-Max daily Tylenol (acetaminophen) dose is 3 grams from ALL \\nsources, note that narcotic pain medication also contains \\nTylenol\\n\\n-Do not drive or drink alcohol while taking narcotics and do not \\noperate dangerous machinery. Also, if the Foley catheter and Leg \\nBag are in place--Do NOT drive (you may be a passenger).\\n\\nWHEN YOU ARE DISCHARGED WITH A FOLEY CATHETER:\\n-Please also reference the nursing handout and instructions on \\nroutine care and hygiene\\n\\n-Your Foley should be secured to the catheter secure on your \\nthigh at ALL times until your follow up with the surgeon.\\n\\n-DO NOT have anyone else other than your Surgeon or your \\nsurgeon's representative remove your Foley for any reason.\\n\\n-Wear Large Foley bag for majority of time; the leg bag is only \\nfor short-term periods for when leaving the house.\\n\\n-Do NOT drive if you have a Foley in place (for your safety)\\n \\nFollowup Instructions:\\n___\\n\",\n",
              " \" \\nName:  ___                 Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___\\n \\nChief Complaint:\\nencephalopathy/malaise\\n \\nMajor Surgical or Invasive Procedure:\\nEGD ___\\n\\n \\nHistory of Present Illness:\\nMr. ___ is a ___ yo M patient of Dr. ___ with \\nhistory of EtOH cirrhosis s/p combined ___ transplant \\nin ___ at ___. He has had multiple ___ biliary \\ncomplications. He has had multiple episodes of cholangitis ___ \\nstricture c/b bacteremia and septic shock. He has had multiple \\nERCP's and CBD stent placements at ___. In ___, he moved his \\ncare to ___, where multiple more\\nERCP's were performed and ultimately, it was decided to revise \\nhis biliary anastomosis with a ___ hepaticojejunostomy. In \\n___ he was found to have intrahepatic biliary ductal \\ndilation at\\nthe proximal common duct and anastomotic stricture on MRCP. On \\n___ he received a balloon dilation and \\n___\\nbiliary stent was placed (which required ___. Liver \\nbiopsy on ___ showed chronic rejection. \\n\\nHe is now ___ for transplant due to being cirrhotic, \\nChild's C w/MELD of 31 previously complicated by hepatic \\nencephalopathy. His most recent EGD was ___ showing 3 cords \\nof grade ___ varices in the lower third of the esophagus. The \\nvarices were not bleeding. Additionally he had portal \\nhypertensive gastropathy, and esophagitis in lower third of \\nesophagus. \\n\\nHe was recently hospitalized from ___ for hepatic \\nencephalopathy and new ___. His symptoms at that time resolved \\nwith lactulose, albumin and two units of pRBCs. \\n\\nThe patient was directly admitted to ___ on ___ due to \\nfatigue and encephalopathy, with concern that his hepatic \\nfunction may be worsening. Of note the patient had labs drawn on \\n___ which were notable for a hemoglobin of 7.4. The rest of \\nthe labs were unavailable at the time of interview. \\n\\nThe patient reports that over the past month he feels he has \\nworsening fatigue, that has progressively worsened over the \\npreceding week. His confusion has waxed and waned throughout \\nthis period somewhat as well, with increasing forgetfulness. The \\npatient has been doing a lot of work outside the home and feels \\nthat his strength Is decreasing. The patient denies any chest \\npain, shortness of breath, abdominal pain, dysuria, cough, \\nnausea, vomiting, or fevers. Does get daily chills at home but \\nnever had a fever. The patient denies any sick contacts or \\nrecent travel. No bloody stools, hemoptysis, hematemesis. The \\npatient has baseline loose stools up to ___ per day that have \\nbecome more malodorous but have not otherwise changed in \\nquality. Of note the patient did have a tick found on his scalp \\nyesterday but was present for < 1 hour and was easily removed. \\n\\nOtherwise a 10 point ROS is negative.\\n \\nPast Medical History:\\n___ gunshot wounds in ___ status post exploratory\\nlaparotomy and colostomy.\\n___ colostomy was reversed.  \\n___, he had a history of ___ obstruction with\\nmultiple surgeries that retrieved most of his small bowel.  \\n___, laparotomy again had multiple surgeries again for \\nsmall\\nbowel obstruction.\\n___, he had a right knee arthroscopy.\\n___, diagnosis of cirrhosis and bleeding varices.  \\n___, he had hepatorenal syndrome and liver failure and he\\nhad his combined liver and kidney transplant at ___.\\nH/o cholangitis, multiple ERCP with plastic/metal stents.\\n___ cystoscopy to remove a stent that was placed that was\\ncausing urosepsis (this resulted in a lawsuit against ___).  \\n___, he underwent a lysis of adhesions at ___.\\n___ cholangitis/ s/p ERCP and stent placement.\\n___. Hepaticojejunostomy with ___.\\n___  PTC and liver biopsy with chronic rejection.\\nHepatic encephalopathy\\nGout\\nDepression\\nInsomnia \\n \\nSocial History:\\n___\\nFamily History:\\nMother - dementia (___)\\nFather - diabetes/prostate cancer (___)\\n2 Children, 3 Grandchildren all healthy\\n \\nPhysical Exam:\\n=====================================\\nPHYSICAL EXAMINATION ON ADMISSION\\n=====================================\\nVS: T 98.3 HR 63 BP 119/60 RR 18 100 RA Weight 70.3kg\\nGeneral: No acute distress, jaundiced, comfortable lying in bed\\nHEENT: NCAT, MMM, PERRL, no JVD appreciated \\nCV:  RRR, with systolic murmur appreciated throughout\\nLungs: CTAB, no wheezes, rales, rhonchi\\nAbdomen: + BS, well healed surgical scars, NTND, no ascites \\nappreciated\\nGU: No foley\\nExt:  www 1+ edema bilaterally \\nNeuro: Alert and oriented x3, no asterixis, CN ___ grossly \\nintact, moving all extremities with purpose\\nSkin: Severe jaundice\\n\\n=====================================\\nPHYSICAL EXAMINATION ON DISCHARGE\\n=====================================\\nVS: \\n68.6kg --> NR\\n98.7, 112/63, pulse 59, rr18, 100% on RA\\n8H: 200, BRP\\n24H: 2620, 300+ w/6BMs\\n\\nGeneral: No acute distress, jaundiced, comfortable lying in bed \\nreading \\nHEENT: NCAT, MMM, icteric sclerae\\nCV:  RRR, with systolic murmur appreciated throughout\\nLungs: CTAB, no wheezes, rales, rhonchi\\nAbdomen: + BS, well healed surgical scars, NTND, no ascites \\nappreciated\\nGU: No foley\\nExt:  www trace edema bilaterally \\nNeuro: Alert and oriented x3, no asterixis, moving all \\nextremities with purpose\\nSkin: Severe jaundice\\n \\nPertinent Results:\\n=====================\\nLABS ON ADMISSION\\n=====================\\n___ 09:20PM BLOOD ___ \\n___ Plt ___\\n___ 09:20PM BLOOD ___ \\n___ Im ___ \\n___\\n___ 09:20PM BLOOD ___ ___\\n___ 06:10AM BLOOD ___ \\n___ \\n___\\n___ 06:10AM BLOOD Ret ___ Abs ___\\n___ 09:20PM BLOOD ___ \\n___\\n___ 09:20PM BLOOD ___ LD(LDH)-156 ___ \\n___\\n___ 09:20PM BLOOD ___\\n___ 06:10AM BLOOD ___\\n___ 06:10AM BLOOD tacroFK-<2.0*\\n___ 06:46PM URINE ___ Sp ___\\n___ 06:46PM URINE ___ \\n___\\n___ 06:46PM URINE ___ \\nEpi-<1\\n___ 06:46PM URINE ___\\n___ 06:46PM URINE ___\\n\\n=====================\\nLABS ON DISCHARGE\\n=====================\\n___ 04:20AM BLOOD ___ \\n___ Plt ___\\n___ 04:20AM BLOOD ___ ___\\n___ 04:20AM BLOOD ___ \\n___\\n___ 12:45PM BLOOD ___ \\n___\\n___ 04:20AM BLOOD ___ \\n___\\n___ 04:20AM BLOOD ___\\n___ 12:45PM BLOOD ___\\n___ 04:20AM BLOOD ___\\n\\n=====================\\nMICROBIOLOGY\\n=====================\\n___ - Urine Culture - MIXED BACTERIAL FLORA ( >= 3 COLONY \\nTYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION.\\n___ - Blood Culture x2 - FINAL -  No Growth\\n\\n=====================\\nENDOSCOPY\\n=====================\\n___ EGD\\nFindings:\\nEsophagus: \\nProtruding Lesions 1 cord of small varices were seen in the \\ndistal esophagus.\\n \\nStomach: \\nMucosa: Erythema and mosaic appearance of the mucosa were noted \\nin the stomach. These findings are compatible with portal \\nhypertensive gastropathy. \\nOther Possible gastric varices were noted upon retroflexion in \\nthe fundus.  \\nDuodenum: Normal duodenum.\\n\\nOtherfindings: No definitive source of patient's recent \\nworsening anemia was identified. No stigmata of recent bleed.  \\n\\nImpression: Varices at the distal esophagus\\nErythema and mosaic appearance in the stomach compatible with \\nportal hypertensive gastropathy\\nPossible gastric varices were noted upon retroflexion in the \\nfundus.\\nNo definitive source of patient's recent worsening anemia was \\nidentified. No stigmata of recent bleed.\\nOtherwise normal EGD to third part of the duodenum\\n\\n=====================\\nIMAGING/STUDIES\\n=====================\\n___ ECG\\nSinus bradycardia. Anterior T wave changes are biphasic. \\nConsider ischemia.\\nCompared to the previous tracing of ___ anterior T wave \\nchanges are now\\nseen. \\nQTc ___\\n\\n___ RUQ US\\n1. Cirrhosis with patent hepatic vasculature.\\n2. Splenomegaly\\n\\n___ CXR\\nCompared to chest radiographs ___ and ___.\\nAn apparent oval ring shadow projecting over the right lung base \\nlaterally hasa thicker wall today than in ___.  Lungs are \\notherwise clear. \\nCardiomediastinal and hilar silhouettes and pleural surfaces are \\nnormal. \\nRECOMMENDATION(S):  Chest CT for possible indolent infection or \\nsuperinfection\\nof cystic right lower lobe lung lesion.\\n\\n___ CT Chest WO Contrast\\n1.  The recent radiographic finding can be explained by a small \\nloculated\\neffusion with adjacent atelectasis in the right lower lobe. \\n2.  Multiple millimetric pulmonary nodules do not require any \\nspecific ___.\\n3.  Please refer to the MRI abdomen of ___ for \\nsubdiaphragmatic\\nfindings in this ___ transplant patient.\\n \\nBrief Hospital Course:\\n___ yo M with history of ETOH cirrhosis s/p ___ \\ntransplant ___ at ___, ___/chronic rejection and recurrent \\nChild's C cirrhosis, MELD 31 on admission, presenting as direct \\nadmission with fatigue and malaise, with concern for worsening \\nhepatic encephalopathy, improving with treatment of complicated \\nUTI. \\n\\n# EtOH cirrhosis s/p ___ transplant: patient originally \\ndeveloped EtOH cirrhosis and underwent ___ transplant \\nin ___. Unfortunately he developed ___ or \\nalloimmune hepatitis resulting in graft \\ndysfunction/liver failure and is again listed for transplant. \\nCurrently Childs class C, c/b new HE (presenting symptom, \\ndescribed below). EGD with 1 cord of small varices at distal \\nesophagus and portal hypertensive gastropathy. The patient was \\ncontinued on tacrolimus 0.5 mg daily, and ursodiol during the \\nadmission. As below, hepatic encephalopathy improved with \\ntreatment complicated UTI. \\n\\n# Hepatic encephalopathy: History of hepatic encephalopathy in \\nthe past and on recent previous admission. Full workup was \\npursued. RUQ US with dopplers which was negative for thrombus or \\nother acute process. Full infectious workup was pursued \\nincluding chest x ray, urine and blood cultures. The patient had \\nno ascites amenable to diagnostic paracentesis. There was no \\nevidence of active bleeding as below. The patient was found to \\nhave pyuria and was started on IV ceftriaxone which was \\ntransitioned to PO ciprofloxacin to complete a 10 day course for \\na complicated UTI. Urine culture was unfortunately contaminated, \\nthough patient had no history of resistant UTI in the past. The \\npatient improved on antibiotics. Continued on home lactulose and \\nrifaximin. The patient was alert and oriented without confusion \\non discharge. \\n\\n# Complicated UTI: Patient found to have pyuria on UA though \\naymptomatic. Urine culture contaminated though as above no \\nhistory of resistant UTI. Started on IV ceftriaxone which was \\ntransitioned to PO ciprofloxacin for a total of 10 days \\n(___). \\n\\n# Acute on chronic kidney disease: patient has a baseline Cr \\n___ (background disease of likely chronic allograft \\nnephropathy). Cr on prior discharge ___. Slightly elevated \\nto 1.7 on admission. Improved with treatment of above UTI and \\ntransfusions for anemia as below. Had slight bump prior to \\ndischarge that was likely due to dehydration from being NPO for \\nEGD, it remained stable at 1.6, and he will have it rechecked on \\n___.\\n\\n# Anemia: Baseline ___. The patient required 3u PRBC during the \\nadmission. There was no evidence of active bleeding or \\nhemolysis. The patient underwent EGD without source to \\nexplaining etiology of worsening anemia. Anemia thought \\nsecondary to chronic disease in setting of cirrhosis and \\nunderproduction. The patient's H/H remained stable after \\ntransfusion and was discharged with H/H of ___.\\n\\n# GIB/Varices: The patient underwent EGD during the admission \\nwith 1 cord of small varices in distal esophagus and portal \\nhypertensive gastropathy. Continued on home nadolol and \\nomeprazole. \\n\\n# CXR with oval ring shadow: The patient underwent subsequent CT \\nwithout concerning findings. Finding explained by small \\nloculated effusion with adjacent atelectasis.\\n\\n====================\\nCHRONIC ISSUES\\n====================\\n# Depression: Patient continued home esciptalopram. \\n\\n# Gout: Patient continued home allopurinol with renal dosing.\\n\\n# Insomnia: Patient continued home trazodone.\\n\\n====================\\nTRANSITIONAL ISSUES\\n====================\\n- Continue oral antibiotics for UTI for a total of 10 days \\n(___)\\n- Ensure weekly MELD Labs\\n- Ensure follow up in ___ and with PCP\\n- ___ colonoscopy as an outpatient\\n- Check chem10, LFTs on ___, trend creatinine\\n\\n#CODE: Full \\n#CONTACT: ___ (wife) ___ \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Allopurinol ___ mg PO DAILY \\n2. Escitalopram Oxalate 15 mg PO DAILY \\n3. Lactulose 15 mL PO TID \\n4. Magnesium Oxide 400 mg PO DAILY \\n5. Nephrocaps 1 CAP PO DAILY \\n6. Omeprazole 20 mg PO DAILY \\n7. Rifaximin 550 mg PO BID \\n8. Tacrolimus 0.5 mg PO DAILY \\n9. TraZODone 50 mg PO QHS:PRN insomnia \\n10. Ursodiol 300 mg PO TID \\n11. Nadolol 40 mg PO DAILY \\n12. Cyanocobalamin 1000 mcg IM/SC ONCE MONTHLY \\n\\n \\nDischarge Medications:\\n1. Allopurinol ___ mg PO DAILY \\n2. Escitalopram Oxalate 15 mg PO DAILY \\n3. Lactulose 30 mL PO TID \\nRX *lactulose 20 gram/30 mL 30 mL by mouth three times a day \\nRefills:*0\\n4. Nadolol 40 mg PO DAILY \\n5. Omeprazole 20 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Tacrolimus 0.5 mg PO DAILY \\n8. TraZODone 50 mg PO QHS:PRN insomnia \\n9. Ursodiol 300 mg PO TID \\n10. Multivitamins W/minerals 1 TAB PO DAILY \\nRX ___  1 tablet(s) by mouth once a day \\nDisp #*30 Tablet Refills:*0\\n11. Cyanocobalamin 1000 mcg IM/SC ONCE MONTHLY \\n12. Magnesium Oxide 400 mg PO DAILY \\n13. Ciprofloxacin HCl 500 mg PO Q12H Duration: 17 Doses \\nTo complete 10 day (20 dose) course. \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*17 Tablet Refills:*0\\n14. Outpatient Lab Work\\nICD10: ___\\nPlease obtain: CHEM10, AST/ALT/alk phos/T. bili/LDH/albumin, \\n___ on ___\\nSEND TO: ___, MD\\nPhone: ___ Fax: ___ \\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary Diagnoses\\n====================\\nHepatic Encephalopathy\\nComplicated Urinary Tract Infection\\nEtOH cirrhosis s/p ___ transplant\\nAcute on chronic kidney disease\\nAnemia\\n\\nSecondary Diagnoses\\n====================\\nGastric Varices\\nDepression\\nGout\\nInsomnia \\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nIt was a pleasure caring for you during your stay at ___. You \\nwere admitted to the hospital with fatigue and confusion. You \\nwere found to have signs of a urinary tract infection and were \\nstarted on antibiotics. You will need to continue antibiotics \\nfor a total of 10 days. \\n\\nYour blood counts were also found to be low during the \\nadmission, and were given blood transfusions while you were here \\nwhich you responded well to. You underwent an endoscopy which \\ndid not reveal any signs of bleeding. The low blood counts are \\nmost likely from your cirrrhosis and the fact that your body \\nisn't producing as many cells as it should. \\n\\nYour medication list and outpatient appointments are listed in \\nyour discharge paperwork.  \\n\\nIt is very important you have your labs checked on ___, \\n___ including your kidney function and liver labs. \\n\\nWe wish you the best!\\n-your ___ Care team\\n \\nFollowup Instructions:\\n___\\n\",\n",
              " ' \\nName:  ___                      Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___.\\n \\nChief Complaint:\\nWrist pain, swelling\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\nThis is a ___ yo man with history of HIV on Triumeq, IV drug use \\nand multiple episodes of cellulitis presenting with two day \\nhistory of right wrist pain and swelling. Two days ago he \\ninjected crystal meth into right wrist. The following day it \\nstarted to hurt and swell. Today he presented to primary care \\ndoctor who referred him to ___. Said that he was injecting \\nbecause he had bad event in his life recently. He also injected \\nin left wrist and antecubital fossa but does not have symptoms \\nthere. He reports that he did not have any trauma to the wrist. \\nReports having ___ episodes of cellulitis in past. denies \\nsystemic infectious symptoms, chest \\npain/pressure/sob/n/v/diarrhea/constipation. Took his Triumeq \\nthis am. \\n  \\nIn the ED, initial vitals were: 98.3 70 ___ 100%RA \\n \\n- Exam notable for: right wrist erythematous, no spread past \\nmarking from clinic this morning. No abscess appreciated. Track \\nmarks and cut marks up both arms. \\n- Labs notable for:  CBC wnl, Chem 10 wnl, lactate 1.8\\n- Imaging was notable for:  R wrist Xray: No acute fracture or \\ndislocation. Diffuse wrist soft tissue swelling.\\n- Patient was given:  Acetaminophen 650 mg, Vancomycin 1000 mg, \\nUnasyn 3g\\n- Patient was seen by social work who identified that the \\npatient was at zero in terms of readiness for treatment.\\n\\nUpon arrival to the floor, patient reports ongoing pain in his \\nright wrist. Denies fever, nausea, vomiting, involvement of any \\nother joints. He reports a history of skin abscesses as well as \\nbacteremia due to IVDU, but denies a history of endocarditis or \\njoint infection. \\n \\nPast Medical History:\\n-HIV\\n-IV methamphetamine use with multiple episodes of cellulitis\\n-Insomnia\\n-Depression\\n \\nSocial History:\\n___\\nFamily History:\\nNon-contributory\\n \\nPhysical Exam:\\nON ADMISSION\\n============\\nVITAL SIGNS: 98.6 93/59 64 18 99% Ra \\nGENERAL: Appears mildly uncomfortable due to wrist pain; \\ngenerally non-toxic appearing\\nHEENT: NCAT, moist mucous membranes\\nNECK: Supple, no LAD\\nCARDIAC: RRR, nl S1/S2, no murmurs\\nLUNGS: Clear to auscultation b/l\\nABDOMEN: Soft, non-tender, non-distended, no masses\\nEXTREMITIES: RUE: multiple injection sites scattered around \\nforearm. On volar wrist, small area of erythema with surrounding \\nedema. Tender to palpation throughout volar and dorsal forearm. \\nNo crepitus. ROM in wrist flexion/extension limited by pain. \\nNEUROLOGIC: Moving all extremities equally\\nSKIN: On b/l forearms, multiple injection sites with prominent \\nscars from cuts on L arm\\n\\nON DISCHARGE\\n============\\nVITAL SIGNS: 98.1 PO 115 / 72 L Lying 70 14 95 Ra  \\nGENERAL: Comfortable, NAD, anxious appearing\\nHEENT: NCAT, moist mucous membranes\\nNECK: Supple, no LAD\\nCARDIAC: RRR, nl S1/S2, no murmurs\\nLUNGS: Clear to auscultation b/l\\nABDOMEN: Soft, non-tender, non-distended, no masses\\nEXTREMITIES: RUE: multiple injection sites scattered around \\nforearm. On volar wrist, trace erythema. Minimally tender to \\npalpation throughout volar and dorsal forearm. No crepitus. ROM \\n~60 degrees with minimal pain in wrist flexion/extension. \\nNEUROLOGIC: Moving all extremities equally\\nSKIN: On b/l forearms, multiple injection sites with prominent \\nscars from cuts on L arm\\n \\nPertinent Results:\\nADMISSION LABS\\n==============\\n___ 04:10PM BLOOD WBC-6.7 RBC-4.78 Hgb-14.9 Hct-43.1 MCV-90 \\nMCH-31.2 MCHC-34.6 RDW-13.4 RDWSD-43.7 Plt ___\\n___ 04:10PM BLOOD Neuts-59.3 ___ Monos-12.7 Eos-1.8 \\nBaso-0.3 Im ___ AbsNeut-3.95 AbsLymp-1.72 AbsMono-0.85* \\nAbsEos-0.12 AbsBaso-0.02\\n___ 04:10PM BLOOD Glucose-113* UreaN-14 Creat-1.1 Na-138 \\nK-5.0 Cl-102 HCO3-24 AnGap-17\\n___ 04:09PM BLOOD Lactate-1.8\\n\\nPERTINENT LABS\\n==============\\n___ 04:10PM BLOOD CK(CPK)-392*\\n___ 04:10PM BLOOD CRP-14.2*\\n\\nDISCHARGE LABS\\n==============\\n___ 07:25AM BLOOD WBC-5.0 RBC-4.76 Hgb-15.2 Hct-43.3 MCV-91 \\nMCH-31.9 MCHC-35.1 RDW-13.2 RDWSD-43.8 Plt ___\\n___ 07:25AM BLOOD Glucose-114* UreaN-14 Creat-1.0 Na-139 \\nK-3.6 Cl-104 HCO3-26 AnGap-13\\n___ 07:25AM BLOOD Calcium-8.4 Phos-3.5 Mg-2.2\\n\\nIMAGING\\n=======\\nWRIST ___: No acute fracture or dislocation.  Diffuse wrist \\nsoft tissue swelling. \\n\\nMICROBIOLOGY\\n============\\n___ 4:10 pm BLOOD CULTURE\\n   Blood Culture, Routine (Pending at time of discharge)\\n  \\n\\n \\nBrief Hospital Course:\\nThis is a ___ yo man with history of HIV on Triumeq, IV drug use \\nand multiple episodes of cellulitis presenting with two day \\nhistory of right wrist pain and swelling after injecting crystal \\nmeth into his wrist. He was admitted for management of \\ncellulitis. He was afebrile with no leukocytosis or evidence of \\nsepsis throughout his admission. Blood cultures were drawn and \\ndid not grow anything by the time of discharge. He was initially \\nstarted on Vancomycin and Unasyn. He was evaluated by the \\nsurgical team who felt that this was simple cellulitis and they \\nwere not concerned about necrotizing fasciitis or septic \\narthritis. He was monitored for 24 hours and his hand pain \\nimproved significantly. We transitioned him to oral Keflex and \\nBactrim to complete a 10 day course. He should have follow up \\nwith his PCP on discharge to be re-evaluated.\\n\\nHe also developed some abdominal cramping, nausea, and vomiting \\nprior to discharge. His abdominal exam was benign. Suspect his \\nsymptoms are most likely due to combination of nausea from \\nantibiotics as well as constipation. He was given anti-emetics \\nwith good effect, and was tolerating PO by the time of \\ndischarge. \\n\\nTransitional Issues:\\n[] Follow up rash within 48-72 hours to monitor clinical \\nimprovement.\\n[] Complete 10 day course of Keflex and Bactrim (end date ___\\n[] Provide patient with resources for ongoing substance abuse\\n[] F/u pending blood cultures at ___\\n\\n# CODE: full (presumed) \\n# CONTACT: Husband, ___ (___) \\n \\n___ on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral \\nDAILY \\n\\n \\nDischarge Medications:\\n1.  Calcium Carbonate 500 mg PO QID:PRN upset stomach  \\n2.  Cephalexin 500 mg PO Q6H Duration: 8 Days \\nend date ___ \\nRX *cephalexin 500 mg 1 capsule(s) by mouth every six hours Disp \\n#*32 Capsule Refills:*0 \\n3.  Docusate Sodium 100 mg PO BID \\nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \\nDisp #*20 Capsule Refills:*0 \\n4.  Psyllium Powder 1 PKT PO DAILY \\nRX *psyllium husk (aspartame) [Metamucil MultiHealth Fiber] 3.4 \\ngram/5.8 gram 1 powder(s) by mouth once a day Disp #*660 Gram \\nGram Refills:*0 \\n5.  Senna 8.6 mg PO BID:PRN constipation \\nRX *sennosides 8.6 mg 1 tab by mouth twice a day Disp #*20 \\nTablet Refills:*0 \\n6.  Sulfameth/Trimethoprim DS 2 TAB PO BID Duration: 8 Days \\nend date ___ \\nRX *sulfamethoxazole-trimethoprim 800 mg-160 mg 2 tablet(s) by \\nmouth Twice daily Disp #*32 Tablet Refills:*0 \\n7.  Triumeq (abacavir-dolutegravir-lamivud) 600-50-300 mg oral \\nDAILY  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary: Cellulitis of R wrist\\nSecondary: IV methamphetamine abuse, HIV\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nYou were admitted to ___ because you were having right hand \\npain. You have a skin infection called \"cellulitis\" that we \\ntreated with IV antibiotics. Your hand improved slightly so we \\nfelt that you could be discharged home on antibiotic medication \\nby mouth. Our colleagues from the surgery team evaluated your \\nhand and did not feel that you had a deeper infection of the \\njoint or underlying tissues. We would recommend that you see \\nyour PCP next week and that you avoid anything that could injure \\nyour arm and hand to prevent future infections.  \\n\\nYou were also having some abdominal cramping. We believe this is \\ndue to constipation. The antibiotics can cause some GI upset as \\nwell. We will prescribe you some medication to help you move \\nyour bowels, and for stomach upset. \\n\\nWe wish you all the best.\\n\\nSincerely,\\n\\nYour care team at ___\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___                   Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nSulfa (Sulfonamide Antibiotics) / clavulanic acid / amoxicillin \\n/ levofloxacin\\n \\nAttending: ___.\\n \\nChief Complaint:\\nhyperglycemia\\n \\nMajor Surgical or Invasive Procedure:\\nendotracheal intubation\\ncentral line placement\\npercutaneous nephrostomy tube placement\\n \\nHistory of Present Illness:\\nPatient is a ___ female with a past medical history of \\ninsulin-dependent diabetes, depression, hypertension, \\nhyperlipidemia who presents to the emergency department with \\nconcerns for sepsis.\\n\\nPatient is currently living in a nursing home after multiple \\nhospitalizations and has been noncompliant with her medications. \\nPer nursing home reports, patient has been having multiple \\nepisodes of emesis and has been refusing her medications \\nincluding insulin so she was sent for further evaluation. She \\npresented to ___ emergency department and there \\nwas found to have hyperglycemia with sugars to 700s, VBG ph \\n7.4/36.4/41.8/22.3, acetone to 4.1, and  trace ketones in urine) \\nso was started on an insulin drip. Lactate went from 2.8 to 5.6, \\nWBC to 14.9, and she had a CT of her abdomen done which is \\nconcerning for 2 obstructing left proximal ureteral calculi with \\nthe largest being 1.1cm, hydronephrosis, and concomitant UTI \\nconcerning for an infected stone. CT head negative for acute \\nprocess, CXR clear. She was given vancomycin and ceftazidime(and \\n___. Per review of records, she received 2 L of LR. Patient \\nalso had a CT of her head done with no evidence of intracranial \\nhemorrhage. She was transferred here for further care given the \\nconcern for sepsis and need for ICU level care.\\n\\nOn arrival to the ED, history was obtained with help of husband \\nand sign language interpreter. She described 2 weeks of not \\nfeeling well and having decreased p.o. intake. Her husband has \\nbeen concerned for her ability to care for herself and feels \\nthat she has depression. She denied any chest pain or pressure, \\ndyspnea, dysuria, melena.\\n\\nED Course notable for:\\nInitial vitals: \\n99.0 97 158/100 16 95% RA \\n\\nLabs:\\nHCO3 of 21, BUN 52, Cr 2.6, glucose 311 \\nCa ___, Mg 1.6, P 1.9 ALT 46, AST 56, ALP 177\\nWBC 29, hgb 14.1, plt 159\\nINR 1.6, PTT ___ 17.6\\nserum tox negative\\ntrop 0.05\\n\\nCK 305, MB 3\\n\\nLactate 4.7 \\nVBG ___\\n\\nA1c 9.7% \\n\\nUA: lg leuks, negative nitrite, mod blood, 600 protein, 0 WBC, \\nfew bacteria \\n\\nShe received 1L NS and 500cc LR. \\n\\nConsults: \\nUrology: \\nRecommended left percutaneous nephrostomy tube for decompression \\nand continue IV abx\\n\\nTransfer vitals: \\n98.2 118 135/75 20 96% RA \\n \\nOn arrival to the MICU, the patient complained of back pain but \\notherwise denied any complaints. Per the patient\\'s husband, she \\nhas been increasingly confused over the past few weeks. On one \\noccasion, she called the police on her husband and accused him \\nof abuse even though he had not been home all day.  He says she \\nhas not been eating and not taking her pills and she vomits \\nafter pill ingestion. \\n\\n \\nPast Medical History:\\nType 2 Diabetes Mellitus \\nDeafness\\nAnxiety\\nHypertension\\nHypothyroidism\\nObesity \\n \\nSocial History:\\n___\\nFamily History:\\nn/a\\n \\nPhysical Exam:\\nADMISSION PHYSICAL EXAM:\\n=================================\\nVITALS: Reviewed in metavision  \\nGENERAL: Awake, chronically ill appearing, looks older than \\nstated age, no acute distress  \\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNECK: supple, JVP not elevated, no LAD  \\nLUNGS: Clear to auscultation bilaterally, no wheezes, rales, \\nrhonchi  \\nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \\ngallops  \\nABD: soft, non-tender, non-distended, bowel sounds present, no \\nrebound tenderness or guarding, no organomegaly  \\nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema  \\nSKIN: stage 2 ulcer on buttox\\nNEURO:  Following commands \\n\\nDISCHARGE PHYSICAL EXAM:\\n==================================\\nGENERAL: No acute distress  \\nHEENT: AT/NC, anicteric sclera, dry mucous membranes\\nNECK: supple\\nCV: RRR, normal S1, S2, no murmurs, rubs or gallops\\nPULM: No increased WOB, CTAB\\nGI: Intertrigo in skin folds, soft, obese, nontender in all\\nquadrants, no rebound/guarding. There are scattered ecchymoses \\nin\\nthe lower quadrant.\\nTHORAX: Perc nephrostomy had normal urine output\\nSKIN: intertrigo in all skinfold areas\\nEXTREMITIES: 1+ pitting edema in extremities\\nNEURO: AOx3\\n\\n \\nPertinent Results:\\nADMISSION LABS:\\n=======================\\n___ 11:00PM   WBC-20.0* RBC-5.20 HGB-14.1 HCT-43.3 MCV-83 \\nMCH-27.1 MCHC-32.6 RDW-15.2 RDWSD-45.3\\n___ 11:00PM   NEUTS-79.9* LYMPHS-9.6* MONOS-9.3 EOS-0.1* \\nBASOS-0.3 NUC RBCS-0.2* IM ___ AbsNeut-15.95* AbsLymp-1.93 \\nAbsMono-1.87* AbsEos-0.03* AbsBaso-0.06\\n___ 11:00PM   ___ PTT-21.5* ___\\n___ 11:00PM   GLUCOSE-311* UREA N-52* CREAT-2.6* SODIUM-144 \\nPOTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-21* ANION GAP-24*\\n___ 11:00PM   ALT(SGPT)-46* AST(SGOT)-56* CK(CPK)-305* ALK \\nPHOS-177* TOT BILI-1.0\\n___ 11:00PM   LIPASE-17\\n___ 11:00PM   cTropnT-0.05*\\n___ 11:00PM   CK-MB-3\\n___ 11:00PM   %HbA1c-9.7* eAG-232*\\n___ 11:00PM   VANCO-<4.0*\\n___ 10:40PM URINE  BLOOD-MOD* NITRITE-NEG PROTEIN-600* \\nGLUCOSE-300* KETONE-NEG BILIRUBIN-SM* UROBILNGN-2* PH-6.0 \\nLEUK-LG*\\n___ 10:40PM URINE  RBC-8* WBC-0 BACTERIA-FEW* YEAST-NONE \\nEPI-28\\n\\nPERTINENT MICROBIOLOGY:\\n===============================\\n___ UCx: NO GROWTH\\n___: URINE CX (KIDNEY FLUID): NO GROWTH\\n___: BCx: NO GROWTH\\n\\nPERTINENT IMAGING:\\n===============================\\n___: Successful placement of 8 ___ nephrostomy on the \\nleft.\\n___ CXR:  \\nET tube appropriately positioned.  Right IJ central venous \\ncatheter in place.  No pneumothorax. \\n\\n___ VIDEO OROPHARYNGEAL SWALLOW STUDY: \\nNo penetration or aspiration of thin liquids on limited video \\noropharyngeal swallow study. \\n  \\nPlease note that a detailed description of dynamic swallowing as \\nwell as a \\nsummative assessment and recommendations are reported separately \\nin a \\nstandalone note by the Speech-Language Pathologist (OMR, Notes, \\nRehabilitation Services). \\n\\nDISCHARGE LABS:\\n============================\\n___ 07:40AM BLOOD WBC-7.6 RBC-3.62* Hgb-10.3* Hct-34.0 \\nMCV-94 MCH-28.5 MCHC-30.3* RDW-17.2* RDWSD-58.3* Plt ___\\n \\nBrief Hospital Course:\\nMs. ___ is a ___ female with a past medical \\nhistory of deafness, type 2 diabetes on insulin, \\ndepression/anxiety on diazepam, hypertension, hyperlipidemia who \\ninitially presented with obstructing L ureteral calculi, now s/p \\nperc nephrostomy\\ntube on ceftaz for a 10 day course for empiric treatment of UTI. \\nHospital course notable for poor PO intake. \\n\\n#Obstructing L ureteral calculi\\n#Suspected UTI\\nPresented to OSH with N/V found to have L obstructive ureteral \\nstone and severe hydronephrosis now status post nephrostomy \\nplacement on ___ on IV ceftaz for ___s empiric \\ncoverage given neg cultures which she completed on ___. Urology \\nto perform definitive stone management after discharge with Dr. \\n___. On the day of discharge, the nephrostomy was \\nin place and draining well. Urology will reach out to the \\npatient to schedule an appt for definitive stone management \\nwhich was confirmed on day of discharge. \\n\\n#Nausea/vomiting\\n#Subacute anorexia/malnutrition\\n#Suspected GERD\\nPer report patient has experience several weeks of poor Po \\nintake and nausea and vomiting at times. She was admitted twice \\nat ___ with UTIs. For this part of the admission, \\nshe had presented to ___ with nausea and vomiting and \\nwas found to have obstructing stone as per above. Now with \\nimproving appetite and no vomiting in recent days raising \\nsuspicion that symptoms were due to her nephrolithiasis. Also \\ntreating GERD with PPI. At this point cleared for thin liquids \\nby speech and swallow as well as soft solids. No plan for \\nfurther GI workup unless symptoms recur or fails to meet \\nnutrition needs. Please continue taking omeprazole 40mg daily.\\n\\n#Suspected refeeding syndrome-resolved\\nLikely refeeding syndrome in the setting of giving D5 NS after \\nprolonged oral aversion, with low K, mg and phos. This was \\nresolved on the day of discharge and patient was also started on \\na Multivitamin with minerals.\\n\\n# Hypothyroidism: \\nPatient has a history of hypothyroidism. On ___, TSH 37 and FT4 \\n0.6, likely due to medication non-adherence since pre-admission. \\nRecheck TSH and FT4 after 6 weeks. Please continue levothyroxine \\n125 mcg PO daily.\\n\\n#Subacute cough\\nPatient reports cough is much better. Chest x-ray (___) \\nindicated no pneumonia. She has no white count and is afebrile. \\nThe etiology of the cough is currently unclear, but\\nlikely due to secretion accumulation after long term swallowing \\naversion and/or complicated by GERD. Please continue omeprazole \\nas above.\\n\\n#Encephalopathy\\nHusband reports some cognitive and behavioral changes for a year \\nwith worsening in recent weeks in the setting of her medical \\nillness. Suspect TME on admission secondary to obstructive renal \\nstone/infection. Also suspicion for underlying neurologic or\\npsych process. Overall markedly improvement since admission. \\nDischarge summary from ___ regarding last \\nhospitalization in ___ showed that she had short-term memory\\nloss, which improved after UTI treatment. Consider outpatient \\npsych and neuro follow up if patient\\'s mental status shows \\nlittle improvement after her acute medical issues are addressed.\\n\\n#Hyperglycemia: \\n#Type 2 DM: \\nHad initially presented to ___ with glucose in the 800s \\ndue to nonadherence. Patient with A1c of 9.7%. ___ consulted \\nrecommending short/long acting insulin regime with daily \\ntitrations.\\n\\nCHRONIC ISSUES: \\n=============== \\n# Hypertension: \\nPatient on lisinopril and furosemide for hypertension at home.\\nNot volume overloaded on exam. Home lisinopril was held during \\nadmission and Lasix 20 mg PO daily was restarted before \\ndischarge. \\n\\nTRANSITIONAL ISSUES\\n===============================\\n[] Please recheck TFTs 6 weeks after discharge. TSH was elevated \\nat 37 on admission due to medication non-adherence. Patient \\nreceived home levothyroxine 125 mcg PO daily during admission. \\n[] Please ensure Urology has scheduled follow-up appointment \\nwith Dr. ___ definitive stone management. Per \\nUrology, they will contact her personally to schedule a \\nfollow-up appointment. \\n[] Perform voiding trial at rehab. Foley was left in place given \\nsacrum had extensive rash in order to keep area dry.\\n[] Wound care followed patient during this admission for the \\nfollowing wounds. \\n1. Right Medial heel, 2 X 1 cm intact skin, deep red with 0.5\\ndark purple area at 10 O\\'clock. defined edges, periwound intact\\n2. Right Lateral heel, 2 X 2 cm intact skin, black tissue,\\nsoft and boggy to palpate, defined edges, periwound intact \\n3. Right Lateral foot, 4.5 X 1 cm, intact skin, black tissue,\\nfirm to palpation, defined edges, periwound intact.\\n4. Plantar ___ metatarsal, 1 X 0.5 cm, intact skin deep maroon\\nwith black center. \\n[] Wound care recommendations were as follows. \\nPressure relief per pressure injury guidelines\\n Support surface: SW Alternate Air\\n Turn and reposition every ___ hours and prn off affected area\\n Heels off bed surface at all times\\nWaffle Boots ( x ) Multipodis Splints ( ) \\n If OOB, limit sit time to one hour at a time and \\n Sit on a pressure redistribution cushion-\\n Bariatric Air ( X )\\n ROHO ( ) Obtain from ___\\n OR ___ air full length chair cushion ( ) (Obtain from ___\\n Elevate ___ while sitting.\\n Moisturize B/L ___ and feet, intact skin only BID with Sooth\\nAnd Cool Ointment. \\n\\nTopical Therapy:\\n Commercial wound cleanser or normal saline to cleanse wounds.\\n Pat the tissue dry with dry gauze.\\n\\n Right Lateral Venous Stasis Wound - apply Adaptic dressing,\\n cover with 4x4\\'s and wrap with Kerlix. Secure with 2\" \\n Medipore tape.\\n\\n Change dressing daily.\\n\\n Fecal Incontinence - cleanse sacrum/perineal tissue with \\n foam cleanser. Pat dry. Apply thin layer of Critic aid \\n clear skin barrier ointment daily. ___ reapply after each\\n ___ cleansing. Place Xeroform dressing (antibacterial) over \\n site. Change daily and or as needed.\\n\\n Apply moisturize to intact BLE\\'s daily.\\n[] Patient presents with functional pharyngeal swallow and mild \\noral phase deficits related to partially edentulous state, \\nlimiting advancement of diet texture. No aspiration on video \\nswallow. Patient may be at increased risk for post prandial \\naspiration. Recommending aspiration precautions and soft \\nsolids/thin liquids diet. \\n[] If patient is hypertensive at rehab, consider restarting \\nlisinopril 2.5 mg PO daily which was held during admission. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Lisinopril 2.5 mg PO DAILY \\n2. Simvastatin 10 mg PO QPM \\n3. Levothyroxine Sodium 125 mcg PO DAILY \\n4. TraMADol 25 mg PO Q6H:PRN Pain - Moderate \\n5. Diazepam 2 mg PO QHS \\n6. Furosemide 20 mg PO DAILY \\n7. Gabapentin 300 mg PO TID \\n8. HumuLIN 70/30 U-100 Insulin (insulin NPH and regular human) \\n35 U subcutaneous Q12H \\n9. Vitamin D ___ UNIT PO DAILY \\n10. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1.  Glargine 10 Units Breakfast\\nGlargine 30 Units Bedtime\\nHumalog 6 Units Breakfast\\nHumalog 6 Units Lunch\\nHumalog 6 Units Dinner\\nInsulin SC Sliding Scale using HUM Insulin \\n2.  Miconazole Powder 2% 1 Appl TP BID  \\n3.  Multivitamins W/minerals 1 TAB PO DAILY  \\n4.  Omeprazole 40 mg PO DAILY GERD symptomatic   \\n5.  Aspirin 81 mg PO DAILY  \\n6.  Diazepam 2 mg PO QHS  \\n7.  Furosemide 20 mg PO DAILY  \\n8.  Gabapentin 300 mg PO TID  \\n9.  Levothyroxine Sodium 125 mcg PO DAILY  \\n10.  Simvastatin 10 mg PO QPM  \\n11.  TraMADol 25 mg PO Q6H:PRN Pain - Moderate  \\n12.  Vitamin D ___ UNIT PO DAILY  \\n13. HELD- Lisinopril 2.5 mg PO DAILY  This medication was held. \\nDo not restart Lisinopril until you are instructed to restart. \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\n#UTI\\n#L ureteral obstructing nephrolithiasis with hydronephrosis s/p \\nPCN\\n#Acute/subacute on chronic encephalopathy\\n\\n#UTI\\n#L ureteral obstructing nephrolithiasis with hydronephrosis s/p \\nPCN\\n#Acute/subacute on chronic encephalopathy\\n\\n \\nDischarge Condition:\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Bed bound.\\nMental Status: Clear and coherent.\\n\\n \\nDischarge Instructions:\\n======================  \\nDISCHARGE INSTRUCTIONS  \\n======================  \\nDear Ms ___,  \\nIt was a pleasure caring for you at ___.  \\n\\nWHY WAS I IN THE HOSPITAL?  \\n- You were admitted to the hospital because you had confusion \\nand were having nausea and vomiting. We then did some imaging of \\nyour abdomen that showed that you had a kidney stone that was \\npreventing your urine from flowing normally.\\n\\nWHAT HAPPENED TO ME IN THE HOSPITAL?  \\n- We placed a tube to help drain your urine since you had a \\nstone that was blocking the flow of your urine.\\n- We gave you antibiotics to treat your urinary tract infection \\nfor 10 days.\\n- You had problems with nausea and vomiting and you were scared \\nto eat solid food. You passed a swallow test so we started you \\non soft foods and transitioned you to a regular diet.\\n \\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  \\n- Continue to take all your medicines and keep your \\nappointments.  \\n- Dr. ___ urology ___ contact you regarding \\ndefinitive stone management.\\n\\nWe wish you the best!  \\n\\nSincerely,  \\nYour ___ Team  \\n\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___.                  Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: PLASTIC\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\nAttending: ___.\\n \\nChief Complaint:\\nForeign body left proximal tibia\\n \\nMajor Surgical or Invasive Procedure:\\nRemoval foreign body, deep.\\nWashout and debridement down to and inclusive of bone.\\nApplication of VAC sponge x3\\nWashout and debridement down to and inclusive of bone.\\nRepair patellar tendon disruption.\\nLeft lower leg debridement of skin and subcutaneous fat.\\nLeft lower extremity gastrocnemius muscle flap\\nLeft lower extremity local advancement closure of donor site.\\nLeft lower extremity split-thickness skin graft 20 x 12 cm\\n\\n \\nHistory of Present Illness:\\n___ male with a history of a traumatic injury to the \\nanterior surface of the tibia with an open wound over patellar \\ntendon ___. He underwent a\\npatella tendon repair as well. Decision was made to bring him\\nto the operating room for repair and wound closure with\\ncoverage with gastrocnemius flap and split-thickness skin\\ngraft.  \\n \\nPhysical Exam:\\nAVSS\\nNAD\\nRRR\\nCTAB\\nABD Soft NT ND\\nExt: Skin graft donor site: xeroform partially intact, healing \\nwell\\nGastroc flap w/ STSG:  Full take, healing well\\n\\n \\nPertinent Results:\\n___ 10:45AM BLOOD WBC-10.5# RBC-4.40* Hgb-12.1* Hct-37.5* \\nMCV-85 MCH-27.6 MCHC-32.4 RDW-13.2 Plt ___\\n___ 10:45AM BLOOD Glucose-101 UreaN-10 Creat-0.7 Na-141 \\nK-4.0 Cl-102 HCO3-30 AnGap-13\\n___ 10:45AM BLOOD ALT-65* AST-39 AlkPhos-64\\n___ 10:45AM BLOOD Calcium-9.1 Phos-3.9 Mg-2.2\\n\\nCT LEFT LOWER EXTREMITY WITHOUT INTRAVENOUS CONTRAST: \\n  \\nAt the site of foreign body extraction, there is a large, \\napproximately 3.7 x \\n1.7 x 1.7 cm osseous defect within the proximal tibia at the \\nmetadiaphysis, \\nwhich does not involve the tibial articular surface (2:40, \\n450A:42). There is \\nassociated interruption of the cortex at the anteromedial aspect \\nof the tibia, \\nwhere tiny locules of gas are seen. There is overlying soft \\ntissue defect of \\nskin and fat, with packing at the site of surgical debridement. \\nThe defect \\nextends up to, but does not breach, the posterior tibial cortex. \\nNo other \\nsbony injury is detected. The patellar tendon appears \\nessentially intact, \\nconsistent with the history of surgical repair. There is \\nexpected surrounding \\nsoft tissue edema. A tiny subcentimeter locule of fat is seen \\nwithin the \\npatellofemoral joint (2:14). \\n  \\nThe distal tibia and fibula appear normal. The ankle mortise \\nintact and \\nappears normal. Incidental note is made of an approximately 1.1 \\nx 0.9 x 0.5 cm \\nintraosseous lipoma of the middle portion of the calcaneus \\n(450A:61, 451B:46). \\n  \\nIMPRESSION: \\n  \\n1. Proximal tibial osseous and soft tissue defects at site of \\nforeign body \\nextraction, extending up tp, but not breaching, the posterior \\ntibial cortex, \\nwith surrounding soft tissue edema. \\n  \\n2. Intraosseous lipoma of calcaneus incidentally noted.\\n\\n LEFT KNEE, TWO VIEWS: An 81 x 11 mm radiopaque foreign body is \\nseen embedded \\nwithin the proximal tibial metaphysis. The object enters the \\nbone obliquely \\nand measures approximately 1.5 cm at the site of entry. There \\nappears to be \\nassociated subcutaneous air along the proximal shin; however, \\nthis is \\ndifficult to definitively visualize due to overexposure of the \\nsoft tissue \\ncomponents. No joint effusion is seen in the suprapatellar \\nspace. The rest \\nof the visualized bony structures appear within normal limits. \\n  \\nIMPRESSION: Foreign object embedded within the proximal tibial \\nmetaphysis. \\n  \\n\\n \\nBrief Hospital Course:\\n___:  To OR by Ortho trauma for removal of foreign object, \\ndebridement, VAC\\n___:  To OR by Ortho trauma for debridement, VAC, patellar \\ntendon repair\\n___:  To OR by Plastic surgery for L gastroc flap, debridement, \\nSTSG, VAC placement\\n___:  Superficial cellulitis LLE: Abx-Vanc, then  \\nDicloxicillin.  Improved.  To complete 14d course abx.\\n\\nIncremental increases in LLE dangling from bed daily.  Worked \\nwith ___ on ___ and ___ for eval for home.\\n\\nTolerating regular diet, pain well controlled.  Patient \\nambulating with crutches, and able to use crutches with stairs \\n(stairs at home).\\n\\n \\nMedications on Admission:\\nn/a\\n \\nDischarge Medications:\\n1. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical \\nQID (4 times a day) as needed for pruritis.  \\n2. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday) as needed for constipation.  \\n3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).  \\n4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 \\ntimes a day).\\nDisp:*21 Capsule(s)* Refills:*1*\\n5. Dicloxacillin 500 mg Capsule Sig: One (1) Capsule PO Q6H \\n(every 6 hours) for 8 days.\\nDisp:*32 Capsule(s)* Refills:*0*\\n6. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every \\n6 hours) as needed for pain or fever.  \\n7. Diazepam 5 mg Tablet Sig: One (1) Tablet PO q6 hours as \\nneeded for muscle spasm.\\nDisp:*12 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nImpaled foreign body left proximal tibia\\nPatellar tendon tear.\\nOpen wound left lower extremity\\n\\n \\nDischarge Condition:\\nGood\\n\\n \\nDischarge Instructions:\\nTouch down weight bearing status, use crutches when ambulating.  \\nKeep knee immobilizer when out of bed.  Continue multi-podus \\nsplint on Left lower extremity.  Keep ACE wrap to left lower \\nextremity up to knee.  Keep skin graft covered with xeroform. \\nand wrapped with Kerlix.\\n\\nGENERAL DISCHARGE SUMMARY\\nReturn to the ER if: \\n* If you are vomiting and cannot keep in fluids or your \\nmedications.\\n* If you have shaking chills, fever greater than 101.5 (F) \\ndegrees or 38 (C) degrees, increased redness, swelling or \\ndischarge from incision, chest pain, shortness of breath, or \\nanything else that is troubling you.\\n* Any serious change in your symptoms, or any new symptoms that \\nconcern you.\\n* Please resume all regular home medications and take any new \\nmeds as ordered. \\n* Do not drive or operate heavy machinery while taking any \\nnarcotic pain medication. You may have constipation when taking \\nnarcotic pain medications (oxycodone, percocet, vicodin, \\nhydrocodone, dilaudid, etc.); you should continue drinking \\nfluids, you may take stool softeners, and should eat foods that \\nare high in fiber.\\n\\n \\nFollowup Instructions:\\n___\\n',\n",
              " \" \\nName:  ___               Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nCodeine / Imitrex / Toradol / Aspirin / morphine\\n \\nAttending: ___.\\n \\nChief Complaint:\\nabdominal pain\\n \\nMajor Surgical or Invasive Procedure:\\nNA\\n \\nHistory of Present Illness:\\n___ year old female PMH of CVA (paraplegic with neurogenic \\nvoiding dysfunction), RA, lupus, possible Crohn's (not \\nconsistent pathology on prior admission), chronic abdominal pain \\n(multiple SBOs s/p subtotal colectomy), nephrolithiasis, DM2, \\nanxiety, and depression, narcotics dependence, now s/p SPT \\nreplacement on ___ with new onset abdominal symptoms and pain. \\n  \\n\\nThe patient has been having lower abdominal pain and has been \\nhaving bilateral lower back pain. The patient has intermittent \\nobjective fevers to 102 during this time. The patient otherwise \\nis having some chills. The patient states that there has been \\nurine leaking around the suprapubic cath. She went to ___ \\n___ and started on PO ABx for UTI (Keflex). The patient had \\na CT scan at ___ which was unremarkable, but as she has had \\ncontinued pain and UTI symptoms. She had an initial lactic of \\n3.0 that improved after fluids. \\n\\nPertinent ED course:\\nInitial vitals: T98.5, HR 108, BP 122/97, RR 18, 97% Ra\\n\\nExam: redness around suprapubic site with significant \\ntenderness, afebrile during entire ED stay\\n\\nRelevant labs: \\nBMP: Na 138, K 4.1, Cl 102, HCO3 21, BUN 8, Cr 0.7\\nCBC: WBC 12.0, Hgb 11.6, platelets 224\\nUA: cloudy with large leuk, mod blood, nitrate positive, protein \\n600, gluc 150, RBC 78, WBC 182, Bact many\\nBcx and ucx pending\\n\\nPatient was given:\\n- Hydromorphone 1 mg x 8\\n- NS 2 L\\n- Cefepime 2g \\n- Acetaminophen 1 g x2\\n- Insulin \\n\\nConsult: urology\\n \\nVitals on transfer: T97.8, HR 102, BP 107/73, RR 16, 98% Ra\\n\\nUpon arrival to the floor, the patient reports that she is in \\nterrible pain. She says this is significantly worse than pain \\nshe has had on prior admissions. She says it is nothing like her \\nadmission in ___ for similar complaints.  The patient \\nreports she has had fevers at home up to 102. She says the pain \\nstarted right after her procedure on ___. It has only gotten \\nworse since then. She notes headache, chills, no rigors, no \\nlightheadedness. She notes the catheter was draining red liquid \\nand now it is clear. Her appetite is decreased and she has had \\nsome nausea and vomiting. She states she has been having normal \\nbowel movements and that this does not feel like her prior small \\nbowel obstructions.\\n\\nShe says she has both pain and anxiety right now. She says she \\ntakes Xanax up to 3x a day. \\n\\nThe patient states she knows her medications and doses, but on \\nreview of her medications the only thing she is able to share is \\nshe is not taking her methotrexate right now because she is \\nworried she is infected. She has confusion surrounding some of \\nher meds including atorvastatin that she said she discontinued, \\nand paroxetine she says she may be taking 2x a day. She says she \\ntook all 40 of her oxycodone within the first week or so after \\nher catheter placement.   \\n \\nREVIEW OF SYSTEMS:  \\n(+) per HPI\\n(-) for chest pain, palpitations, shortness of breath, cough\\n\\n \\nPast Medical History:\\n 1. Seropositive rheumatoid arthritis.  \\n 2. ?SLE diagnosed in ___ in the setting of Humira. Never on  \\n hydroxychloroquine. No kidney biopsy or history of nephritis.  \\n 3. ?Crohn's disease complicated by multiple small bowel  \\n obstructions.  \\n 4. CVAs and ?spinal cord infarct in ___ cardiac \\narrest, resulting in bilateral lower extremity paralysis, atonic \\nbladder now s/p SPT  \\n 5. Diabetes diagnosed at age ___.  \\n 6. Depression.  \\n 7. Insomnia.  \\n 8. Narcotic dependence.  \\n 9. ___ femoral head avascular necrosis  \\n \\nSocial History:\\n___\\nFamily History:\\nMother - RA, DM\\nFather - CAD, DM, RA\\nMGM - RA, DM\\nPGM - RA, DM\\nMaternal aunt and maternal cousins - breast cancer\\n \\nPhysical Exam:\\nADMISSION PHYSICAL\\n================\\nGENERAL: appears distressed, rolling over in bed with complaints \\nof abdominal pain. \\nHEENT: pupils equal and reactive, but small, nonicteric sclera, \\ndry MMM, neck soft without lymphadenopathy \\nCV: normal S1, S2, RRR, no mururs/rubs/gallops\\nRESP: clear to auscultation, no wheezes or gallops\\nGI/GU: abdomen with normal bowel sounds, non-distended, rigid on \\nexam. Site around supra-pubic catheter has small ~1 cm erythema \\nthat dull in color, exquisitely tender to palpation with \\npositive costophrenic tenderness (patient reports abdominal pain \\nw/ test). \\nMSK: cool extremities, 2+ DP, no peripheral edema\\nSKIN: no excoriations, rashes noted\\nNEURO: does not move legs spontaneously, moves other extremities \\nw/o difficulty. \\nPSYCH: AOx2\\n\\nDISCHARGE PHYSICAL\\n===================\\nVITALS: 97.9 PO128 / 74 L Lying 71 1695RA  \\nGENERAL: appears more comfortable today\\nHEENT: pupils equal and reactive, but small, nonicteric sclera\\nMMM, neck soft without lymphadenopathy \\nCV: normal S1, S2, RRR, no mururs/rubs/gallops\\nRESP: clear to auscultation, no wheezes or gallops\\nGI/GU: abdomen with normal bowel sounds, softer on exam this\\nAM, distractible, SPT site looks lcean and dry\\nMSK: warm extremities, 2+ DP, trace edema bilaterally\\nSKIN: no excoriations, rashes noted\\nNEURO: does not move legs spontaneously, no sensation in LEs,\\nmoves other extremities w/o difficulty. \\n \\nPertinent Results:\\nADMISSION \\n=========\\n___ 12:15AM BLOOD WBC-12.0*# RBC-4.14 Hgb-11.6 Hct-37.0 \\nMCV-89 MCH-28.0 MCHC-31.4* RDW-14.5 RDWSD-47.2* Plt ___\\n___ 12:15AM BLOOD Neuts-60 Bands-0 ___ Monos-6 Eos-2 \\nBaso-0 Atyps-2* ___ Myelos-0 AbsNeut-7.20* AbsLymp-3.84* \\nAbsMono-0.72 AbsEos-0.24 AbsBaso-0.00*\\n___ 12:15AM BLOOD Glucose-179* UreaN-8 Creat-0.7 Na-138 \\nK-4.1 Cl-102 HCO3-21* AnGap-15\\n\\nDISCHARGE\\n=========\\n___ 07:15AM BLOOD WBC-7.1 RBC-4.01 Hgb-11.4 Hct-35.9 MCV-90 \\nMCH-28.4 MCHC-31.8* RDW-14.6 RDWSD-47.2* Plt ___\\n___ 07:15AM BLOOD Glucose-106* UreaN-4* Creat-0.6 Na-143 \\nK-4.1 Cl-104 HCO3-23 AnGap-16\\n___ 07:15AM BLOOD Calcium-9.1 Phos-4.4 Mg-1.7\\n\\nMICRO\\n=====\\n___ 1:15 am URINE\\n\\n                            **FINAL REPORT ___\\n\\n   URINE CULTURE (Final ___: \\n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \\nWITH FECAL\\n      CONTAMINATION. \\n\\n___ BCx: NGTD\\n\\nIMAGING \\n=======\\n\\n___ KUB\\nFINDINGS:\\n \\nThere is a moderate amount of gas in the stomach and small bowel \\nloops. Fecal\\nmaterial is seen in the rectum. There is marked dilation of the \\nsigmoid colon\\nwhich is increased from prior exam.\\nSupine assessment limits detection for free air; there is no \\ngross\\npneumoperitoneum.\\nOsseous structures are unremarkable.\\nCurvilinear metallic densities are seen again in the right \\nhemiabdomen,\\nunchanged from previous studies.\\nThere are no unexplained soft tissue calcifications or \\nradiopaque foreign\\nbodies.\\n \\nIMPRESSION:\\n \\nMarked dilation of the sigmoid colon, increased from prior exam. \\nConsider\\ncontrast enhanced CT to evaluate for active disease.\\n\\n___ KUB\\nFINDINGS: \\n \\nA moderate amount of gas is again noted in the stomach and \\nproximal smallbowel. There is interval improvement of the \\ndilated sigmoid colon when compared to the most recent study.  \\nOverall, there is a nonobstructive gas pattern. There is no free \\nintraperitoneal air.\\nOsseous structures are unremarkable. Curvilinear metallic \\ndensities are seen again in the right hemiabdomen, unchanged \\nfrom the previous study.\\nThere are no unexplained soft tissue calcifications or \\nradiopaque foreign bodies.\\n \\nIMPRESSION: \\n \\nInterval improvement of the sigmoid colon dilation.\\n\\n \\nBrief Hospital Course:\\n___ year old female PMH of CVA (paraplegic with neurogenic \\nvoiding dysfunction), RA, lupus, possible Crohn's, chronic \\nabdominal pain (multiple SBOs s/p subtotal colectomy), \\nnephrolithiasis, DM2, anxiety, and depression, now s/p SPT \\nreplacement on ___ with new onset abdominal symptoms and pain \\nconcerning for complicated UTI. \\n\\nACUTE/ACTIVE PROBLEMS:\\n#Sepsis secondary to UTI\\nPatient with initial fever, leukocytosis, tachycardia, and \\nrecent instrumentation and UA concerning for ongoing urinary \\ntract infection meeting sepsis criteria. Patient has had a \\nmultitude of various urinary tract infections previously \\nincluding proteus and. e-coli. Most recent available culture on \\nadmission showed proteus resistant to keflex, started on \\ncefepime to cover for this. Cultures from OSH showed E. Coli in \\nthe urine pan sensitive, and mixed flora from suprapubic ostomy \\nswab that were sensitive to quinolone, so patient was switched \\nto levofloxacin and sent home with oral levofloxcain to continue \\nuntil ___.  Leukocytosis resolved with IVF and Antibiotics.   \\nPt had improvement in symptoms and was tolerating po diet \\nwithout difficulty by the time of discharge.\\n\\n#Abdominal pain: \\n#Lower back pain:\\n#Opiate related constipation\\nPatient has no abnormal findings of air on her OSH CT scan other \\nthan some fat stranding around SPT felt consistent with recent \\nreplacement. Urology was consulted in ED and during admission \\nand saw no need for any surgical intervention. SPT looked clean, \\nostomy site with no evidence of active infection. She was given \\npain control initially with standing tylenol and IV dilaudid, \\ndilaudid PCA. She was converted to PO oxycodone which was \\ntapered down to 5mg q8h on discharge. She had a KUB on ___ \\nwhich showed dilated sigmoid colon with large stool burden, but \\nreceived methylnatrexone and had multiple BMs.  Repeat KUB \\nshowed improvement in dilation and symptoms improved. She was \\nmaintained on an aggressive bowel regimen. Oxybutinin was also \\nadded as patient likely having bladder spasm, and gabapentin \\nadded for non-opioid pain control to help taper down on opioid \\ndose, given concerns for opioid induced constipation with h/o \\nSBO.   Pt was educated about the importance of avoiding opiates \\nand weaning down off oxycodone as soon as possible.\\n\\n#Nutrition:\\nPatient taking poor PO intake with dry MM on admission. Intake \\nimproved over the course of the hospitalization.\\n\\n#Anxiety: \\n#Psych: \\n#Insomnia \\nContinued trazadone (home is 300 mg nightly, gave 150 mg), paxil \\ncontinued 40 mg daily, amitriptyline 50mg QHS, continued \\nalpraxolam 0.5 mg BID \\n\\n#DM2: \\nHeld home metformin 1000 mg BID, started ISS\\n\\nTRANSITIONAL ISSUSES:\\n=====================\\n[] Some concern around narcotics use during admission and \\nassociated constipation. \\n[] Discharged with 14 pills of 5mg oxycodone\\n[] Would check a chem-10 at PCP ___ appointment, magnesium \\nrequired replacement during admission likely due to multiple BMs\\n[] Would likely benefit from connection to a pain management \\nspecialist\\n[] Uptitrate gabapentin as tolerated, discharged on 300 mg TID \\n[] Patient with intermittent use of methotrexate would benefit\\nfrom outpatient Rheum follow up (previously in system) \\n[] Likely would benefit from GI follow up in ___ clinic \\n(___\\nrecommended Dr. ___ or Dr. ___ on a\\nprior admission)\\n[] NEW MEDS: Gabapentin 300mg TID, oxybutynin 5mg BID, \\nlevofloxacin 500mg q24h through ___\\n# HCP: sister: ___ ___\\n \\n___ on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. TraZODone 300 mg PO QHS \\n2. MetFORMIN (Glucophage) 1000 mg PO BID \\n3. PARoxetine 40 mg PO DAILY \\n4. Amitriptyline 50 mg PO QHS \\n5. ALPRAZolam 0.5 mg PO BID \\n6. Glargine 10 Units Breakfast\\nGlargine 10 Units Dinner\\n7. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \\n\\n \\nDischarge Medications:\\n1.  Acetaminophen 1000 mg PO TID \\nRX *acetaminophen 500 mg 2 capsule(s) by mouth every eight (8) \\nhours Disp #*270 Capsule Refills:*0 \\n2.  Docusate Sodium 100 mg PO BID \\nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \\nDisp #*90 Capsule Refills:*0 \\n3.  Gabapentin 300 mg PO TID \\nRX *gabapentin [Neurontin] 300 mg 1 capsule(s) by mouth three \\ntimes a day Disp #*135 Capsule Refills:*0 \\n4.  Levofloxacin 500 mg PO Q24H Duration: 6 Days \\nRX *levofloxacin 500 mg 1 tablet(s) by mouth daily Disp #*5 \\nTablet Refills:*0 \\n5.  Oxybutynin 5 mg PO BID \\nRX *oxybutynin chloride 5 mg 1 tablet(s) by mouth twice a day \\nDisp #*90 Tablet Refills:*0 \\n6.  OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - \\nModerate \\nRX *oxycodone 5 mg 1 tablet(s) by mouth twice a day Disp #*14 \\nTablet Refills:*0 \\n7.  Polyethylene Glycol 17 g PO DAILY \\nRX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by \\nmouth daily Disp #*45 Packet Refills:*0 \\n8.  Senna 8.6 mg PO BID \\nRX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp \\n#*90 Tablet Refills:*0 \\n9.  Glargine 10 Units Breakfast\\nGlargine 10 Units Dinner \\n10.  ALPRAZolam 0.5 mg PO BID  \\n11.  Amitriptyline 50 mg PO QHS  \\n12.  Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies  \\n\\n13.  MetFORMIN (Glucophage) 1000 mg PO BID  \\n14.  PARoxetine 40 mg PO DAILY  \\n15.  TraZODone 300 mg PO QHS  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary Diagnosis\\n=============\\nComplicated urinary tract infection\\n\\nSecondary Diagnosis\\n================\\nAbdominal pain\\nOpiate induced constipation\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Out of Bed with assistance to chair or \\nwheelchair.\\n\\n \\nDischarge Instructions:\\nMs. ___,\\n\\nIt was a pleasure to take care of you at ___. \\n\\nWHY WAS I HERE?\\nYou were admitted to the hospital because you had been having \\nabdominal pain and had a urinary infection.\\n\\nWHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL\\n- You were treated with antibiotics for your infection\\n- You were given medications to help control your pain\\n\\nWHAT SHOULD I DO WHEN I GET HOME?\\n1) Follow up with your Primary Care Doctor.\\n2) Please take all your medications as prescribed\\n\\nWe wish you the best!\\n\\nYour ___ Care Team\\n \\nFollowup Instructions:\\n___\\n\",\n",
              " ' \\nName:  ___               Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPenicillins\\n \\nAttending: ___.\\n \\nChief Complaint:\\nAnorexia, nausea, vomiting, diffuse pruritus x 1 month, found to \\nhave hypertensive urgency\\n \\nMajor Surgical or Invasive Procedure:\\nTunneled hemodialysis line placement \\n\\n \\nHistory of Present Illness:\\nMr. ___ is a ___ year-old male with history of diabetes \\nmellitus (last A1c was 6.36% in ___ complicated by \\nnephropathy, retinopathy, s/p PRP (___), HTN, HLD, CKD stage \\nIV s/p RUE AVF placement (___), OSA, MDD, and schizophrenia \\nwho presents with anorexia, nausea, vomiting, and diffuse \\npruritis for 1 month. He has had relatively quick progressive \\nrenal dysfunction believed to be secondary to diabetic \\nnephropathy. Patient has had multiple recent admissions related \\nto volume overload. He was seen by his nephrologist, Dr ___ \\non ___ complaining of these same symtpoms. Dr. ___ \\n___ Mr. ___ to be directly admitted for HD \\ninitiation, but he reports that he \"had things to take care of.\" \\nHe reports that he is now ready to initiate HD. He denies chest \\npain, shortness of breath, dysuria, hematuria. He does note \\nincreased urine volume after increasing his diuretic. He has \\nnoticed a corresponding decrease in his ___ edema. He did not \\ntake his medications this morning however. Related to this, he \\nhas an occasional \"funny\" sensation on his right thumb, but no \\nsymptoms consistent with steal.  \\n\\nThe patient is additionally reporting orthopnea and paroxysmal \\nnocturnal dyspnea. He denies chest pain, abdominal pain, bowel \\nor bladder changes (although he does note dark urine lately). Pt \\nhad AVF placed on ___, which is not yet mature.  \\n\\n \\nPast Medical History:\\n-CHF/Cardiomyopathy: Mild systolic and severe diastolic \\ndysfunction.  \\n-Diabetes  \\n-Hypertension  \\n-Hypercholesterolemia  \\n-CKD, stage 3  \\n-Depression/Schizophrenia  \\n-OSA  \\n \\nSocial History:\\n___\\nFamily History:\\nMother and maternal grandmother had diabetes and both used \\ninsulin.  Mother died of cancer. Grandfather (maternal) also has \\ndiabetes. Father is alive at ___. He does not know his father\\'s \\nhealth  status. No early CAD or sudden cardiac death.\\n \\nPhysical Exam:\\nOn admission: \\nVitals - T: 98.5 BP: 190/94 HR: 80 RR: 16 02 sat: 99%RA  \\nGen: Young man lying comfortably in bed, in no acute distress  \\nHEENT: No conjunctival pallor. No icterus. MMM. OP clear. \\nDecreased vision in right eye.  \\nNECK: Supple, No LAD. JVP 12. Normal carotid upstroke without \\nbruits. No thyromegaly.  \\nCV: RRR. normal S1, loud P2. ___ HSM at ___  \\nLUNGS: Crackles bilateral bases. No wheezes. Breathing \\ncomfortably.  \\nABD: Nondistended, +BS, nontender in all quadrants, no \\nrebound/guarding, no hepatosplenomegaly  \\nEXT: WWP, 1+ edema bilaterally. Full distal pulses bilaterally.  \\n\\nNo femoral bruits. Right AV fistula in the patient\\'s wrist with \\na palpable thrill.  \\nSKIN: No rashes/lesions, ecchymoses.  \\nNEURO: A&Ox3. CN ___ grossly intact. Preserved sensation  \\nthroughout. ___ strength throughout. ___ reflexes, equal ___.  \\n\\nOn discharge:\\nVS - Temp 98.3 BP 174/72 HR 72 RR 18 SpO2 95% RA  \\nGeneral: well-appearing, NAD  \\nHEENT: MMM, EOMI right, left eye closed without eye patch  \\nNeck: Supple. JVP at angle of mandible.  \\nCV: RRR, S1/S2, I/VI systolic murmur at left sternal border  \\nLungs: Crackles right base > left base. Good air movement.  \\nAbdomen: Obese. Soft, nontender. +BS. No palpable masses.  \\nExt: No cyanosis. Trace edema bilaterally to mid-calf. Bilateral \\nradial pulses 2+, palpable thrill and bruit auscultated over R \\nforearm AV fistula  \\nNeuro: CN grossly intact. Vision decreased in right eye (patient \\nstates chronic)  \\nSkin: Xerosis over bilateral legs. No rashes or other lesions.  \\n\\n \\nPertinent Results:\\nOn admission:\\n___ 12:45PM BLOOD WBC-5.3 RBC-2.72* Hgb-8.0* Hct-26.2* \\nMCV-96 MCH-29.3 MCHC-30.4* RDW-15.0 Plt ___\\n___ 12:45PM BLOOD Neuts-72.3* ___ Monos-4.9 \\nEos-4.3* Baso-0.6\\n___ 12:45PM BLOOD ___ PTT-34.7 ___\\n___ 10:00AM BLOOD UreaN-60* Creat-4.7* Na-144 K-3.7 Cl-105 \\nHCO3-26 AnGap-17\\n___ 10:00AM BLOOD Calcium-8.3* Phos-4.6*\\n___ PPD planted and negative at 72 hours\\n\\nAt discharge:\\n___ 06:32AM BLOOD WBC-4.3 RBC-2.77* Hgb-8.3* Hct-25.7* \\nMCV-93 MCH-29.9 MCHC-32.2 RDW-14.1 Plt ___\\n___ 06:32AM BLOOD Glucose-127* UreaN-48* Creat-4.7* Na-137 \\nK-3.9 Cl-100 HCO3-29 AnGap-12\\n\\nIn the interim:\\n___ 06:32AM BLOOD Calcium-8.6 Phos-4.5 Mg-2.0\\n___ 12:45PM BLOOD cTropnT-0.47*\\n___ 12:45PM BLOOD CK-MB-11*\\n___ 01:04PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE \\nHBcAb-NEGATIVE\\n\\nMicrobiology:\\nUrine culture (___):\\nNo evidence of deep vein thrombosis in the left upper extremity. \\n Moderate subcutaneous edema in the arm. \\n\\nImaging:\\nECG ___\\nSinus rhythm. Prolonged Q-T interval. Possible left atrial \\nabnormality. \\nNon-specific inferolateral ST-T wave abnormalities. Compared to \\nthe previous tracing of ___ no significant change. \\n  Intervals Axes \\nRate PR QRS QT/QTc P QRS T \\n74 ___ 54 48 -20 \\n\\nCXR ___  \\nImpression: Severe cardiomegaly with mild pulmonary vascular \\ncongestion. Continued elevation of the right hemidiaphragm again \\nraises concern for a subpulmonic effusion. Bibasilar \\natelectasis.  \\n\\nCT head without contrast ___  \\nImpresion: New hypodensity in the splenium of the corpus \\ncallosum, for which MRI is recommended. \\n\\nTunneled dialysis catheter placement ___\\nSuccessful placement of a 15.5 ___ tunneled dialysis line.  \\nThe tip of the catheter terminates in the right atrium. The \\ncatheter is ready for use. \\n\\nNeck soft tissue ultrasound ___\\nMinimal subcutaneous gas, within expected postprocedural limits. \\nNo soft \\ntissue hematoma or abscess identified.  Anechoic area deep to \\ncatheter may be artifactual, but if there is continued concern \\nfor hematoma, neck CT would be necessary to evaluate. \\n\\nLeft upper extremity venous ultrasound ___\\nNo evidence of deep vein thrombosis in the left upper extremity. \\n Moderate subcutaneous edema in the arm. \\n\\n \\nBrief Hospital Course:\\nMr. ___ is a ___ with history of end stage renal disease \\nwho was admitted for nausea/vomiting/pruritus, as well as \\nhypertensive emergency, with systolic blood pressures up to \\n200-230s upon presentation. He was noted to be in progressive \\nrenal failure in urgent need of initiation of hemodialysis. \\n\\nACTIVE ISSUES:\\n#Hypertensive emergency: Patient presented with systolic blood \\npressures up to 223/112 in the ED and troponinemia concerning \\nfor end-organ damage, though troponinemia confounded by ESRD. \\nCardiology evaluated the patient in the ED before admission and \\nfelt that there was no need to continue trending cardiac enzymes \\ndue to  low suspicion for acute coronary syndrome, advising \\ninstead improved blood pressure control. He did not endorse any \\ndizziness, lightheadedness, chest pain, palpitations, or \\nheadaches upon presentation, and decreased vision bilaterally \\nwas unchanged from baseline and felt to be attributable to \\nbilateral vitreous hemorrhage as below. Over the course of his \\nstay, he was maintained on his home antihypertensive regimen, \\nwhich included labetalol, hydralazine, lisinopril, and \\nisosorbide, with addition of amlodipine for improved blood \\npressure control, with systolic blood pressures largely under \\n170s at discharge. \\n\\n#End stage renal disease: On admission, patient was endorseing \\nnausea, vomiting, and pruritus likely secondary to uremia. Also, \\nhe reported orthopnea and paroxysmal noctural dyspnea presumed \\nto be secondary to volume overload. He was scheduled to have an \\n___ tunneled line placed the morning after admission, as \\nhis AV fisula that was placed on ___ was not yet mature. \\nPlacement of the left-sided line was uneventful. He received 4 \\nsessions of HD in-house, and during each of the last 2 sessions, \\nhe had 4L volume taken off. Overall, he tolerated the sessions \\nwell. During session #4, his systolic blood pressure rose again \\nto the 200s, and his anti-hypertensives which had not been \\nadministered prior to the session were given during dialysis. \\nSystolic blood pressure decreased to 95, and UF was adjusted \\naccordingly. He returned to the floor complaining of dizziness, \\nwhich self-resolved within ___ hours. PPD placed and hepatitis \\nserologies sent this admission, all of which returned negative. \\nHe was placed at an outpatient HD center on a \\n___ schedule. He was discharged on \\n___, and per discussion with renal, would initiate \\noutpatient sessions on ___. He has follow-up \\nscheduled with Dr. ___ his AV fistula; once that has \\nadequately matured, patient\\'s tunneled line can be discontinued. \\nHis sevelamer and calcitriol were continued throughout this \\nstay.\\n\\n#Left upper extremity swelling: Patient did complaint of left \\nupper extremity swelling during this admission, which improved. \\nHe did have a left upper extremity ultrasound, which returned \\nnegative for DVT. Swelling was thought to be secondary to volume \\noverload in the setting of need for initiation of dialysis.\\n\\n#Visual changes: Patient reports decreased vision in his right \\neye, and was noted to have a right vitreous hemorrhage, possible \\nsecondary to diabetic retinopathy, on a prior admission. He was \\ntransported to the ophthalmology clinic during this admission \\nfor follow-up visits, as well as a laser procedure in the right \\neye. Patient tolerated the procedure well. He has a scheduled \\nlaser treatment for his left eye for the week after discharge, \\nwhich also contains some degree of vitreous hemorrhage. He was \\ninstructed not to drive, and was discharged safely to ensure \\nthat someone could take care of him considering his visual loss \\non the right. \\n\\n# CT head changes/ splenium hypodensity: Patient received a CT \\nhead upon presentation to rule out intracranial hemorrhage/ \\nincreased intracranial pressure in the setting of hypertensive \\nemergency. While CT was negative for intracranial hemorrhage, it \\ndid reveal a new hypodensity in the splenium of the corpus \\ncallosum in the absence of focal neurologic deficits, hence of \\nunclear significance. An MRI could be considered for further \\nwork-up; however, the patient was not to receive gadolinium \\nduring his initial sessions of hemodialysis due to \\nnephrotoxicity. If further evaluation is necessary in the \\nfuture, nephrology will need to be consulted before any studies \\nare ordered and obtained. \\n\\nINACTIVE ISSUES:\\n#Chronic Diastolic heart failure: Last echo demonstrated an EF \\nof 50% and diastolic dysfunction with severe pulmonary \\nhypertension and increased TR/MR. ___ continued his home \\ndiuretics of Torsemide and Metolazone during this admission, \\nwith continued urine output.\\n\\n#Hyperlipidemia: Continued home Atorvastatin.\\n\\n#Anemia: At baseline. Likely iron-deficiency complicated by CKD. \\nWe continued iron replacement, and maintained an active type and \\nscreen. Patient received 1 unit PRBC this admission, with \\nappropriate response in hemoglobin and hematocrit. \\n\\n#Diabetes mellitus type 2: His last A1c 6.3% in ___. \\nComplicated by diabetic retinopathy (likely) and diabetic \\nnephropathy.  Patient was maintained on a humalon ISS in-house. \\n\\nTRANSITIONAL ISSUES:\\n-Patient will need close follow-up with nephrology at his \\noutpatient dialysis appointments.\\n-He has follow-up scheduled at the ___ with Dr. \\n___ his maturity of his fistula/ readiness for use will \\nbe assessed at that time.\\n-Patient should follow-up with his PCP to optimize blood \\npressure control regimen.\\n-Patient is already being seen in the ophthalmology clinic and \\nbeing followed for his right eye vitreous hemorrhage, for which \\nhe received an initial laser treatment on this admission. Close \\nfollow-up is scheduled.\\n-MRI is advised for further characterization of corpus callosum \\nlesion noted incidentally on admission CT, with gadolinium \\ncontraindicated in the initial sessions of hemodialysis (and \\nperhaps indefinitely) due to nephrotoxicity; there were no clear \\nfocal neurologic deficits, with visual changes felt to be \\nattributable to vitreous hemorrhage as above.\\n-No pending studies.\\n-Code status: Full \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Aspirin 81 mg PO DAILY \\n2. Atorvastatin 40 mg PO DAILY \\n3. Calcitriol 0.25 mcg PO DAILY \\n4. HydrALAzine 50 mg PO TID \\n5. Isosorbide Dinitrate 40 mg PO TID \\n6. Lisinopril 40 mg PO DAILY \\n7. Ferrous Sulfate 325 mg PO BID \\n8. Vitamin D 50,000 UNIT PO 1X/WEEK (MO) \\n9. Torsemide 60 mg PO DAILY \\n10. sevelamer CARBONATE 800 mg PO TID W/MEALS \\n11. Metolazone 5 mg PO EVERY OTHER DAY \\n12. Labetalol 400 mg PO TID \\n13. Insulin SC \\n      Sliding Scale\\nInsulin SC Sliding Scale using HUM Insulin\\n\\n \\nDischarge Medications:\\n1. Atorvastatin 40 mg PO DAILY \\n2. Calcitriol 0.25 mcg PO DAILY \\n3. Ferrous Sulfate 325 mg PO BID \\n4. HydrALAzine 50 mg PO TID \\n5. Isosorbide Dinitrate 40 mg PO TID \\n6. Labetalol 400 mg PO TID \\n7. Lisinopril 40 mg PO DAILY \\n8. Metolazone 5 mg PO EVERY OTHER DAY \\n9. sevelamer CARBONATE 800 mg PO TID W/MEALS \\n10. Torsemide 60 mg PO DAILY \\n11. Vitamin D 50,000 UNIT PO 1X/WEEK (MO) \\n12. Amlodipine 10 mg PO DAILY \\nRX *amlodipine 10 mg 1 tablet(s) by mouth once a day Disp #*30 \\nTablet Refills:*0\\n13. Insulin SC \\n      Sliding Scale\\n\\nFingerstick QACHS\\nInsulin SC Sliding Scale using HUM Insulin\\n14. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPRIMARY DIAGNOSES: End stage renal disease on hemodialysis\\nHypertensive emergency\\n\\nSECONDARY DIAGNOSES: \\nHeart failure with preserved ejection fraction\\nHyperlipidemia\\nAnemia of chronic kidney disease\\nDiabetes mellitus type 2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nIt was a pleasure taking care of you while you were admitted to \\n___ for worsening kidney failure and inititaion of \\nhemodialysis.  You were found to have very high blood pressure \\nat admission, causing your heart to work very hard. We increased \\nyour blood pressure medicines, and the interventional \\nradiologists placed a dialysis line because your AV fistula was \\nnot mature yet.  You were started on hemodialysis for a total of \\nfour sessions during this admission.  \\n\\nWhile you were admitted, you saw the ophthalmology doctors for \\nfollow/up for your right eye hemorrhage. You were seen in the \\noffice on ___ and returned for a follow-up visit on ___ \\nfor a second follow-up, as well as a laser eye treatment.\\n\\nYou had a CT scan of your head because we were concerned about \\nyour high blood pressure and your vision changes for the past 2 \\nmonths. We also saw a small change in a CT scan of your head, \\nfor which we recommend a follow-up MRI.  \\n\\nWeigh yourself every morning, and please call your MD if your \\nweight goes up more than 3 lbs\\n \\nFollowup Instructions:\\n___\\n',\n",
              " ' \\nName:  ___                   Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___\\n \\nChief Complaint:\\ncough and shortness of breath\\n \\nMajor Surgical or Invasive Procedure:\\nnone\\n \\nHistory of Present Illness:\\nMs. ___ is a ___ woman with a history of autoimmune hepatitis\\non chronic prednisone, HTN, severe COPD, lung nodules\\nrepresenting likely lung cancer planned for biopsy, and remote\\nPE, presenting with 2 weeks of increasing cough and shortness of\\nbreath.  \\n\\n Patient reports not feeling well for the past two weeks, with\\nintermittent chills, increased coughing and sputum production,\\nand weakness. She also noticed streaks of blood in her sputum a\\ncouple of days ago. She has had mild nausea, although no\\nvomiting, diarrhea or abdominal pain. Does not endorse myalgias.\\nShe also endorses \"foul smelling urine\" for about a week, but no\\ndysuria. She lives alone at baseline and is fully functional,\\nalthough says she has not been eating for the last two weeks,\\nalthough she has been drinking minimally and taking her meds. \\nHer\\nson was \"really sick\" about two weeks ago, just at the onset of\\nher symptoms, although never required medical care. Of note, she\\nhas been followed here at ___ for lung nodules, and is planned\\nfor a VATS with Dr. ___ on ___.  \\n\\n In the ED, initial VS were: T 98.1, HR 65, BP 128/71, RR 20,  \\n 95% RA  \\n Exam notable for:  \\n Gen- Weak appearing, although not in acute distress  \\n Chest- Diminished lung sounds bilaterally, inspiratory wheezes  \\n\\n Abd- Soft, non-tender, non-distended  \\n Ext- Trace lower extremity edema  \\n Labs showed:  \\n - CBC: WBC 9.8, Hgb 13.0, Hct 40.8, Plt 312  \\n \\n - Lytes:  \\n 145 / 106 / 30  \\n -------------- 122  \\n 6.2 \\\\ 18 \\\\ 1.1  \\n - proBNP: 285  \\n - Lactate:2.3  \\n - repeat K 5.2  \\n Imaging notable for CXR showing:  \\n \\n 1. No new focal opacities suggest pneumonia.  \\n 2. Redemonstrated cavitary left upper lobe lesion is difficult\\nto compare prior chest CT and may have slightly grown. This \\ncould\\nbe further evaluated with nonemergent noncontrast chest CT, if\\nindicated.  \\n 3. Emphysema.  \\n \\n Patient received:  \\n /___ 00:28 IH Albuterol 0.083% Neb Soln 1 NEB  \\n ___ 00:28 IH Ipratropium Bromide Neb 1 NEB  \\n ___ 00:53 IVF NS Started  \\n ___ 01:00 IVF NS 1000 mL Stopped (___)  \\n ___ 02:41 IH Albuterol 0.083% Neb Soln 1 NEB  \\n ___ 02:41 IH Ipratropium Bromide Neb 1 NEB  \\n ___ 03:10 PO Benzonatate 100 mg  \\n ___ 03:10 IV Azithromycin 500 mg  \\n ___ 03:10 PO PredniSONE 60 mg  \\n\\n Transfer VS were: T 98.0, HR 102, BP 98/79, RR 22, 95% RA  \\n \\nPast Medical History:\\n-COPD\\n-Autoimmune Hepatitis (stage 1 fibrosis)\\n-Perforation during colonoscopy in ___ requiring ex lap \\n-Pulmonary Embolism ___ (provoked by surgery above)\\n-Systolic Dysfunction on echo (EF 45% ___ but no CHF \\nhistory\\n-Osteoporosis\\n-GERD\\n-Anemia\\n-S/p Cholecystectomy \\n\\n \\nSocial History:\\n___\\nFamily History:\\nHeart disease\\nDiabetes mellitus\\n \\nPhysical Exam:\\nADMISSION EXAM: \\nVital Signs: 24 HR Data (last updated ___ @ 1444)\\n    Temp: 98.1 (Tm 98.6), BP: 117/76 (113-122/70-77), HR: 88\\n(88-100), RR: 20 (___), O2 sat: 97% (95-97), O2 delivery: RA,\\nWt: 153.9 lb/69.81 kg   \\nGeneral: calm, NAD\\nHEENT: OP clear, no LAD\\nCV: RRR, no murmurs\\nPULM: Markedly decreased air movement in all lung ___ without\\nwheezing, no rales, no asymmetry\\nABD: obese, soft, NT, ND\\nEXT: No ___ edema, WWP\\n\\nDISCHARGE EXAM:\\n24 HR Data (last updated ___ @ 032)\\n    Temp: 98.4 (Tm 98.6), BP: 118/73 (106-128/69-80), HR: 76\\n(76-130), RR: 22 (___), O2 sat: 98% (90-98), O2 delivery: Ra  \\n\\nGeneral: alert, oriented, no acute distress\\nEyes:  Sclera anicteric\\nHEENT: MMM, oropharynx clear  \\nNeck: supple, no LAD  \\nResp: clear to auscultation bilaterally, distant breath sounds,\\nimproved air movement, faint crackles b/l at the bases. no\\nwheezes ronchi. \\nCV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\\ngallops  \\nGI: soft, non-tender, non-distended, bowel sounds present, no\\nrebound tenderness or guarding, no organomegaly  \\nMSK: warm, well perfused, 2+ pulses, no clubbing, cyanosis or\\nedema  \\nNeuro: CNs2-12 intact, motor function grossly normal  \\n \\nPertinent Results:\\nDISCHARGE LABS:\\n___ 06:16AM BLOOD WBC-8.1 RBC-3.43* Hgb-10.3* Hct-33.2* \\nMCV-97 MCH-30.0 MCHC-31.0* RDW-14.6 RDWSD-53.0* Plt ___\\n___ 06:16AM BLOOD Plt ___\\n___ 06:16AM BLOOD Glucose-121* UreaN-15 Creat-0.8 Na-141 \\nK-5.1 Cl-104 HCO3-27 AnGap-10\\n___ 10:33PM BLOOD proBNP-285\\n___ 06:16AM BLOOD Calcium-9.4 Phos-3.0 Mg-1.6\\n___ 10:17AM BLOOD Lactate-2.4* K-4.___ woman with a history of autoimmune hepatitis on chronic \\nprednisone, HTN, severe COPD, lung nodules representing likely \\nlung cancer planned for biopsy, and remote PE, presenting with 2 \\nweeks of increasing cough and shortness of breath, with \\ndecreased air movement on exam and no focal consolidation on \\nCXR, concerning for COPD exacerbation. \\n\\n#Dyspnea, cough\\n#COPD exacerbation:\\nHas severe obstructive defect by PFTs (FEV1 0.56L, 44% \\npredicted), followed by Dr. ___ as outpatient. Though per \\npatient report has not had significant limitiation and does not \\nappear to have frequent exacerbations. This admission, poor air \\nmovement and increased sputum point to this as etiology though. \\nReceived 60mg prednisone and dropped to 40mg. Discharged on a \\ntaper (40mg x 3d, 30mg x 3d, 20mg until surgery) per Dr. \\n___. Received azithromycin and discharged on 250mg x 4 \\ndays (last dose ___.\\n\\n# Enlarging FDG-avid pulmonary nodule:\\nVATS scheduled for ___ prior to this hospitalization. Original \\npre-op appointment being rescheduled due to this \\nhospitalization. Dr. ___ Dr. ___ have been \\nnotified and are coordinating care. \\n\\n# CHF: Continued home metoprolol, ASA. Held home lisinopril \\ninitially but restarted prior to discharge. \\n\\n#Chronic: autoimmune hepatitis, CHF, GERD\\nno modifications \\n\\n===================TRANSITIONAL ISSUES===============\\n[] prednisone taper per Dr. ___: 40mg x 2d (starting \\n___, 30mg x 3d (starting ___ 20mg daily (starting ___ \\nuntil instructed otherwise by Dr. ___\\n[] VATS preop appointment with Dr. ___ being \\nrescheduled\\n[] follow up appointment with Dr. ___ \\ncurrently being rescheduled\\n\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Ursodiol 500 mg PO BID \\n2. budesonide 0.5 mg/2 mL inhalation DAILY \\n3. PredniSONE 10 mg PO DAILY \\n4. Ipratropium Bromide Neb 1 NEB IH Q6H \\n5. AzaTHIOprine 50 mg PO DAILY \\n6. Magnesium Oxide 400 mg PO DAILY \\n7. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing \\n8. Lisinopril 2.5 mg PO DAILY \\n9. Atorvastatin 10 mg PO QPM \\n10. Alendronate Sodium 70 mg PO 1X/WEEK (___) \\n11. Omeprazole 40 mg PO DAILY \\n12. Metoprolol Succinate XL 25 mg PO DAILY \\n13. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1.  Azithromycin 250 mg PO DAILY Duration: 1 Dose \\nJust take this once.  \\n2.  Benzonatate 100 mg PO TID  \\n3.  PredniSONE 20 mg PO DAILY \\nStarting ___: 40mg daily\\nStarting ___: 30mg daily Starting ___: 20mg daily  \\n4.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing  \\n5.  Alendronate Sodium 70 mg PO 1X/WEEK (FR)  \\n6.  Aspirin 81 mg PO DAILY  \\n7.  Atorvastatin 10 mg PO QPM  \\n8.  AzaTHIOprine 50 mg PO DAILY  \\n9.  Budesonide 0.5 mg/2 mL inhalation DAILY  \\n10.  Ipratropium Bromide Neb 1 NEB IH Q6H  \\n11.  Lisinopril 2.5 mg PO DAILY  \\n12.  Magnesium Oxide 400 mg PO DAILY  \\n13.  Metoprolol Succinate XL 25 mg PO DAILY  \\n14.  Omeprazole 40 mg PO DAILY  \\n15.  Ursodiol 500 mg PO BID  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nprimary: COPD exacerbation\\n\\nsecondary: \\nlung nodule, hypertension, autoimmune hepatitis, heart failure, \\nhiatal hernia, gastroesophageal reflux disease\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\n================================================  \\n  MEDICINE Discharge Worksheet  \\n================================================  \\n  Dear ___,  \\n  It was a pleasure taking part in your care here at ___!  \\n\\n Why was I admitted to the hospital?  \\n  - You were admitted to ___ for cough and difficulty \\nbreathing. Your COPD was worsened, likely due to exposure to \\nyour son who was sick. \\n\\n What was done for me while I was in the hospital?  \\n  - You received your usual inhaler medications, antibiotics, \\nand a higher dose of prednisone than what you take normally. You \\nalso received a thorough investigation including blood tests and \\na chest X-ray. \\n  - We have notified Dr. ___ Dr. ___ are \\ncoordinating your care together to prepare you for your upcoming \\nVATS lung procedure. \\n\\n What should I do when I leave the hospital?  \\n  - You should take the new medications we\\'ve prescribed for you \\nand follow up with your scheduled appointments. \\n  - Dr. ___ is scheduling a follow up appointment in the \\nnext week and will be in contact with you. \\n\\n Sincerely,  \\n  Your ___ Care Team  \\n\\n \\nFollowup Instructions:\\n___\\n',\n",
              " \" \\nName:  ___                  Unit No:   ___\\n \\nAdmission Date:  ___              Discharge Date:   ___\\n \\nDate of Birth:  ___             Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\nAttending: ___.\\n \\nChief Complaint:\\nFever\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ h/o DM2 (uncontrolled), poorly differentiated Gastric CA \\nT2N0Mx s/p subtotal gastrectomy ___ admitted with fever, \\nweakness.  At baseline, reports that his sugar has been labile \\nwith BS intermittently going high to 300s.  Nearly ___ days ago, \\ndeveloped cough, sore-throat, fevers, associated with worsened \\nhyperglycemia 400's.  Also notes having concurrent dysuria.  \\nReports 3d ago developing temp to 103 and then 2d PTA temp 102.  \\nHe went to PCP yesterday and noted to be hypotensive to the \\n___, unwell.  As a result, was sent to the ED.\\n   In the ED, reportedly he was no longer hypotensive.  WBC \\n11.1, CXR neg, U/A with ___ large, Nit neg, WBC 15.  He was given \\ntotal of 3.5 L IVF over span of ED stay and given vanc/zosyn for \\nempiric coverge (presumed urosepsis).   He was admitted for \\nfurther mgmt.\\n  \\n\\nROS: per HPI, denies night sweats, headache, vision changes, \\nrhinorrhea, congestion, shortness of breath, chest pain, \\nabdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, \\nmelena, hematochezia, hematuria.  A 10 pt review of sxs was \\notherwise negative.\\n\\n \\nPast Medical History:\\n# Hyperchol\\n# DM2 - uncontrolled, mild retinopathy\\n# poorly differentiated Gastric CA with signet ring features \\nT2N0Mx\\n - s/p 6 cycles of ECF completed ___\\n - s/p robotic-assisted subtotal gastrectomy with RNY \\nreconstruction, radical lymphadenectomy ___\\n# Asthma\\n# Spinal stenosis\\n# BPH s/p prostate surgery x2\\n# Anxiety/depression\\n# Compression fx L1 Lumbar vertebra\\n \\nSocial History:\\n___\\nFamily History:\\nFamily History: sister - eye cancer, father - prostate cancer\\nMother- T2 diabetes, MI in ___\\n \\nPhysical Exam:\\nADMISSION PHYSICAL EXAM\\nVital Signs: 98.0  154/75  96 20 98% RA \\nGEN: NAD, well-appearing, lying in bed, interactive, pleasant\\nEYES: PERRL, EOMI, conjunctiva clear, anicteric\\nENT: moist mucous membranes, no exudates \\nNECK: supple \\nCV: RRR s1s2 nl, no m/r/g\\nPULM: CTA, no r/r/w \\nGI: normal BS, NT/ND, no HSM, no CVAT  \\nEXT: warm, no c/c/e\\nSKIN: no rashes \\nNEURO: alert, oriented x 3, answers ? appropriately, follows \\ncommands, non focal\\nPSYCH: appropriate\\nACCESS: PIV\\nFOLEY: absent\\n\\nDISCHARGE PHYSICAL EXAM\\nVS: 97.9 165/80 81 18 95 RA \\nGEN: NAD, well-appearing, lying in bed, interactive, pleasant\\nEYES: anicteric, non-injected\\nENT: MMM, grossly nl OP. No tonsilar euxudates, no significant \\nerythema or coblestoning. \\nNECK: supple, non meningismus, no LAD\\nBACK: no spinous process tenderness, no CVAT\\nCV: RRR nl S1/S2 no g/r/m 2+ rad/DP pulses\\nCHEST: CTAB no w/r/r\\nABD: soft, NT/ND, NABS, no HSM. CGM in LLQ, no erythema\\nGU: no suprapubic fullness/tenderness. \\nEXT: warm, no c/c/e, no joint effusions. \\nSKIN: no rashes \\nNEURO: alert, oriented x 3. moves all extremities spontaneously \\nand with purpose. Facial movements symmetrical, speech fluent, \\neyes conjugate, sensation to light touch preserved grossly. \\nPSYCH: pleasant and appropriate\\n \\nPertinent Results:\\nADMISSION LABS:\\n___ 04:05PM BLOOD WBC-11.1* RBC-4.48* Hgb-12.2* Hct-38.6* \\nMCV-86 MCH-27.2 MCHC-31.6* RDW-14.4 RDWSD-45.7 Plt ___\\n___ 04:05PM BLOOD Neuts-65.3 Lymphs-18.3* Monos-15.5* \\nEos-0.4* Baso-0.3 Im ___ AbsNeut-7.26* AbsLymp-2.04 \\nAbsMono-1.72* AbsEos-0.05 AbsBaso-0.03\\n___ 04:05PM BLOOD ___ PTT-34.3 ___\\n___ 04:05PM BLOOD Plt ___\\n___ 04:05PM BLOOD Glucose-129* UreaN-29* Creat-1.1 Na-141 \\nK-3.9 Cl-102 HCO3-27 AnGap-12\\n___ 04:05PM BLOOD ALT-29 AST-26 AlkPhos-66 TotBili-0.4\\n___ 04:05PM BLOOD Albumin-4.1\\n___ 04:18PM BLOOD ___ pO2-28* pCO2-57* pH-7.34* \\ncalTCO2-32* Base XS-1\\n___ 04:18PM BLOOD Lactate-2.5*\\n___ 04:18PM BLOOD O2 Sat-43\\n\\nIMAGING\\n# CXR (___): Lungs are clear bilaterally.   There is a right \\nchest wall Port-A-Cath with tip extending to the level of the  \\nmid SVC. There is no focal consolidation, effusion, or \\npneumothorax. The  cardiomediastinal silhouette is normal. \\nImaged osseous structures are intact.   No free air below the \\nright hemidiaphragm is seen. Clips are noted in the  left upper \\nabdomen.  IMPRESSION:   No acute intrathoracic process. \\nPort-A-Cath positioned appropriately \\n\\nMICRO:\\n- UCx: URINE CULTURE (Final ___:    < 10,000 CFU/mL. \\n- BCx: No growth to date\\n\\nDISCHARGE LABS:\\n___ 05:00AM BLOOD WBC-4.6 RBC-3.84* Hgb-10.5* Hct-33.1* \\nMCV-86 MCH-27.3 MCHC-31.7* RDW-14.2 RDWSD-45.3 Plt ___\\n___ 05:00AM BLOOD Glucose-225* UreaN-12 Creat-0.8 Na-144 \\nK-4.4 Cl-107 HCO3-28 AnGap-9*\\n___ 05:00AM BLOOD Plt ___\\n___ 05:00AM BLOOD Calcium-8.5 Phos-3.2 Mg-1.9\\n \\nBrief Hospital Course:\\nMr ___ is a ___ year old man with a history of IDDM2 \\n(uncontrolled), poorly differentiated gastric CA T2N0Mx s/p \\nsubtotal gastrectomy (___) admitted with fever and weakness.\\n\\n# Fever / Sepsis\\n# Weakness\\n# Hypotension (transiently): Admitted with high fevers (103 at \\nhome), hypotension, WBC 11.1. His only localizing symptoms on \\nadmission were a sore throat (with normal exam) and dysuria \\n(+pyuria, but UCx NGTD). CXR was normal. He was started on \\nceftriaxone for a presumed UTI but urine culture returned with \\nno growth. He was maintained on antibiotics until blood cultures \\nwere without growth for 3 days. CBC differential was notable for \\nmonocytosis on admission, suggesting a viral process. AT time of \\ndischarge, patient had been afebrile for 72 hours, blood \\ncultures were still without growth, patient was feeling \\nsubjectively much improved: tolerating regular diet, having more \\nengery and walking independently and steadily in the hallways. \\nAntibiotics were stopped and he was discharged to home with \\nintent to follow-up with his PCP. \\n\\n# IDDM2\\n# Hyperglycemia: Blood sugars were elevated during admission, \\nranging from 200-350. FSBS correlated well with patient's \\ncontinuous glucose monitor. He was maintained on home glargine \\ndosing, a diabetic diet and was kept on a sliding scale in favor \\nof his home correctional scale short acting. \\n\\n# Depression/Anxiety: Continued home citalopram and clonazepam\\n# Asthma/COPD: Continue home advair.\\n# HTN: Decreased home metoprolol to 12.5.\\n\\nTRANSITIONAL ISSUES\\n- Medication changes: metoprolol decreased to 12.5mg daily\\n\\nTime spent coordinating discharge > 30 minutes\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Aspirin 81 mg PO DAILY \\n2. Bethanechol 50 mg PO TID \\n3. calcium carbonate-vitamin D3 500 mg calcium- 400 unit/5 mL \\noral DAILY \\n4. Vitamin D 1000 UNIT PO DAILY \\n5. Citalopram 20 mg PO QHS \\n6. ClonazePAM 1 mg PO QAM \\n7. ClonazePAM 2 mg PO QHS \\n8. colestipol 1 gram oral BID \\n9. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \\n10. Gabapentin 600 mg PO TID \\n11. Glargine 11 Units Breakfast\\nGlargine 4 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n12. Loratadine 10 mg PO QAM \\n13. Metoprolol Succinate XL 25 mg PO DAILY \\n14. Omeprazole 20 mg PO DAILY \\n15. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \\nLine \\n16. Rosuvastatin Calcium 40 mg PO QPM \\n17. Tamsulosin 0.4 mg PO QHS \\n\\n \\nDischarge Medications:\\n1.  Metoprolol Succinate XL 12.5 mg PO DAILY \\nRX *metoprolol succinate 25 mg 0.5 (One half) tablet(s) by mouth \\nDAILY Disp #*14 Tablet Refills:*0 \\n2.  Glargine 11 Units Breakfast\\nGlargine 4 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin \\n3.  Aspirin 81 mg PO DAILY  \\n4.  Bethanechol 50 mg PO TID  \\n5.  calcium carbonate-vitamin D3 500 mg calcium- 400 unit/5 mL \\noral DAILY  \\n6.  Citalopram 20 mg PO QHS  \\n7.  ClonazePAM 1 mg PO QAM  \\n8.  ClonazePAM 2 mg PO QHS  \\n9.  colestipol 1 gram oral BID  \\n10.  Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID  \\n11.  Gabapentin 600 mg PO TID  \\n12.  Loratadine 10 mg PO QAM  \\n13.  Omeprazole 20 mg PO DAILY  \\n14.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \\nLine  \\n15.  Rosuvastatin Calcium 40 mg PO QPM  \\n16.  Tamsulosin 0.4 mg PO QHS  \\n17.  Vitamin D 1000 UNIT PO DAILY  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nFever\\nViral Infection\\nWeakness\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr ___,\\n\\nYou were admitted to the hospital because you had a fever and \\nfelt weak. Ther was concern that you had a bacterial infection \\nand you were treated with antibiotics. Your blood and urine work \\nindicated that you did not clearly have an infection and your \\nantibiotics were stopped. You did not have any further fevers \\nand with time, your weakness and energy improved. We believe \\nyour symptoms were likely due to a viral infection.\\n\\nPlease note that your metoprolol has been decreased to 12.5mg \\ndaily (from 25mg daily)\\n\\nYou will need to follow-up with your primary care doctor after \\nyou leave the hospital. \\n\\nPlease take all medications as prescribed and keep all scheduled \\ndoctor's appointments. Seek medical attention if you develop a \\nworsening or recurrence of the same symptoms that originally \\nbrought you to the hospital, experience any of the warning signs \\nlisted below, or have any other symptoms that concern you.\\n\\nIt was a pleasure taking care of you!\\nYour ___ Care Team\\n\\n \\nFollowup Instructions:\\n___\\n\"]"
            ]
          },
          "metadata": {},
          "execution_count": 3
        }
      ],
      "source": [
        "notes"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "metadata": {
        "id": "RXYvTeYk07zm"
      },
      "outputs": [],
      "source": [
        "# Here everything is done dont worry\n",
        "# replacement of None Values Exercise\n",
        "def replace_placeholders(text, placeholder=\"___\", replacement=\"None\"):\n",
        "    return text.replace(placeholder, replacement)\n",
        "\n",
        "# Extracting key information using regex\n",
        "def extract_information(text):\n",
        "    info = {}\n",
        "    patterns = {\n",
        "        \"Name\": r\"Name:\\s+(.*?)\\s+Unit No\",\n",
        "        \"Unit No\": r\"Unit No:\\s+(.*?)\\n\",\n",
        "        \"Admission Date\": r\"Admission Date:\\s+(.*?)\\s+Discharge Date\",\n",
        "        \"Discharge Date\": r\"Discharge Date:\\s+(.*?)\\n\",\n",
        "        \"Date of Birth\": r\"Date of Birth:\\s+(.*?)\\s+Sex\",\n",
        "        \"Sex\": r\"Sex:\\s+(\\w)\",\n",
        "        \"Service\": r\"Service:\\s+(.*?)\\n\",\n",
        "        \"Allergies\": r\"Allergies:\\s+(.*?)\\n\",\n",
        "        \"Chief Complaint\": r\"Chief Complaint:\\n(.*?)\\n\",\n",
        "        \"Major Surgical or Invasive Procedure\": r\"Major Surgical or Invasive Procedure:\\n(.*?)\\n\",\n",
        "        \"History of Present Illness\": r\"History of Present Illness:\\n(.*?)\\n\\n\",\n",
        "        \"Review of systems\": r\"Review of systems:\\s+(.*?)\\n\\n\",\n",
        "        \"Past Medical History\": r\"Past Medical History:\\n(.*?)\\n\\n\",\n",
        "        \"Social History\": r\"Social History:\\n(.*?)\\n\",\n",
        "        \"Family History\": r\"Family History:\\n(.*?)\\n\\n\",\n",
        "        \"Physical Exam\": r\"Physical Exam:\\n(.*?)\\n\\n\",\n",
        "        \"Brief Hospital Course\": r\"Brief Hospital Course:\\n(.*?)\\n\\n\",\n",
        "        \"Discharge Diagnosis\": r\"Discharge Diagnosis:\\n(.*?)\\n\\n\",\n",
        "        \"Discharge Condition\": r\"Discharge Condition:\\n(.*?)\\n\\n\",\n",
        "        \"Discharge Instructions\": r\"Discharge Instructions:\\n(.*?)\\n\\n\",\n",
        "    }\n",
        "\n",
        "    for key, pattern in patterns.items():\n",
        "        match = re.search(pattern, text, re.DOTALL)\n",
        "        info[key] = match.group(1).strip() if match else \"None\"\n",
        "\n",
        "    return info\n",
        "def structure_data(clinical_text):\n",
        "    # Replace placeholders in the clinical text\n",
        "    processed_text = replace_placeholders(clinical_text)\n",
        "\n",
        "    # Extract information into a dictionary\n",
        "    return extract_information(processed_text)\n",
        "\n",
        "structure_notes = [ structure_data(note) for note in notes]\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "h439_YNa07zn"
      },
      "source": [
        "# Null values treatment"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "metadata": {
        "id": "Vvj0SLZJ07zo",
        "outputId": "5753c146-874d-48de-a843-4eb78ec3d205",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 597
        }
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-5-6b87928251e2>:1: FutureWarning: Downcasting behavior in `replace` is deprecated and will be removed in a future version. To retain the old behavior, explicitly call `result.infer_objects(copy=False)`. To opt-in to the future behavior, set `pd.set_option('future.no_silent_downcasting', True)`\n",
            "  df = pd.DataFrame(structure_notes).replace('None',np.NaN)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "  Name  Unit No  Admission Date  Discharge Date  Date of Birth Sex  \\\n",
              "0  NaN      NaN             NaN             NaN            NaN   F   \n",
              "1  NaN      NaN             NaN             NaN            NaN   M   \n",
              "2  NaN      NaN             NaN             NaN            NaN   F   \n",
              "\n",
              "        Service                                    Allergies Chief Complaint  \\\n",
              "0      MEDICINE                                      Codeine    I feel shaky   \n",
              "1      MEDICINE                                      Demerol         Dyspnea   \n",
              "2  ORTHOPAEDICS  No Known Allergies / Adverse Drug Reactions        RLE pain   \n",
              "\n",
              "     Major Surgical or Invasive Procedure  \\\n",
              "0                                     NaN   \n",
              "1                            Bronchoscopy   \n",
              "2  Right short trochanteric fixation nail   \n",
              "\n",
              "                          History of Present Illness  \\\n",
              "0  Pt is a None year old woman who presents to ED...   \n",
              "1  This is an None yo M with history of mild deme...   \n",
              "2  None, blown over by gust of wind w/R ITFx now ...   \n",
              "\n",
              "                                   Review of systems  \\\n",
              "0  (+) Per HPI. Also notes recent weight gain whi...   \n",
              "1                                                NaN   \n",
              "2                                                NaN   \n",
              "\n",
              "                                Past Medical History  Social History  \\\n",
              "0  -IDDM c/b retinopathy\\n-HTN\\n-AFib, diagnosed ...             NaN   \n",
              "1  gastroesophageal reflux disease\\nhypercholeste...             NaN   \n",
              "2  MedHx:\\n-HTN\\n-Hypercholesterolemia\\n-Eczema\\n...             NaN   \n",
              "\n",
              "                                      Family History  \\\n",
              "0  - 6 children, one daughter died last year from...   \n",
              "1  strong family history of diabetes mellitus, an...   \n",
              "2  Mother deceased with HTN, CAD. Father deceased...   \n",
              "\n",
              "                                       Physical Exam  \\\n",
              "0  FEX ON ADMISSION\\nVitals: T: 98.4 BP: 176/96 P...   \n",
              "1  VS: T 98.6max, 97.3current, BP None, HR 79 RR ...   \n",
              "2                                                NaN   \n",
              "\n",
              "                               Brief Hospital Course  \\\n",
              "0  None year old woman with IDDM and AFib on coum...   \n",
              "1  None year old  male with complaints of dyspnea...   \n",
              "2  The patient presented to the emergency departm...   \n",
              "\n",
              "                                 Discharge Diagnosis  \\\n",
              "0  Lactic acidosis\\nHyperglycemia\\nUrinary tract ...   \n",
              "1            Lung mass\\nAcute renal failure\\nHypoxia   \n",
              "2             right intertrochanteric femur fracture   \n",
              "\n",
              "                                 Discharge Condition  \\\n",
              "0  Mental Status: Clear and coherent.\\nLevel of C...   \n",
              "1                    Stable, for home with services.   \n",
              "2                AAOx3, mentating appropriately, NVI   \n",
              "\n",
              "                              Discharge Instructions  \n",
              "0                                     Dear Ms. None,  \n",
              "1  You were admitted to the hospital because of y...  \n",
              "2  Weigh yourself every morning, call MD if weigh...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-bd254e4a-90f7-47dc-ab15-7f467202c139\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Name</th>\n",
              "      <th>Unit No</th>\n",
              "      <th>Admission Date</th>\n",
              "      <th>Discharge Date</th>\n",
              "      <th>Date of Birth</th>\n",
              "      <th>Sex</th>\n",
              "      <th>Service</th>\n",
              "      <th>Allergies</th>\n",
              "      <th>Chief Complaint</th>\n",
              "      <th>Major Surgical or Invasive Procedure</th>\n",
              "      <th>History of Present Illness</th>\n",
              "      <th>Review of systems</th>\n",
              "      <th>Past Medical History</th>\n",
              "      <th>Social History</th>\n",
              "      <th>Family History</th>\n",
              "      <th>Physical Exam</th>\n",
              "      <th>Brief Hospital Course</th>\n",
              "      <th>Discharge Diagnosis</th>\n",
              "      <th>Discharge Condition</th>\n",
              "      <th>Discharge Instructions</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>F</td>\n",
              "      <td>MEDICINE</td>\n",
              "      <td>Codeine</td>\n",
              "      <td>I feel shaky</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Pt is a None year old woman who presents to ED...</td>\n",
              "      <td>(+) Per HPI. Also notes recent weight gain whi...</td>\n",
              "      <td>-IDDM c/b retinopathy\\n-HTN\\n-AFib, diagnosed ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>- 6 children, one daughter died last year from...</td>\n",
              "      <td>FEX ON ADMISSION\\nVitals: T: 98.4 BP: 176/96 P...</td>\n",
              "      <td>None year old woman with IDDM and AFib on coum...</td>\n",
              "      <td>Lactic acidosis\\nHyperglycemia\\nUrinary tract ...</td>\n",
              "      <td>Mental Status: Clear and coherent.\\nLevel of C...</td>\n",
              "      <td>Dear Ms. None,</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>M</td>\n",
              "      <td>MEDICINE</td>\n",
              "      <td>Demerol</td>\n",
              "      <td>Dyspnea</td>\n",
              "      <td>Bronchoscopy</td>\n",
              "      <td>This is an None yo M with history of mild deme...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>gastroesophageal reflux disease\\nhypercholeste...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>strong family history of diabetes mellitus, an...</td>\n",
              "      <td>VS: T 98.6max, 97.3current, BP None, HR 79 RR ...</td>\n",
              "      <td>None year old  male with complaints of dyspnea...</td>\n",
              "      <td>Lung mass\\nAcute renal failure\\nHypoxia</td>\n",
              "      <td>Stable, for home with services.</td>\n",
              "      <td>You were admitted to the hospital because of y...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>F</td>\n",
              "      <td>ORTHOPAEDICS</td>\n",
              "      <td>No Known Allergies / Adverse Drug Reactions</td>\n",
              "      <td>RLE pain</td>\n",
              "      <td>Right short trochanteric fixation nail</td>\n",
              "      <td>None, blown over by gust of wind w/R ITFx now ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>MedHx:\\n-HTN\\n-Hypercholesterolemia\\n-Eczema\\n...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Mother deceased with HTN, CAD. Father deceased...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>The patient presented to the emergency departm...</td>\n",
              "      <td>right intertrochanteric femur fracture</td>\n",
              "      <td>AAOx3, mentating appropriately, NVI</td>\n",
              "      <td>Weigh yourself every morning, call MD if weigh...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bd254e4a-90f7-47dc-ab15-7f467202c139')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bd254e4a-90f7-47dc-ab15-7f467202c139 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bd254e4a-90f7-47dc-ab15-7f467202c139');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-12e60c5b-85e7-4003-9ef1-4079c322f596\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-12e60c5b-85e7-4003-9ef1-4079c322f596')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-12e60c5b-85e7-4003-9ef1-4079c322f596 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 15,\n  \"fields\": [\n    {\n      \"column\": \"Name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"None.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Unit No\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": null,\n        \"max\": null,\n        \"num_unique_values\": 0,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Admission Date\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": null,\n        \"max\": null,\n        \"num_unique_values\": 0,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Discharge Date\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": null,\n        \"max\": null,\n        \"num_unique_values\": 0,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Date of Birth\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": null,\n        \"max\": null,\n        \"num_unique_values\": 0,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Sex\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Service\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 5,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Allergies\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Chief Complaint\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 15,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Major Surgical or Invasive Procedure\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 10,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"History of Present Illness\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 15,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Review of systems\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Past Medical History\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Social History\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": null,\n        \"max\": null,\n        \"num_unique_values\": 0,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Family History\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Physical Exam\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Brief Hospital Course\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Discharge Diagnosis\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 15,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Discharge Condition\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 9,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Discharge Instructions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 12,\n        \"samples\": [],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 5
        }
      ],
      "source": [
        "df = pd.DataFrame(structure_notes).replace('None',np.NaN)\n",
        "df.head(3)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 6,
      "metadata": {
        "id": "ac321tN_07zo",
        "outputId": "2411008f-1368-4960-b9a8-5ebf8db3bea3",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 711
        }
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Name                                    14\n",
              "Unit No                                 15\n",
              "Admission Date                          15\n",
              "Discharge Date                          15\n",
              "Date of Birth                           15\n",
              "Sex                                      0\n",
              "Service                                  0\n",
              "Allergies                                0\n",
              "Chief Complaint                          0\n",
              "Major Surgical or Invasive Procedure     4\n",
              "History of Present Illness               0\n",
              "Review of systems                       14\n",
              "Past Medical History                     1\n",
              "Social History                          15\n",
              "Family History                           1\n",
              "Physical Exam                            1\n",
              "Brief Hospital Course                    1\n",
              "Discharge Diagnosis                      0\n",
              "Discharge Condition                      0\n",
              "Discharge Instructions                   0\n",
              "dtype: int64"
            ],
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>0</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>Name</th>\n",
              "      <td>14</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Unit No</th>\n",
              "      <td>15</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Admission Date</th>\n",
              "      <td>15</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Discharge Date</th>\n",
              "      <td>15</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Date of Birth</th>\n",
              "      <td>15</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Sex</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Service</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Allergies</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Chief Complaint</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Major Surgical or Invasive Procedure</th>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>History of Present Illness</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Review of systems</th>\n",
              "      <td>14</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Past Medical History</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Social History</th>\n",
              "      <td>15</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Family History</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Physical Exam</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Brief Hospital Course</th>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Discharge Diagnosis</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Discharge Condition</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>Discharge Instructions</th>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div><br><label><b>dtype:</b> int64</label>"
            ]
          },
          "metadata": {},
          "execution_count": 6
        }
      ],
      "source": [
        "df.isnull().sum()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "metadata": {
        "id": "Mfe-wksD07zp"
      },
      "outputs": [],
      "source": [
        "# Drop columns with nan values\n",
        "df_treated = df.dropna(axis=1)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "8gxx0P6S07zp"
      },
      "source": [
        "# Complete yourself"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "metadata": {
        "id": "O_4B5BGV07zp"
      },
      "outputs": [],
      "source": [
        "# Lets start building a corpus\n",
        "discharged_diagnosis = ' '.join(df_treated['Discharge Diagnosis'].to_list())"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "metadata": {
        "id": "dTXVjoWe07zp"
      },
      "outputs": [],
      "source": [
        "\n",
        "# Function to clean individual lines\n",
        "def clean_line(line):\n",
        "    # Remove HTML-like tags\n",
        "    line = re.sub(r'<.*?>', '', line)\n",
        "    # Remove unwanted characters (e.g., non-ASCII characters)\n",
        "    line = re.sub(r'[^\\x00-\\x7F]+', '', line)\n",
        "    # Strip leading/trailing whitespace\n",
        "    return line.strip()\n",
        "\n",
        "def speaking_text_cleaner(speaking_text):\n",
        "    # Process each line to clean it\n",
        "    cleaned_lines = []\n",
        "    for line in speaking_text.splitlines():\n",
        "        cleaned_line = clean_line(line)\n",
        "        if cleaned_line:  # Only add non-empty lines\n",
        "            cleaned_lines.append(cleaned_line)\n",
        "    return \"\\n\".join(cleaned_lines)\n",
        "\n",
        "cleaned_discharged_diagnosis = speaking_text_cleaner(discharged_diagnosis)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 10,
      "metadata": {
        "id": "-Iz1cDOA07zq"
      },
      "outputs": [],
      "source": [
        "def corpus_cleaner(cleaned_text,n_min = 4 ):\n",
        "    n_min = 4                                                           # Minimum number of characters.\n",
        "    corpus = []\n",
        "    lemmatizer = WordNetLemmatizer()\n",
        "\n",
        "    pre = re.sub(r'\\W', ' ', cleaned_text)                          # Substitute the non-alphanumerics character by space.\n",
        "                                        # Remove numbers.                                      # Exercise\n",
        "    pre = nltk.word_tokenize(pre)                                   # Tokenize into words.                                 # Exercise\n",
        "    pre = [x for x in pre if len(x) > n_min]                        # Minimum length.\n",
        "    pre = [x.lower() for x in pre]                                  # Convert into the lowercase.\n",
        "    pre = [x for x in pre if x not in stopwords.words('english')]   # Remove stopwords.\n",
        "    pre = [lemmatizer.lemmatize(x) for x in pre]                    # Lemmatize.\n",
        "    corpus += pre                                                   # Back to the corpus.\n",
        "    return corpus"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 11,
      "metadata": {
        "id": "G_VVodSV07zq"
      },
      "outputs": [],
      "source": [
        "corpus_clean  = corpus_cleaner( cleaned_discharged_diagnosis )"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "LK5UNH6O07zq"
      },
      "source": [
        "# Count the words"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "metadata": {
        "id": "V8QXCStK07zq",
        "outputId": "23c80599-78a8-40a3-800b-cdfe12acec73",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 550
        }
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<Axes: >"
            ]
          },
          "metadata": {},
          "execution_count": 17
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ],
      "source": [
        "from collections import Counter\n",
        "\n",
        "# choose words you want to remove\n",
        "remove_words = ['primary','secondary','going','diagnosis','right']\n",
        "treated_corpus = [x for x in corpus_clean if x not in remove_words]\n",
        "pd.Series(Counter(corpus_clean)).sort_values()[-50:].plot(kind='bar')"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "ebtZPCCP07zq"
      },
      "source": [
        "# Word Cloud"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 18,
      "metadata": {
        "id": "U207oD-807zq",
        "outputId": "0b5ec9e2-ff08-4aa8-b808-fb7c72dba8a2",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 424
        }
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x1000 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ],
      "source": [
        "a_long_sentence = ' '.join(corpus_clean)\n",
        "wc = WordCloud(background_color='white', max_words=70,colormap='gist_gray')                  # Customize the output.\n",
        "wc.generate(a_long_sentence)\n",
        "# wc.words_                                                          # Check for the top ranking words.\n",
        "plt.figure(figsize=(10,10))\n",
        "plt.imshow(wc, interpolation='bilinear')\n",
        "plt.axis(\"off\")                                    # Turn off the axes.\n",
        "#plt.savefig('clinical_notes.png',bbox_inches='tight')\n",
        "plt.show()"
      ]
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "base",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.11.5"
    },
    "colab": {
      "provenance": []
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}